{"subnetworks": [{"diseases": ["ATOPIC ECZEMA", "EOSINOPHILIC ESOPHAGITIS", "ASTHMA", "CENTRAL NERVOUS SYSTEM CANCER", "TUBERCULOSIS", "ULCERATIVE COLITIS", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "IDIOPATHIC PULMONARY FIBROSIS", "PANCREATIC CARCINOMA", "ALOPECIA AREATA", "CONGENITAL ISOLATED HYPERINSULINISM", "LIVER DISEASE", "PROSTATE CARCINOMA", "ALLERGIC RHINITIS", "SYSTEMIC SCLERODERMA", "CROHN'S DISEASE", "KELOID"], "links": [{"source": "ENSG00000077238", "target": "ENSG00000113520", "reverse": "rev-stimulatory"}, {"source": "ENSG00000077238", "type": "stimulatory", "target": "ENSG00000131724", "reverse": "rev-stimulatory"}, {"source": "ENSG00000077238", "type": "stimulatory", "target": "ENSG00000166888", "reverse": "rev-stimulatory"}, {"source": "ENSG00000077238", "target": "ENSG00000169194", "reverse": "rev-stimulatory"}, {"source": "ENSG00000107485", "type": "stimulatory", "target": "ENSG00000136634"}, {"source": "ENSG00000107485", "target": "ENSG00000166888", "reverse": "rev-stimulatory"}, {"source": "ENSG00000113520", "target": "ENSG00000123496"}, {"source": "ENSG00000113520", "type": "stimulatory", "target": "ENSG00000131724"}, {"source": "ENSG00000118520", "target": "ENSG00000166888", "reverse": "rev-stimulatory"}, {"source": "ENSG00000123496", "target": "ENSG00000169194", "reverse": "rev-stimulatory"}, {"source": "ENSG00000131724", "type": "stimulatory", "target": "ENSG00000166888"}, {"source": "ENSG00000131724", "target": "ENSG00000169194", "reverse": "rev-stimulatory"}, {"source": "ENSG00000134216", "target": "ENSG00000166888", "reverse": "rev-stimulatory"}], "drugs": [{"indications": [{"efo_term": "ASTHMA", "stage": 3}, {"efo_term": "ALOPECIA AREATA", "stage": 2}, {"efo_term": "CONGENITAL ISOLATED HYPERINSULINISM", "stage": 2}, {"efo_term": "ULCERATIVE COLITIS", "stage": 2}, {"efo_term": "IDIOPATHIC PULMONARY FIBROSIS", "stage": 2}, {"efo_term": "ATOPIC ECZEMA", "stage": 2}, {"efo_term": "PANCREATIC CARCINOMA", "stage": 1}, {"efo_term": "LIVER DISEASE", "stage": 1}, {"efo_term": "PROSTATE CARCINOMA", "stage": 1}], "max_phase": 3, "name": "TRALOKINUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743081", "mechanisms": ["Interleukin-13 inhibitor"], "genes": ["IL13"], "type": "Antibody", "diseases": ["ASTHMA", "PANCREATIC CARCINOMA", "ALOPECIA AREATA", "CONGENITAL ISOLATED HYPERINSULINISM", "LIVER DISEASE", "ULCERATIVE COLITIS", "IDIOPATHIC PULMONARY FIBROSIS", "PROSTATE CARCINOMA", "ATOPIC ECZEMA"]}, {"indications": [{"efo_term": "EOSINOPHILIC ESOPHAGITIS", "stage": 2}, {"efo_term": "ALLERGIC RHINITIS", "stage": 2}, {"efo_term": "SYSTEMIC SCLERODERMA", "stage": 2}, {"efo_term": "IDIOPATHIC PULMONARY FIBROSIS", "stage": 2}, {"efo_term": "CROHN'S DISEASE", "stage": 2}, {"efo_term": "KELOID", "stage": 2}, {"efo_term": "ASTHMA", "stage": 2}], "max_phase": 2, "name": "QAX-576", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109465", "mechanisms": ["Interleukin-13 inhibitor"], "genes": ["IL13"], "type": "Antibody", "diseases": ["EOSINOPHILIC ESOPHAGITIS", "ALLERGIC RHINITIS", "SYSTEMIC SCLERODERMA", "IDIOPATHIC PULMONARY FIBROSIS", "CROHN'S DISEASE", "KELOID", "ASTHMA"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 3}, {"efo_term": "ATOPIC ECZEMA", "stage": 2}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}, {"efo_term": "IDIOPATHIC PULMONARY FIBROSIS", "stage": 2}], "max_phase": 3, "name": "LEBRIKIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743035", "mechanisms": ["Interleukin-13 inhibitor"], "genes": ["IL13"], "type": "Antibody", "diseases": ["ASTHMA", "ATOPIC ECZEMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "IDIOPATHIC PULMONARY FIBROSIS"]}, {"indications": [{"efo_term": "ATOPIC ECZEMA", "stage": 4}, {"efo_term": "ASTHMA", "stage": 3}, {"efo_term": "EOSINOPHILIC ESOPHAGITIS", "stage": 2}], "max_phase": 4, "name": "DUPILUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108675", "mechanisms": ["Interleukin-4 receptor subunit alpha antagonist"], "genes": ["IL4R"], "type": "Antibody", "diseases": ["ATOPIC ECZEMA", "EOSINOPHILIC ESOPHAGITIS", "ASTHMA"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "ULCERATIVE COLITIS", "stage": 2}], "max_phase": 2, "name": "ANRUKINZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1742985", "mechanisms": ["Interleukin-13 inhibitor"], "genes": ["IL13"], "type": "Antibody", "diseases": ["ASTHMA", "ULCERATIVE COLITIS"]}, {"indications": [{"efo_term": "CENTRAL NERVOUS SYSTEM CANCER", "stage": 1}], "max_phase": 1, "name": "CINTREDEKIN BESUDOTOX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108583", "mechanisms": ["Interleukin-13 receptor subunit alpha-1, Interleukin-4 receptor subunit alpha binding agent", "Interleukin-13 receptor subunit alpha-2 binding agent"], "genes": ["IL4R", "IL13RA2", "IL13RA1"], "type": "Protein", "diseases": ["CENTRAL NERVOUS SYSTEM CANCER"]}, {"indications": [{"efo_term": "TUBERCULOSIS", "stage": 2}], "max_phase": 2, "name": "PASCOLIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108119", "mechanisms": ["Interleukin-4 inhibitor"], "genes": ["IL4"], "type": "Antibody", "diseases": ["TUBERCULOSIS"]}, {"indications": [], "max_phase": 2, "name": "SCH-708980", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109460", "mechanisms": ["Interleukin-10 inhibitor"], "genes": ["IL10"], "type": "Antibody", "diseases": []}], "heat": 0.41960095635877004, "nodes": [{"assoc": 1.0, "id": "ENSG00000077238", "label": "IL4R"}, {"assoc": 0.66563236779, "id": "ENSG00000107485", "label": "GATA3"}, {"assoc": 0.291806678628, "id": "ENSG00000113520", "label": "IL4"}, {"assoc": 0.0788740331693, "id": "ENSG00000118520", "label": "ARG1"}, {"assoc": 0.0527577688474, "id": "ENSG00000123496", "label": "IL13RA2"}, {"assoc": 0.125575144284, "id": "ENSG00000131724", "label": "IL13RA1"}, {"assoc": 0.101942708443, "id": "ENSG00000134216", "label": "CHIA"}, {"assoc": 0.259494605401, "id": "ENSG00000136634", "label": "IL10"}, {"assoc": 0.619926257025, "id": "ENSG00000166888", "label": "STAT6"}, {"assoc": 1.0, "id": "ENSG00000169194", "label": "IL13"}], "size": 10}, {"diseases": ["HYPOTENSION", "PAIN", "INGUINAL HERNIA", "OSTEOARTHRITIS", "BONE FRACTURE", "BREAST CARCINOMA", "INJURY", "PROSTATE CARCINOMA", "HALLUX VALGUS", "POST OPERATIVE NAUSEA AND VOMITING", "OSTEOARTHRITIS, HIP", "BREAST NEOPLASM", "CANCER", "CORONARY ARTERY DISEASE", "DILATED CARDIOMYOPATHY", "TYPE II DIABETES MELLITUS", "ATRIAL FIBRILLATION", "ACUTE CORONARY SYNDROME", "IRRITABLE BOWEL SYNDROME", "PROLONGED QT INTERVAL", "PULMONARY HYPERTENSION", "CARDIOVASCULAR DISEASE", "VASCULAR DISEASE", "ANGINA PECTORIS", "MYOCARDIAL ISCHEMIA", "DIASTOLIC HEART FAILURE", "PREGNANCY", "EPILEPSY", "SEIZURES", "OPTIC NEURITIS", "OSTEOARTHRITIS, KNEE", "PERIPHERAL NEUROPATHY", "SUDDEN CARDIAC ARREST", "SYSTEMIC SCLERODERMA", "CARCINOMA", "PREMATURE BIRTH", "URINARY TRACT INFECTION", "POST-OPERATIVE SIGN OR SYMPTOM", "CARPAL TUNNEL SYNDROME", "COUGH", "PRURITUS", "TINNITUS", "ANXIETY", "FIBROMYALGIA", "COCAINE DEPENDENCE", "DYSMENORRHEA", "NEUROPATHIC PAIN", "PARATHYROID DISEASE", "PREECLAMPSIA", "POSTMENOPAUSAL OSTEOPOROSIS", "PREMATURE EJACULATION", "TENDINOPATHY", "CARDIAC ARRHYTHMIA", "OBESITY", "UTERINE FIBROID", "AGE-RELATED MACULAR DEGENERATION", "FROZEN SHOULDER", "STROKE", "NUTRITIONAL DISORDER", "ARTHRITIS", "MYALGIA", "OVERACTIVE BLADDER", "CHRONIC INTERSTITIAL CYSTITIS", "PARTIAL EPILEPSY", "BIPOLAR DISORDER", "TRIGEMINAL NEURALGIA", "CATARACT", "FISH-EYE DISEASE", "MENTAL OR BEHAVIOURAL DISORDER", "MOOD DISORDER", "UNIPOLAR DEPRESSION", "NEUROFIBROMATOSIS TYPE 1", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "LENNOX-GASTAUT SYNDROME", "GENERALIZED TONIC-CLONIC SEIZURES", "DRUG DEPENDENCE", "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "POST-TRAUMATIC STRESS DISORDER", "ATAXIA", "AUTISM SPECTRUM DISORDER", "ALZHEIMERS DISEASE", "CUTANEOUS MELANOMA", "PROXIMAL SPINAL MUSCULAR ATROPHY", "AMYOTROPHIC LATERAL SCLEROSIS", "OBSESSIVE-COMPULSIVE DISORDER", "ALCOHOL DEPENDENCE", "PARKINSON'S DISEASE", "EATING DISORDER", "ESSENTIAL TREMOR", "NICOTINE DEPENDENCE", "MIGRAINE DISORDER", "NEUROPATHY", "DIABETIC NEUROPATHY", "MULTIPLE SCLEROSIS", "SCHIZOPHRENIA", "COMPLEX PARTIAL EPILEPSY", "ALCOHOL DRINKING", "CONGENITAL HEART DISEASE", "METAMPHETAMINE DEPENDENCE", "GAMBLING BEHAVIOUR", "SMOKING CESSATION", "MARIJUANA DEPENDENCE", "PRADER-WILLI SYNDROME", "CEREBRAL ISCHEMIA", "DYSURIA", "HIP FRACTURE"], "links": [{"source": "ENSG00000169432", "type": "manual", "target": "ENSG00000129682"}, {"source": "ENSG00000129682", "type": "manual", "target": "ENSG00000196876"}, {"source": "ENSG00000185313", "type": "manual", "target": "ENSG00000161958"}, {"source": "ENSG00000161958", "type": "manual", "target": "ENSG00000196876"}, {"source": "ENSG00000136531", "type": "manual", "target": "ENSG00000161958"}, {"source": "ENSG00000007314", "type": "manual", "target": "ENSG00000161958"}, {"source": "ENSG00000168356", "type": "manual", "target": "ENSG00000129682"}, {"source": "ENSG00000144285", "type": "manual", "target": "ENSG00000129682"}, {"source": "ENSG00000153253", "type": "manual", "target": "ENSG00000129682"}, {"source": "ENSG00000183873", "type": "manual", "target": "ENSG00000161958"}], "drugs": [{"indications": [{"efo_term": "PRURITUS", "stage": 4}, {"efo_term": "TENDINOPATHY", "stage": 4}, {"efo_term": "CARDIAC ARRHYTHMIA", "stage": 4}, {"efo_term": "FROZEN SHOULDER", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "ARTHRITIS", "stage": 4}, {"efo_term": "MYALGIA", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "PERIPHERAL NEUROPATHY", "stage": 3}, {"efo_term": "SUDDEN CARDIAC ARREST", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "CARPAL TUNNEL SYNDROME", "stage": 3}, {"efo_term": "COUGH", "stage": 3}, {"efo_term": "FIBROMYALGIA", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 3}, {"efo_term": "PARATHYROID DISEASE", "stage": 3}, {"efo_term": "PREECLAMPSIA", "stage": 3}, {"efo_term": "POSTMENOPAUSAL OSTEOPOROSIS", "stage": 3}, {"efo_term": "PREMATURE EJACULATION", "stage": 3}, {"efo_term": "OBESITY", "stage": 3}, {"efo_term": "NUTRITIONAL DISORDER", "stage": 3}, {"efo_term": "PREGNANCY", "stage": 3}, {"efo_term": "OVERACTIVE BLADDER", "stage": 3}, {"efo_term": "OSTEOARTHRITIS, KNEE", "stage": 2}, {"efo_term": "SYSTEMIC SCLERODERMA", "stage": 2}, {"efo_term": "CARCINOMA", "stage": 2}, {"efo_term": "URINARY TRACT INFECTION", "stage": 2}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "ANXIETY", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "DYSMENORRHEA", "stage": 2}, {"efo_term": "OSTEOARTHRITIS", "stage": 2}, {"efo_term": "UTERINE FIBROID", "stage": 2}, {"efo_term": "AGE-RELATED MACULAR DEGENERATION", "stage": 2}, {"efo_term": "STROKE", "stage": 2}, {"efo_term": "CHRONIC INTERSTITIAL CYSTITIS", "stage": 2}, {"efo_term": "PREMATURE BIRTH", "stage": 1}, {"efo_term": "POST-OPERATIVE SIGN OR SYMPTOM", "stage": 1}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 1}, {"efo_term": "TINNITUS", "stage": 0}], "max_phase": 4, "name": "LIDOCAINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL79", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["OSTEOARTHRITIS, KNEE", "PAIN", "PERIPHERAL NEUROPATHY", "SUDDEN CARDIAC ARREST", "SYSTEMIC SCLERODERMA", "CARCINOMA", "PREMATURE BIRTH", "URINARY TRACT INFECTION", "BREAST CARCINOMA", "POST-OPERATIVE SIGN OR SYMPTOM", "CANCER", "CARPAL TUNNEL SYNDROME", "COUGH", "PRURITUS", "TINNITUS", "ANXIETY", "FIBROMYALGIA", "COCAINE DEPENDENCE", "DYSMENORRHEA", "NEUROPATHIC PAIN", "PARATHYROID DISEASE", "PREECLAMPSIA", "OSTEOARTHRITIS", "POSTMENOPAUSAL OSTEOPOROSIS", "PREMATURE EJACULATION", "TENDINOPATHY", "CARDIAC ARRHYTHMIA", "OBESITY", "UTERINE FIBROID", "AGE-RELATED MACULAR DEGENERATION", "FROZEN SHOULDER", "PULMONARY HYPERTENSION", "STROKE", "NUTRITIONAL DISORDER", "ARTHRITIS", "MYALGIA", "PREGNANCY", "OVERACTIVE BLADDER", "CHRONIC INTERSTITIAL CYSTITIS"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "MIGRAINE DISORDER", "stage": 3}, {"efo_term": "OBESITY", "stage": 3}, {"efo_term": "SMOKING CESSATION", "stage": 3}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 3}, {"efo_term": "PRADER-WILLI SYNDROME", "stage": 3}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "ALCOHOL DRINKING", "stage": 2}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "METAMPHETAMINE DEPENDENCE", "stage": 2}, {"efo_term": "GAMBLING BEHAVIOUR", "stage": 2}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "CEREBRAL ISCHEMIA", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 1}, {"efo_term": "CONGENITAL HEART DISEASE", "stage": 1}], "max_phase": 4, "name": "TOPIRAMATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["COCAINE DEPENDENCE", "EPILEPSY", "ALCOHOL DRINKING", "BIPOLAR DISORDER", "MIGRAINE DISORDER", "ALCOHOL DEPENDENCE", "CONGENITAL HEART DISEASE", "METAMPHETAMINE DEPENDENCE", "GAMBLING BEHAVIOUR", "OBESITY", "SMOKING CESSATION", "NICOTINE DEPENDENCE", "MARIJUANA DEPENDENCE", "PRADER-WILLI SYNDROME", "CEREBRAL ISCHEMIA"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}, {"efo_term": "INGUINAL HERNIA", "stage": 3}, {"efo_term": "BONE FRACTURE", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "INJURY", "stage": 3}, {"efo_term": "HALLUX VALGUS", "stage": 3}, {"efo_term": "POST OPERATIVE NAUSEA AND VOMITING", "stage": 3}, {"efo_term": "BREAST NEOPLASM", "stage": 3}, {"efo_term": "CANCER", "stage": 3}, {"efo_term": "HYPOTENSION", "stage": 2}, {"efo_term": "OSTEOARTHRITIS", "stage": 2}, {"efo_term": "OSTEOARTHRITIS, HIP", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 1}], "max_phase": 4, "name": "BUPIVACAINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1098", "mechanisms": ["Sodium channel protein type IV alpha subunit blocker"], "genes": ["SCN4A"], "type": "Small molecule", "diseases": ["HYPOTENSION", "PAIN", "INGUINAL HERNIA", "OSTEOARTHRITIS", "BONE FRACTURE", "BREAST CARCINOMA", "INJURY", "PROSTATE CARCINOMA", "HALLUX VALGUS", "POST OPERATIVE NAUSEA AND VOMITING", "OSTEOARTHRITIS, HIP", "BREAST NEOPLASM", "CANCER"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "ANGINA PECTORIS", "stage": 4}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 3}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 3}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 3}, {"efo_term": "MYOCARDIAL ISCHEMIA", "stage": 3}, {"efo_term": "DILATED CARDIOMYOPATHY", "stage": 2}, {"efo_term": "ACUTE CORONARY SYNDROME", "stage": 2}, {"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 2}, {"efo_term": "PROLONGED QT INTERVAL", "stage": 2}, {"efo_term": "VASCULAR DISEASE", "stage": 2}, {"efo_term": "DIASTOLIC HEART FAILURE", "stage": 2}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 1}], "max_phase": 4, "name": "RANOLAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1404", "mechanisms": ["Sodium channel protein type IV alpha subunit blocker", "Sodium channel protein type V alpha subunit blocker"], "genes": ["SCN4A", "SCN5A"], "type": "Small molecule", "diseases": ["CORONARY ARTERY DISEASE", "DILATED CARDIOMYOPATHY", "TYPE II DIABETES MELLITUS", "ATRIAL FIBRILLATION", "ACUTE CORONARY SYNDROME", "IRRITABLE BOWEL SYNDROME", "PROLONGED QT INTERVAL", "PULMONARY HYPERTENSION", "CARDIOVASCULAR DISEASE", "VASCULAR DISEASE", "ANGINA PECTORIS", "MYOCARDIAL ISCHEMIA", "DIASTOLIC HEART FAILURE"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "SEIZURES", "stage": 4}, {"efo_term": "LENNOX-GASTAUT SYNDROME", "stage": 4}, {"efo_term": "GENERALIZED TONIC-CLONIC SEIZURES", "stage": 4}, {"efo_term": "PARTIAL EPILEPSY", "stage": 4}, {"efo_term": "MOOD DISORDER", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "NEUROFIBROMATOSIS TYPE 1", "stage": 2}, {"efo_term": "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "DRUG DEPENDENCE", "stage": 2}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}, {"efo_term": "MENTAL OR BEHAVIOURAL DISORDER", "stage": 1}], "max_phase": 4, "name": "LAMOTRIGINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL741", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "EPILEPSY", "FISH-EYE DISEASE", "MENTAL OR BEHAVIOURAL DISORDER", "MOOD DISORDER", "UNIPOLAR DEPRESSION", "NEUROFIBROMATOSIS TYPE 1", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "SEIZURES", "LENNOX-GASTAUT SYNDROME", "GENERALIZED TONIC-CLONIC SEIZURES", "PARTIAL EPILEPSY", "DRUG DEPENDENCE"]}, {"indications": [{"efo_term": "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "ATAXIA", "stage": 2}, {"efo_term": "AUTISM SPECTRUM DISORDER", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "CUTANEOUS MELANOMA", "stage": 2}, {"efo_term": "PROXIMAL SPINAL MUSCULAR ATROPHY", "stage": 2}, {"efo_term": "AMYOTROPHIC LATERAL SCLEROSIS", "stage": 2}, {"efo_term": "OBSESSIVE-COMPULSIVE DISORDER", "stage": 2}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 1}, {"efo_term": "CANCER", "stage": 1}], "max_phase": 4, "name": "RILUZOLE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL744", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "POST-TRAUMATIC STRESS DISORDER", "ATAXIA", "AUTISM SPECTRUM DISORDER", "BIPOLAR DISORDER", "UNIPOLAR DEPRESSION", "ALZHEIMERS DISEASE", "CUTANEOUS MELANOMA", "PROXIMAL SPINAL MUSCULAR ATROPHY", "AMYOTROPHIC LATERAL SCLEROSIS", "CANCER", "OBSESSIVE-COMPULSIVE DISORDER"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "SEIZURES", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "NEUROPATHY", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}, {"efo_term": "OSTEOARTHRITIS", "stage": 2}, {"efo_term": "MIGRAINE DISORDER", "stage": 2}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}, {"efo_term": "FIBROMYALGIA", "stage": 2}], "max_phase": 4, "name": "LACOSAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL58323", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "OSTEOARTHRITIS", "PARTIAL EPILEPSY", "MIGRAINE DISORDER", "NEUROPATHY", "NEUROPATHIC PAIN", "FIBROMYALGIA", "SEIZURES", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "COMPLEX PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}, {"efo_term": "FIBROMYALGIA", "stage": 2}, {"efo_term": "MIGRAINE DISORDER", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 2}], "max_phase": 4, "name": "ESLICARBAZEPINE ACETATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL87992", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "PARTIAL EPILEPSY", "FIBROMYALGIA", "MIGRAINE DISORDER", "BIPOLAR DISORDER", "COMPLEX PARTIAL EPILEPSY", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}, {"efo_term": "EATING DISORDER", "stage": 3}, {"efo_term": "SEIZURES", "stage": 3}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "ESSENTIAL TREMOR", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "ZONISAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL750", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["ALCOHOL DEPENDENCE", "EPILEPSY", "PARKINSON'S DISEASE", "EATING DISORDER", "ESSENTIAL TREMOR", "SEIZURES", "NICOTINE DEPENDENCE"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "SEIZURES", "stage": 2}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}], "max_phase": 4, "name": "OXCARBAZEPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1068", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "SEIZURES", "PARTIAL EPILEPSY", "MULTIPLE SCLEROSIS", "SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "SEIZURES", "stage": 4}, {"efo_term": "INJURY", "stage": 2}, {"efo_term": "OPTIC NEURITIS", "stage": 2}], "max_phase": 4, "name": "PHENYTOIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL16", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "SEIZURES", "INJURY", "OPTIC NEURITIS"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "PARTIAL EPILEPSY", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "TRIGEMINAL NEURALGIA", "stage": 4}], "max_phase": 4, "name": "CARBAMAZEPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL108", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "PARTIAL EPILEPSY", "BIPOLAR DISORDER", "TRIGEMINAL NEURALGIA"]}, {"indications": [{"efo_term": "PRURITUS", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "CATARACT", "stage": 3}, {"efo_term": "PAIN", "stage": 2}], "max_phase": 4, "name": "TETRACAINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL698", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["CATARACT", "PAIN", "PRURITUS"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "LENNOX-GASTAUT SYNDROME", "stage": 4}, {"efo_term": "SEIZURES", "stage": 3}, {"efo_term": "PAIN", "stage": 2}], "max_phase": 4, "name": "RUFINAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201754", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["SEIZURES", "EPILEPSY", "LENNOX-GASTAUT SYNDROME", "PAIN"]}, {"indications": [{"efo_term": "HIP FRACTURE", "stage": 2}, {"efo_term": "BONE FRACTURE", "stage": 2}, {"efo_term": "INGUINAL HERNIA", "stage": 1}, {"efo_term": "PAIN", "stage": 0}], "max_phase": 4, "name": "ROPIVACAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1889140", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["PAIN", "HIP FRACTURE", "INGUINAL HERNIA", "BONE FRACTURE"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}, {"efo_term": "INGUINAL HERNIA", "stage": 2}], "max_phase": 4, "name": "BUPIVACAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200396", "mechanisms": ["Sodium channel protein type IV alpha subunit blocker"], "genes": ["SCN4A"], "type": "Small molecule", "diseases": ["INGUINAL HERNIA", "PAIN"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "STROKE", "stage": 2}], "max_phase": 4, "name": "PRIMIDONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL856", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "STROKE"]}, {"indications": [{"efo_term": "PAIN", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 3, "name": "RALFINAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107771", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["PAIN", "NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "TRIGEMINAL NEURALGIA", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 1}], "max_phase": 2, "name": "RAXATRIGINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544913", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": ["TRIGEMINAL NEURALGIA", "BIPOLAR DISORDER"]}, {"indications": [{"efo_term": "PAIN", "stage": 2}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 2}], "max_phase": 2, "name": "PF-05089771", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545171", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": ["PAIN", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "PREGNANCY", "stage": 3}], "max_phase": 4, "name": "LEVOBUPIVACAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200749", "mechanisms": ["Sodium channel protein type IV alpha subunit blocker"], "genes": ["SCN4A"], "type": "Small molecule", "diseases": ["PREGNANCY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "MEPHENYTOIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL861", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "PHENACEMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL918", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "ESLICARBAZEPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL315985", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "ETHOTOIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1095", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "DYSURIA", "stage": 3}], "max_phase": 4, "name": "PHENAZOPYRIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201022", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["DYSURIA"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}], "max_phase": 4, "name": "ORPHENADRINE (CHLORIDE)", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201023", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "CARDIAC ARRHYTHMIA", "stage": 4}], "max_phase": 4, "name": "QUINIDINE POLYGALACTURONATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201486", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["CARDIAC ARRHYTHMIA"]}, {"indications": [{"efo_term": "ATRIAL FIBRILLATION", "stage": 4}], "max_phase": 4, "name": "DRONEDARONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201729", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["ATRIAL FIBRILLATION"]}, {"indications": [{"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}], "max_phase": 2, "name": "NERISPIRDINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107762", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["MULTIPLE SCLEROSIS"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 2}], "max_phase": 2, "name": "NW-3509", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545207", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "NEUROPATHIC PAIN", "stage": 1}], "max_phase": 1, "name": "AZD3161", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545208", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "ATRIAL FIBRILLATION", "stage": 2}], "max_phase": 2, "name": "AZD1305", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545169", "mechanisms": ["Sodium channel protein type V alpha subunit blocker"], "genes": ["SCN5A"], "type": "Small molecule", "diseases": ["ATRIAL FIBRILLATION"]}, {"indications": [{"efo_term": "PAIN", "stage": 2}], "max_phase": 2, "name": "PF-04531083", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544951", "mechanisms": ["Sodium channel protein type X alpha subunit blocker"], "genes": ["SCN10A"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [], "max_phase": 4, "name": "PROCAINAMIDE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL605", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "IRAMPANEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29741", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "FOSPHENYTOIN SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL919", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CHLOROPROCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL944", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PRILOCAINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1194", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENYTOIN SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1611", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROPOXYCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1769", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MORICIZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200334", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "INDECAINIDE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200341", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ORPHENADRINE CITRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200395", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LIDOCAINE HYDROCHLORIDE HYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200409", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "QUINIDINE GLUCONATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200437", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MEPIVACAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200440", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MERETHOXYLLINE PROCAINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200443", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROPARACAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200464", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DYCLONINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200478", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PRILOCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200586", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ETIDOCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200597", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MEXILETINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200606", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BENOXINATE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200654", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HEXYLCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200715", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TOCAINIDE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200773", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ARTICAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200819", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200841", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DISOPYRAMIDE PHOSPHATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201020", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROPAFENONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201063", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TETRACAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1255654", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "NKTR-171", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545209", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "QUINIDINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707183", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "ELPETRIGINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29919", "mechanisms": ["Sodium channel protein type II alpha subunit blocker", "Sodium channel protein type III alpha subunit blocker"], "genes": ["SCN2A", "SCN3A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "Afacifenacin", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545165", "mechanisms": ["Sodium channel protein type XI alpha subunit  blocker", "Sodium channel protein type X alpha subunit blocker"], "genes": ["SCN11A", "SCN10A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "DSP-2230", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545012", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker", "Sodium channel protein type X alpha subunit blocker"], "genes": ["SCN9A", "SCN10A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "XEN403", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545091", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "RG7893", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707353", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "RG6029", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707380", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIBUCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200612", "mechanisms": ["Sodium channel protein type V alpha subunit blocker", "Sodium channel protein type X alpha subunit blocker"], "genes": ["SCN5A", "SCN10A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "FLECAINIDE ACETATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200822", "mechanisms": ["Sodium channel protein type V alpha subunit blocker"], "genes": ["SCN5A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "AZD7009", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545040", "mechanisms": ["Sodium channel protein type V alpha subunit blocker"], "genes": ["SCN5A"], "type": "Small molecule", "diseases": []}], "heat": 0.8181818181818182, "nodes": [{"assoc": 1.0, "id": "ENSG00000007314", "label": "SCN4A"}, {"assoc": 1.0, "id": "ENSG00000136531", "label": "SCN2A"}, {"assoc": 1.0, "id": "ENSG00000144285", "label": "SCN1A"}, {"assoc": 1.0, "id": "ENSG00000153253", "label": "SCN3A"}, {"assoc": 1.0, "id": "ENSG00000168356", "label": "SCN11A"}, {"assoc": 1.0, "id": "ENSG00000169432", "label": "SCN9A"}, {"assoc": 1.0, "id": "ENSG00000183873", "label": "SCN5A"}, {"assoc": 1.0, "id": "ENSG00000185313", "label": "SCN10A"}, {"assoc": 1.0, "id": "ENSG00000196876", "label": "SCN8A"}, {"assoc": 0, "id": "ENSG00000129682", "label": "FGF13"}, {"assoc": 0, "id": "ENSG00000161958", "label": "FGF11"}], "size": 11}, {"diseases": ["INSOMNIA", "PAIN", "PRURITUS", "SCOLIOSIS", "SICKLE CELL ANEMIA", "TINNITUS", "EPILEPSY", "PROSTATE CARCINOMA", "ALCOHOL DEPENDENCE", "CARPAL TUNNEL SYNDROME", "NEUROPATHIC PAIN", "PREMATURE BIRTH", "FIBROMYALGIA", "LUMBAR DISC DEGENERATION", "NEOPLASM", "PARTIAL EPILEPSY", "CIRRHOSIS OF LIVER", "NICOTINE DEPENDENCE", "SPONTANEOUS ABORTION", "DRUG DEPENDENCE", "OPIOID DEPENDENCE", "VOMITING", "PSYCHOSIS", "DIABETIC NEUROPATHY", "NEUROPATHY", "RESTLESS LEGS SYNDROME", "SEIZURES", "ABNORMALITY OF REFRACTION", "GENERALIZED TONIC-CLONIC SEIZURES", "IRRITABLE BOWEL SYNDROME", "CHRONIC PANCREATITIS", "BONE FRACTURE", "DRY EYE SYNDROME", "SQUAMOUS CELL CARCINOMA", "COUGH", "GENICULATE HERPES ZOSTER", "OVERACTIVE BLADDER", "PREGNANCY", "MARIJUANA DEPENDENCE", "REFLEX SYMPATHETIC DYSTROPHY", "MIGRAINE DISORDER", "ANXIETY", "RENAL INSUFFICIENCY", "COGNITIVE IMPAIRMENT", "ALZHEIMERS DISEASE", "ESSENTIAL TREMOR", "PANIC DISORDER", "POST-TRAUMATIC STRESS DISORDER", "ALCOHOL WITHDRAWAL", "SUBARACHNOID HEMORRHAGE", "MOVEMENT DISORDER", "STROKE", "GLIOBLASTOMA MULTIFORME", "FEVER", "INFERTILITY", "CARDIOVASCULAR DISEASE", "BRAIN ANEURYSM", "ANAL FISSURE", "KIDNEY STONE", "PARKINSON'S DISEASE", "BIPOLAR DISORDER", "CONSTIPATION", "SKIN DISEASE", "ANGINA PECTORIS", "HYPERTENSION", "INTRACEREBRAL HEMORRHAGE", "CORONARY ARTERY DISEASE", "PROTEINURIA", "PRINZMETAL'S ANGINA", "MYOCARDIAL INFARCTION", "ATRIAL FIBRILLATION"], "links": [{"source": "ENSG00000067191", "target": "ENSG00000141837", "reverse": "rev-directed"}, {"source": "ENSG00000141837", "type": "directed", "target": "ENSG00000165995"}, {"source": "ENSG00000141837", "type": "directed", "target": "ENSG00000167535"}, {"source": "ENSG00000141837", "type": "directed", "target": "ENSG00000182389"}, {"source": "ENSG00000148408", "type": "directed", "target": "ENSG00000165995", "reverse": "rev-directed"}, {"source": "ENSG00000148408", "type": "directed", "target": "ENSG00000167535"}, {"source": "ENSG00000151067", "type": "directed", "target": "ENSG00000167535"}], "drugs": [{"indications": [{"efo_term": "FIBROMYALGIA", "stage": 4}, {"efo_term": "SEIZURES", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "NEUROPATHIC PAIN", "stage": 4}, {"efo_term": "NEUROPATHY", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "RESTLESS LEGS SYNDROME", "stage": 3}, {"efo_term": "GENERALIZED TONIC-CLONIC SEIZURES", "stage": 3}, {"efo_term": "LUMBAR DISC DEGENERATION", "stage": 3}, {"efo_term": "BONE FRACTURE", "stage": 3}, {"efo_term": "CIRRHOSIS OF LIVER", "stage": 3}, {"efo_term": "GENICULATE HERPES ZOSTER", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 2}, {"efo_term": "CHRONIC PANCREATITIS", "stage": 2}, {"efo_term": "DRY EYE SYNDROME", "stage": 2}, {"efo_term": "OVERACTIVE BLADDER", "stage": 2}, {"efo_term": "REFLEX SYMPATHETIC DYSTROPHY", "stage": 2}, {"efo_term": "ABNORMALITY OF REFRACTION", "stage": 1}, {"efo_term": "SQUAMOUS CELL CARCINOMA", "stage": 1}, {"efo_term": "COUGH", "stage": 1}, {"efo_term": "PREGNANCY", "stage": 1}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 0}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 0}], "max_phase": 4, "name": "PREGABALIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1059", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNB1", "CACNA1A", "CACNA1B", "CACNA1C", "CACNB2", "CACNB3", "CACNB4"], "type": "Small molecule", "diseases": ["FIBROMYALGIA", "NEUROPATHY", "PAIN", "PARTIAL EPILEPSY", "RESTLESS LEGS SYNDROME", "SEIZURES", "ABNORMALITY OF REFRACTION", "ALCOHOL DEPENDENCE", "EPILEPSY", "GENERALIZED TONIC-CLONIC SEIZURES", "IRRITABLE BOWEL SYNDROME", "NEUROPATHIC PAIN", "LUMBAR DISC DEGENERATION", "CHRONIC PANCREATITIS", "NICOTINE DEPENDENCE", "BONE FRACTURE", "DRY EYE SYNDROME", "SQUAMOUS CELL CARCINOMA", "CIRRHOSIS OF LIVER", "COUGH", "GENICULATE HERPES ZOSTER", "DIABETIC NEUROPATHY", "OVERACTIVE BLADDER", "PREGNANCY", "MARIJUANA DEPENDENCE", "REFLEX SYMPATHETIC DYSTROPHY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "INSOMNIA", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "SCOLIOSIS", "stage": 3}, {"efo_term": "CARPAL TUNNEL SYNDROME", "stage": 3}, {"efo_term": "FIBROMYALGIA", "stage": 3}, {"efo_term": "LUMBAR DISC DEGENERATION", "stage": 3}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "CIRRHOSIS OF LIVER", "stage": 3}, {"efo_term": "VOMITING", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}, {"efo_term": "SICKLE CELL ANEMIA", "stage": 2}, {"efo_term": "TINNITUS", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 2}, {"efo_term": "SPONTANEOUS ABORTION", "stage": 2}, {"efo_term": "OPIOID DEPENDENCE", "stage": 2}, {"efo_term": "PRURITUS", "stage": 1}, {"efo_term": "NEUROPATHIC PAIN", "stage": 1}, {"efo_term": "PREMATURE BIRTH", "stage": 1}, {"efo_term": "DRUG DEPENDENCE", "stage": 1}, {"efo_term": "PSYCHOSIS", "stage": 1}], "max_phase": 4, "name": "GABAPENTIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL940", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNB1", "CACNA1A", "CACNA1B", "CACNA1C", "CACNB2", "CACNB3", "CACNB4"], "type": "Small molecule", "diseases": ["INSOMNIA", "PAIN", "PRURITUS", "SCOLIOSIS", "SICKLE CELL ANEMIA", "TINNITUS", "EPILEPSY", "PROSTATE CARCINOMA", "ALCOHOL DEPENDENCE", "CARPAL TUNNEL SYNDROME", "NEUROPATHIC PAIN", "PREMATURE BIRTH", "FIBROMYALGIA", "LUMBAR DISC DEGENERATION", "NEOPLASM", "PARTIAL EPILEPSY", "CIRRHOSIS OF LIVER", "NICOTINE DEPENDENCE", "SPONTANEOUS ABORTION", "DRUG DEPENDENCE", "OPIOID DEPENDENCE", "VOMITING", "PSYCHOSIS", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "SEIZURES", "stage": 4}, {"efo_term": "PANIC DISORDER", "stage": 3}, {"efo_term": "ALCOHOL WITHDRAWAL", "stage": 3}, {"efo_term": "SUBARACHNOID HEMORRHAGE", "stage": 3}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}, {"efo_term": "MOVEMENT DISORDER", "stage": 3}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "COGNITIVE IMPAIRMENT", "stage": 2}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "GLIOBLASTOMA MULTIFORME", "stage": 2}, {"efo_term": "ESSENTIAL TREMOR", "stage": 1}, {"efo_term": "STROKE", "stage": 1}], "max_phase": 4, "name": "LEVETIRACETAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1286", "mechanisms": ["Voltage-gated N-type calcium channel alpha-1B subunit blocker"], "genes": ["CACNA1B"], "type": "Small molecule", "diseases": ["EPILEPSY", "SEIZURES", "COGNITIVE IMPAIRMENT", "ALZHEIMERS DISEASE", "ESSENTIAL TREMOR", "PANIC DISORDER", "POST-TRAUMATIC STRESS DISORDER", "ALCOHOL WITHDRAWAL", "SUBARACHNOID HEMORRHAGE", "ALCOHOL DEPENDENCE", "MOVEMENT DISORDER", "PARTIAL EPILEPSY", "STROKE", "GLIOBLASTOMA MULTIFORME"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 4}, {"efo_term": "ANGINA PECTORIS", "stage": 4}, {"efo_term": "PRINZMETAL'S ANGINA", "stage": 4}, {"efo_term": "ANGINA PECTORIS", "stage": 4}, {"efo_term": "MYOCARDIAL INFARCTION", "stage": 4}, {"efo_term": "STROKE", "stage": 4}, {"efo_term": "PROTEINURIA", "stage": 3}], "max_phase": 4, "name": "AMLODIPINE BESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200402", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": ["HYPERTENSION", "CORONARY ARTERY DISEASE", "PROTEINURIA", "ANGINA PECTORIS", "PRINZMETAL'S ANGINA", "MYOCARDIAL INFARCTION", "STROKE"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "SUBARACHNOID HEMORRHAGE", "stage": 3}, {"efo_term": "INFERTILITY", "stage": 2}, {"efo_term": "STROKE", "stage": 2}, {"efo_term": "BRAIN ANEURYSM", "stage": 1}], "max_phase": 4, "name": "NIMODIPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1428", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": ["INFERTILITY", "CARDIOVASCULAR DISEASE", "BRAIN ANEURYSM", "STROKE", "SUBARACHNOID HEMORRHAGE"]}, {"indications": [{"efo_term": "RESTLESS LEGS SYNDROME", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "MIGRAINE DISORDER", "stage": 2}], "max_phase": 4, "name": "GABAPENTIN ENACARBIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1628502", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNB1", "CACNA1A", "CACNA1B", "CACNA1C", "CACNB2", "CACNB3", "CACNB4"], "type": "Small molecule", "diseases": ["RESTLESS LEGS SYNDROME", "EPILEPSY", "ALCOHOL DEPENDENCE", "MIGRAINE DISORDER"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "PREMATURE BIRTH", "stage": 3}, {"efo_term": "KIDNEY STONE", "stage": 3}, {"efo_term": "ANAL FISSURE", "stage": 2}], "max_phase": 4, "name": "NIFEDIPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": ["ANAL FISSURE", "PREMATURE BIRTH", "KIDNEY STONE", "CARDIOVASCULAR DISEASE"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "BIPOLAR DISORDER", "stage": 2}, {"efo_term": "OPIOID DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "ISRADIPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1648", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "BIPOLAR DISORDER", "CARDIOVASCULAR DISEASE", "OPIOID DEPENDENCE"]}, {"indications": [{"efo_term": "ANGINA PECTORIS", "stage": 4}, {"efo_term": "ANAL FISSURE", "stage": 3}, {"efo_term": "CONSTIPATION", "stage": 1}, {"efo_term": "SKIN DISEASE", "stage": 1}], "max_phase": 4, "name": "DILTIAZEM HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1697", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": ["CONSTIPATION", "ANAL FISSURE", "SKIN DISEASE", "ANGINA PECTORIS"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 3}, {"efo_term": "SCOLIOSIS", "stage": 2}], "max_phase": 4, "name": "CLEVIDIPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237132", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": ["HYPERTENSION", "SCOLIOSIS", "CARDIOVASCULAR DISEASE"]}, {"indications": [{"efo_term": "ANXIETY", "stage": 3}, {"efo_term": "RENAL INSUFFICIENCY", "stage": 1}], "max_phase": 3, "name": "IMAGABALIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103836", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNB1", "CACNA1A", "CACNA1B", "CACNA1C", "CACNB2", "CACNB3", "CACNB4"], "type": "Small molecule", "diseases": ["ANXIETY", "RENAL INSUFFICIENCY"]}, {"indications": [{"efo_term": "FEVER", "stage": 4}, {"efo_term": "PAIN", "stage": 4}], "max_phase": 4, "name": "ZICONOTIDE ACETATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1795072", "mechanisms": ["Voltage-gated N-type calcium channel alpha-1B subunit blocker"], "genes": ["CACNA1B"], "type": "Protein", "diseases": ["FEVER", "PAIN"]}, {"indications": [{"efo_term": "PAIN", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 3, "name": "RALFINAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107771", "mechanisms": ["Voltage-gated N-type calcium channel alpha-1B subunit blocker"], "genes": ["CACNA1B"], "type": "Small molecule", "diseases": ["PAIN", "NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "INTRACEREBRAL HEMORRHAGE", "stage": 3}], "max_phase": 4, "name": "NICARDIPINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200326", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": ["HYPERTENSION", "INTRACEREBRAL HEMORRHAGE"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 2}], "max_phase": 2, "name": "ATAGABALIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL593430", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNB1", "CACNA1A", "CACNA1B", "CACNA1C", "CACNB2", "CACNB3", "CACNB4"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [{"efo_term": "DIABETIC NEUROPATHY", "stage": 2}], "max_phase": 2, "name": "CNV2197944", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545172", "mechanisms": ["Voltage-gated N-type calcium channel alpha-1B subunit blocker"], "genes": ["CACNA1B"], "type": "Small molecule", "diseases": ["DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}], "max_phase": 4, "name": "FELODIPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1480", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": ["CARDIOVASCULAR DISEASE"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}], "max_phase": 4, "name": "NISOLDIPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1726", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": ["CARDIOVASCULAR DISEASE"]}, {"indications": [{"efo_term": "ATRIAL FIBRILLATION", "stage": 4}], "max_phase": 4, "name": "DRONEDARONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201729", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": ["ATRIAL FIBRILLATION"]}, {"indications": [{"efo_term": "ATRIAL FIBRILLATION", "stage": 2}], "max_phase": 2, "name": "AZD1305", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545169", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": ["ATRIAL FIBRILLATION"]}, {"indications": [], "max_phase": 4, "name": "BEPRIDIL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200382", "mechanisms": ["Voltage-gated calcium channel blocker"], "genes": ["CACNB1", "CACNA1A", "CACNA1B", "CACNA1C", "CACNB2", "CACNB3", "CACNB4"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "ELPETRIGINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29919", "mechanisms": ["Voltage-gated P/Q-type calcium channel alpha-1A subunit blocker", "Voltage-gated N-type calcium channel alpha-1B subunit blocker", "Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1A", "CACNA1B", "CACNA1C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "Z160", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL604710", "mechanisms": ["Voltage-gated N-type calcium channel alpha-1B subunit blocker"], "genes": ["CACNA1B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "VERAPAMIL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1280", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DILTIAZEM MALATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200805", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "AMLODIPINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200984", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": []}], "heat": 1.0, "nodes": [{"assoc": 1.0, "id": "ENSG00000067191", "label": "CACNB1"}, {"assoc": 1.0, "id": "ENSG00000141837", "label": "CACNA1A"}, {"assoc": 1.0, "id": "ENSG00000148408", "label": "CACNA1B"}, {"assoc": 1.0, "id": "ENSG00000151067", "label": "CACNA1C"}, {"assoc": 1.0, "id": "ENSG00000165995", "label": "CACNB2"}, {"assoc": 1.0, "id": "ENSG00000167535", "label": "CACNB3"}, {"assoc": 1.0, "id": "ENSG00000182389", "label": "CACNB4"}], "size": 7}, {"diseases": ["PSORIASIS", "RHEUMATOID ARTHRITIS", "MULTIPLE SCLEROSIS", "ACNE", "PERIODONTITIS", "BLEPHARITIS", "COLORECTAL ADENOCARCINOMA", "DIABETIC RETINOPATHY", "URETHRITIS", "HEMORRHAGE", "NEOPLASM OF MATURE B-CELLS", "ALZHEIMERS DISEASE", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "PAIN", "PLEURAL EFFUSION", "ABDOMINAL AORTIC ANEURYSM", "MARFAN SYNDROME", "PRIMARY SYSTEMIC AMYLOIDOSIS", "DRY EYE SYNDROME", "SEPTICEMIC PLAGUE", "POLYCYSTIC OVARY SYNDROME", "MYOCARDIAL INFARCTION", "PANCREATIC CARCINOMA", "SEIZURES", "DIABETIC FOOT", "AGE-RELATED MACULAR DEGENERATION", "TUBERCULOSIS"], "links": [{"source": "ENSG00000049130", "target": "ENSG00000090554"}, {"source": "ENSG00000049130", "target": "ENSG00000092009"}, {"source": "ENSG00000049130", "target": "ENSG00000105472"}, {"source": "ENSG00000049130", "target": "ENSG00000164400", "reverse": "rev-directed"}, {"source": "ENSG00000092009", "type": "directed", "target": "ENSG00000196611"}], "drugs": [{"indications": [{"efo_term": "PERIODONTITIS", "stage": 3}, {"efo_term": "URETHRITIS", "stage": 3}, {"efo_term": "HEMORRHAGE", "stage": 3}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 3}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 3}, {"efo_term": "PLEURAL EFFUSION", "stage": 3}, {"efo_term": "POLYCYSTIC OVARY SYNDROME", "stage": 3}, {"efo_term": "BLEPHARITIS", "stage": 2}, {"efo_term": "COLORECTAL ADENOCARCINOMA", "stage": 2}, {"efo_term": "ACNE", "stage": 2}, {"efo_term": "DIABETIC RETINOPATHY", "stage": 2}, {"efo_term": "NEOPLASM OF MATURE B-CELLS", "stage": 2}, {"efo_term": "PAIN", "stage": 2}, {"efo_term": "ABDOMINAL AORTIC ANEURYSM", "stage": 2}, {"efo_term": "MARFAN SYNDROME", "stage": 2}, {"efo_term": "PRIMARY SYSTEMIC AMYLOIDOSIS", "stage": 2}, {"efo_term": "DRY EYE SYNDROME", "stage": 2}, {"efo_term": "SEPTICEMIC PLAGUE", "stage": 2}, {"efo_term": "MYOCARDIAL INFARCTION", "stage": 2}, {"efo_term": "PANCREATIC CARCINOMA", "stage": 2}, {"efo_term": "SEIZURES", "stage": 2}, {"efo_term": "DIABETIC FOOT", "stage": 2}, {"efo_term": "AGE-RELATED MACULAR DEGENERATION", "stage": 2}, {"efo_term": "TUBERCULOSIS", "stage": 2}], "max_phase": 4, "name": "DOXYCYCLINE HYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200699", "mechanisms": ["Matrix metalloproteinase-1 inhibitor"], "genes": ["MMP1"], "type": "Small molecule", "diseases": ["BLEPHARITIS", "COLORECTAL ADENOCARCINOMA", "PERIODONTITIS", "ACNE", "DIABETIC RETINOPATHY", "URETHRITIS", "HEMORRHAGE", "NEOPLASM OF MATURE B-CELLS", "ALZHEIMERS DISEASE", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "PAIN", "PLEURAL EFFUSION", "ABDOMINAL AORTIC ANEURYSM", "MARFAN SYNDROME", "PRIMARY SYSTEMIC AMYLOIDOSIS", "DRY EYE SYNDROME", "SEPTICEMIC PLAGUE", "POLYCYSTIC OVARY SYNDROME", "MYOCARDIAL INFARCTION", "PANCREATIC CARCINOMA", "SEIZURES", "DIABETIC FOOT", "AGE-RELATED MACULAR DEGENERATION", "TUBERCULOSIS"]}, {"indications": [{"efo_term": "PSORIASIS", "stage": 2}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 1}], "max_phase": 2, "name": "NAMILUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743044", "mechanisms": ["Granulocyte-macrophage colony-stimulating factor inhibitor"], "genes": ["CSF2"], "type": "Antibody", "diseases": ["PSORIASIS", "RHEUMATOID ARTHRITIS"]}, {"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 1}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 1}], "max_phase": 2, "name": "MOR-103", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109433", "mechanisms": ["Granulocyte-macrophage colony-stimulating factor inhibitor"], "genes": ["CSF2"], "type": "Antibody", "diseases": ["RHEUMATOID ARTHRITIS", "MULTIPLE SCLEROSIS"]}, {"indications": [{"efo_term": "ACNE", "stage": 4}, {"efo_term": "PERIODONTITIS", "stage": 3}], "max_phase": 4, "name": "DOXYCYCLINE HYCLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200567", "mechanisms": ["Matrix metalloproteinase-1 inhibitor"], "genes": ["MMP1"], "type": "Small molecule", "diseases": ["ACNE", "PERIODONTITIS"]}, {"indications": [], "max_phase": 2, "name": "KB-003", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109431", "mechanisms": ["Granulocyte-macrophage colony-stimulating factor inhibitor"], "genes": ["CSF2"], "type": "Antibody", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DOXYCYCLINE CALCIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2364574", "mechanisms": ["Matrix metalloproteinase-1 inhibitor"], "genes": ["MMP1"], "type": "Small molecule", "diseases": []}], "heat": 0.14424727427678333, "nodes": [{"assoc": 0.269599238456, "id": "ENSG00000049130", "label": "KITLG"}, {"assoc": 0.03860717, "id": "ENSG00000090554", "label": "FLT3LG"}, {"assoc": 0.0872742394077, "id": "ENSG00000092009", "label": "CMA1"}, {"assoc": 0.020488, "id": "ENSG00000105472", "label": "CLEC11A"}, {"assoc": 0.240263617643, "id": "ENSG00000164400", "label": "CSF2"}, {"assoc": 0.209251380154, "id": "ENSG00000196611", "label": "MMP1"}], "size": 6}, {"diseases": ["PARKINSON'S DISEASE", "LIVER DISEASE", "DRUG DEPENDENCE", "CORONARY ARTERY DISEASE", "SICKLE CELL ANEMIA", "CORONARY HEART DISEASE", "CARDIOVASCULAR DISEASE", "MYOCARDIAL ISCHEMIA", "DIABETIC FOOT", "COCAINE DEPENDENCE", "HUNTINGTON DISEASE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "NEUROPATHIC PAIN", "NON-SMALL CELL LUNG CARCINOMA", "BILIARY ATRESIA", "DUCHENNE MUSCULAR DYSTROPHY", "CUTANEOUS LEISHMANIASIS", "ENDOMETRIOSIS", "NECROTIZING ENTEROCOLITIS", "PATENT DUCTUS ARTERIOSUS", "HEPATITIS, ALCOHOLIC", "ACUTE KIDNEY INJURY", "HEPATIC STEATOSIS", "PAIN", "NEOPLASM", "MYOCARDIAL INFARCTION", "ACUTE MYELOID LEUKEMIA", "CHRONIC LYMPHOCYTIC LEUKEMIA", "ATRIAL FIBRILLATION", "CARDIOMYOPATHY", "WOLFF-PARKINSON-WHITE SYNDROME", "CORONARY STENOSIS", "ANGINA PECTORIS", "DYSPNEA", "MIGRAINE DISORDER", "AMBLYOPIA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "OBSTRUCTIVE LUNG DISEASE", "ASTHMA", "PREMATURE BIRTH", "CHRONIC KIDNEY DISEASE", "RETINOPATHY OF PREMATURITY", "BLADDER CARCINOMA", "PULMONARY HYPERTENSION", "EMPHYSEMA", "ALTITUDE SICKNESS", "CHRONIC BRONCHITIS", "HEART FAILURE", "CONGESTIVE HEART FAILURE", "OCULAR HYPERTENSION", "CANCER", "ACUTE GRAFT VS. HOST DISEASE", "DIABETES MELLITUS", "TYPE II DIABETES MELLITUS", "ABNORMAL GLUCOSE TOLERANCE", "TYPE I DIABETES MELLITUS", "GESTATIONAL DIABETES", "SCHIZOPHRENIA", "RENAL INSUFFICIENCY"], "links": [{"source": "ENSG00000128271", "target": "ENSG00000163485"}, {"source": "ENSG00000163485", "target": "ENSG00000196839"}, {"source": "ENSG00000169248", "target": "ENSG00000197635", "reverse": "rev-stimulatory"}, {"source": "ENSG00000196839", "target": "ENSG00000197635", "reverse": "rev-inhibitory"}, {"source": "ENSG00000197635", "target": "ENSG00000276085"}], "drugs": [{"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "WOLFF-PARKINSON-WHITE SYNDROME", "stage": 4}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 3}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 3}, {"efo_term": "CORONARY STENOSIS", "stage": 3}, {"efo_term": "ANGINA PECTORIS", "stage": 3}, {"efo_term": "PAIN", "stage": 2}, {"efo_term": "MYOCARDIAL INFARCTION", "stage": 2}, {"efo_term": "CARDIOMYOPATHY", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 1}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 1}, {"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 1}], "max_phase": 4, "name": "ADENOSINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477", "mechanisms": ["Adenosine receptor agonist"], "genes": ["ADORA2A", "ADORA1"], "type": "Small molecule", "diseases": ["CORONARY ARTERY DISEASE", "PAIN", "NEOPLASM", "MYOCARDIAL INFARCTION", "CARDIOVASCULAR DISEASE", "ACUTE MYELOID LEUKEMIA", "CHRONIC LYMPHOCYTIC LEUKEMIA", "ATRIAL FIBRILLATION", "CARDIOMYOPATHY", "WOLFF-PARKINSON-WHITE SYNDROME", "CORONARY STENOSIS", "ANGINA PECTORIS"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "ENDOMETRIOSIS", "stage": 3}, {"efo_term": "HEPATITIS, ALCOHOLIC", "stage": 3}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "BILIARY ATRESIA", "stage": 2}, {"efo_term": "CUTANEOUS LEISHMANIASIS", "stage": 2}, {"efo_term": "NECROTIZING ENTEROCOLITIS", "stage": 2}, {"efo_term": "PATENT DUCTUS ARTERIOSUS", "stage": 2}, {"efo_term": "ACUTE KIDNEY INJURY", "stage": 2}, {"efo_term": "HEPATIC STEATOSIS", "stage": 2}, {"efo_term": "DUCHENNE MUSCULAR DYSTROPHY", "stage": 1}], "max_phase": 4, "name": "PENTOXIFYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL628", "mechanisms": ["Adenosine A2 receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["NON-SMALL CELL LUNG CARCINOMA", "BILIARY ATRESIA", "DUCHENNE MUSCULAR DYSTROPHY", "CUTANEOUS LEISHMANIASIS", "ENDOMETRIOSIS", "NECROTIZING ENTEROCOLITIS", "PATENT DUCTUS ARTERIOSUS", "CARDIOVASCULAR DISEASE", "HEPATITIS, ALCOHOLIC", "ACUTE KIDNEY INJURY", "HEPATIC STEATOSIS"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 3}, {"efo_term": "MIGRAINE DISORDER", "stage": 3}, {"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 3}, {"efo_term": "DYSPNEA", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "AMBLYOPIA", "stage": 1}, {"efo_term": "PAIN", "stage": 1}], "max_phase": 4, "name": "CAFFEINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL113", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A", "ADORA1"], "type": "Small molecule", "diseases": ["CORONARY ARTERY DISEASE", "DYSPNEA", "MIGRAINE DISORDER", "PARKINSON'S DISEASE", "ATRIAL FIBRILLATION", "COCAINE DEPENDENCE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "AMBLYOPIA", "PAIN"]}, {"indications": [{"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}, {"efo_term": "CHRONIC BRONCHITIS", "stage": 4}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 1}, {"efo_term": "ALTITUDE SICKNESS", "stage": 1}, {"efo_term": "BLADDER CARCINOMA", "stage": 0}], "max_phase": 4, "name": "AMINOPHYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1370561", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A", "ADORA1"], "type": "Small molecule", "diseases": ["OBSTRUCTIVE LUNG DISEASE", "ASTHMA", "BLADDER CARCINOMA", "PULMONARY HYPERTENSION", "EMPHYSEMA", "ALTITUDE SICKNESS", "CHRONIC BRONCHITIS"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 3}, {"efo_term": "SICKLE CELL ANEMIA", "stage": 2}, {"efo_term": "MYOCARDIAL ISCHEMIA", "stage": 2}, {"efo_term": "CORONARY HEART DISEASE", "stage": 0}], "max_phase": 4, "name": "REGADENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL317052", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["CORONARY ARTERY DISEASE", "SICKLE CELL ANEMIA", "CORONARY HEART DISEASE", "CARDIOVASCULAR DISEASE", "MYOCARDIAL ISCHEMIA"]}, {"indications": [{"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 3}, {"efo_term": "PREMATURE BIRTH", "stage": 2}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 2}], "max_phase": 4, "name": "THEOPHYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A", "ADORA1"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "OBSTRUCTIVE LUNG DISEASE", "ASTHMA", "PREMATURE BIRTH", "CHRONIC KIDNEY DISEASE"]}, {"indications": [{"efo_term": "DIABETES MELLITUS", "stage": 4}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 3}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 3}, {"efo_term": "ABNORMAL GLUCOSE TOLERANCE", "stage": 2}, {"efo_term": "GESTATIONAL DIABETES", "stage": 2}], "max_phase": 4, "name": "VILDAGLIPTIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL142703", "mechanisms": ["Dipeptidyl peptidase IV inhibitor"], "genes": ["DPP4"], "type": "Small molecule", "diseases": ["DIABETES MELLITUS", "TYPE II DIABETES MELLITUS", "ABNORMAL GLUCOSE TOLERANCE", "TYPE I DIABETES MELLITUS", "GESTATIONAL DIABETES"]}, {"indications": [{"efo_term": "TYPE II DIABETES MELLITUS", "stage": 4}, {"efo_term": "DIABETES MELLITUS", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 1}, {"efo_term": "RENAL INSUFFICIENCY", "stage": 1}], "max_phase": 4, "name": "LINAGLIPTIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL237500", "mechanisms": ["Dipeptidyl peptidase IV inhibitor"], "genes": ["DPP4"], "type": "Small molecule", "diseases": ["TYPE II DIABETES MELLITUS", "SCHIZOPHRENIA", "RENAL INSUFFICIENCY", "DIABETES MELLITUS"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "LIVER DISEASE", "stage": 1}, {"efo_term": "DRUG DEPENDENCE", "stage": 1}], "max_phase": 3, "name": "ISTRADEFYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL431770", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "LIVER DISEASE", "DRUG DEPENDENCE"]}, {"indications": [{"efo_term": "PREMATURE BIRTH", "stage": 3}, {"efo_term": "RETINOPATHY OF PREMATURITY", "stage": 2}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 4, "name": "CAFFEINE, CITRATED", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200569", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A", "ADORA1"], "type": "Small molecule", "diseases": ["PREMATURE BIRTH", "LIVER DISEASE", "RETINOPATHY OF PREMATURITY"]}, {"indications": [{"efo_term": "CANCER", "stage": 4}, {"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 2}], "max_phase": 4, "name": "PENTOSTATIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1580", "mechanisms": ["Adenosine deaminase inhibitor"], "genes": ["ADA"], "type": "Small molecule", "diseases": ["CANCER", "NEOPLASM", "ACUTE GRAFT VS. HOST DISEASE"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 3, "name": "PRELADENANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL240624", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "LIVER DISEASE"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "COCAINE DEPENDENCE", "stage": 0}], "max_phase": 3, "name": "TOZADENANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105747", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "COCAINE DEPENDENCE"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 1}, {"efo_term": "PARKINSON'S DISEASE", "stage": 1}], "max_phase": 2, "name": "V81444", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545288", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "HEART FAILURE", "stage": 3}, {"efo_term": "CONGESTIVE HEART FAILURE", "stage": 3}], "max_phase": 3, "name": "ROLOFYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103819", "mechanisms": ["Adenosine A1 receptor antagonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": ["HEART FAILURE", "CONGESTIVE HEART FAILURE"]}, {"indications": [{"efo_term": "ATRIAL FIBRILLATION", "stage": 2}, {"efo_term": "ANGINA PECTORIS", "stage": 2}], "max_phase": 2, "name": "Capadenoson", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3235279", "mechanisms": ["Adenosine A1 receptor partial agonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": ["ATRIAL FIBRILLATION", "ANGINA PECTORIS"]}, {"indications": [{"efo_term": "DIABETES MELLITUS", "stage": 3}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 3}], "max_phase": 3, "name": "TRELAGLIPTIN SUCCINATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105754", "mechanisms": ["Dipeptidyl peptidase IV inhibitor"], "genes": ["DPP4"], "type": "Small molecule", "diseases": ["DIABETES MELLITUS", "TYPE II DIABETES MELLITUS"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 2}], "max_phase": 2, "name": "VIPADENANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL447664", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "DIABETIC FOOT", "stage": 2}], "max_phase": 2, "name": "SONEDENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1950553", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["DIABETIC FOOT"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 1}], "max_phase": 1, "name": "PBF-509", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545009", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "HUNTINGTON DISEASE", "stage": 1}], "max_phase": 1, "name": "PBF-999", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545271", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["HUNTINGTON DISEASE"]}, {"indications": [{"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 2, "name": "BVT.115959", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545409", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}], "max_phase": 4, "name": "OXTRIPHYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200434", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A", "ADORA1"], "type": "Small molecule", "diseases": ["OBSTRUCTIVE LUNG DISEASE"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 2}], "max_phase": 2, "name": "PBF-680", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545162", "mechanisms": ["Adenosine A1 receptor antagonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": ["ASTHMA"]}, {"indications": [{"efo_term": "HEART FAILURE", "stage": 2}], "max_phase": 2, "name": "BAY1067197", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545405", "mechanisms": ["Adenosine A1 receptor agonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": ["HEART FAILURE"]}, {"indications": [{"efo_term": "OCULAR HYPERTENSION", "stage": 3}], "max_phase": 3, "name": "Trabodenoson", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545407", "mechanisms": ["Adenosine A1 receptor agonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": ["OCULAR HYPERTENSION"]}, {"indications": [{"efo_term": "TYPE II DIABETES MELLITUS", "stage": 4}], "max_phase": 4, "name": "ALOGLIPTIN BENZOATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL227529", "mechanisms": ["Dipeptidyl peptidase IV inhibitor"], "genes": ["DPP4"], "type": "Small molecule", "diseases": ["TYPE II DIABETES MELLITUS"]}, {"indications": [{"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 1}], "max_phase": 1, "name": "GOSOGLIPTIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL515387", "mechanisms": ["Dipeptidyl peptidase IV inhibitor"], "genes": ["DPP4"], "type": "Small molecule", "diseases": ["CHRONIC KIDNEY DISEASE"]}, {"indications": [{"efo_term": "TYPE II DIABETES MELLITUS", "stage": 2}], "max_phase": 2, "name": "CARMEGLIPTIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL591118", "mechanisms": ["Dipeptidyl peptidase IV inhibitor"], "genes": ["DPP4"], "type": "Small molecule", "diseases": ["TYPE II DIABETES MELLITUS"]}, {"indications": [{"efo_term": "TYPE II DIABETES MELLITUS", "stage": 4}], "max_phase": 4, "name": "SITAGLIPTIN PHOSPHATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201174", "mechanisms": ["Dipeptidyl peptidase IV inhibitor"], "genes": ["DPP4"], "type": "Small molecule", "diseases": ["TYPE II DIABETES MELLITUS"]}, {"indications": [{"efo_term": "TYPE II DIABETES MELLITUS", "stage": 4}], "max_phase": 4, "name": "SAXAGLIPTIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201743", "mechanisms": ["Dipeptidyl peptidase IV inhibitor"], "genes": ["DPP4"], "type": "Small molecule", "diseases": ["TYPE II DIABETES MELLITUS"]}, {"indications": [{"efo_term": "TYPE II DIABETES MELLITUS", "stage": 3}], "max_phase": 3, "name": "OMARIGLIPTIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105762", "mechanisms": ["Dipeptidyl peptidase IV inhibitor"], "genes": ["DPP4"], "type": "Small molecule", "diseases": ["TYPE II DIABETES MELLITUS"]}, {"indications": [{"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 3}], "max_phase": 0, "name": "BEGELOMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3833357", "mechanisms": ["Dipeptidyl peptidase IV inhibitor"], "genes": ["DPP4"], "type": "Antibody", "diseases": ["ACUTE GRAFT VS. HOST DISEASE"]}, {"indications": [], "max_phase": 1, "name": "ST1535", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL197669", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "UK432097", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1096896", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "BINODENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1950554", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "APADENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1950649", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "EVODENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1950651", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "AMP579", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545163", "mechanisms": ["Adenosine A2a receptor agonist", "Adenosine A1 receptor agonist"], "genes": ["ADORA2A", "ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "THEOPHYLLINE SODIUM GLYCINATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200578", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A", "ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "FK453", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL440115", "mechanisms": ["Adenosine A1 receptor antagonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "TONAPOFYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL414157", "mechanisms": ["Adenosine A1 receptor antagonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "TECADENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL392149", "mechanisms": ["Adenosine A1 receptor agonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "Derenofylline", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL592435", "mechanisms": ["Adenosine A1 receptor antagonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "SELODENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107371", "mechanisms": ["Adenosine A1 receptor agonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "NAXIFYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107805", "mechanisms": ["Adenosine A1 receptor antagonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "GS-9667", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545011", "mechanisms": ["Adenosine A1 receptor partial agonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "GW493838", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545223", "mechanisms": ["Adenosine A1 receptor agonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "RPR749", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545331", "mechanisms": ["Adenosine A1 receptor agonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}], "heat": 0.4130802561248667, "nodes": [{"assoc": 1.0, "id": "ENSG00000128271", "label": "ADORA2A"}, {"assoc": 1.0, "id": "ENSG00000163485", "label": "ADORA1"}, {"assoc": 0.0952584551414, "id": "ENSG00000169248", "label": "CXCL11"}, {"assoc": 0.103157578566, "id": "ENSG00000196839", "label": "ADA"}, {"assoc": 0.212836225264, "id": "ENSG00000197635", "label": "DPP4"}, {"assoc": 0.0672292777778, "id": "ENSG00000276085", "label": "CCL3L3"}], "size": 6}, {"diseases": ["IRRITABLE BOWEL SYNDROME", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "ATOPIC ECZEMA", "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "MARIJUANA DEPENDENCE", "MULTIPLE MYELOMA", "NON-SMALL CELL LUNG CARCINOMA", "POST OPERATIVE NAUSEA AND VOMITING", "HIV INFECTION", "OPIOID DEPENDENCE", "VOMITING", "ACUTE MYELOID LEUKEMIA", "NAUSEA", "GERM CELL TUMOR", "BREAST CARCINOMA", "HEROIN DEPENDENCE", "PRURITUS", "GASTROPARESIS", "BIPOLAR DISORDER", "POST-TRAUMATIC STRESS DISORDER", "UNIPOLAR DEPRESSION", "ALCOHOL DEPENDENCE", "SCHIZOPHRENIA"], "links": [{"source": "ENSG00000006128", "type": "stimulatory", "target": "ENSG00000075073"}, {"source": "ENSG00000006128", "type": "stimulatory", "target": "ENSG00000115353"}, {"source": "ENSG00000006128", "type": "stimulatory", "target": "ENSG00000169836"}, {"source": "ENSG00000115353", "target": "ENSG00000176358", "reverse": "rev-stimulatory"}], "drugs": [{"indications": [{"efo_term": "POST OPERATIVE NAUSEA AND VOMITING", "stage": 4}, {"efo_term": "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "stage": 4}, {"efo_term": "NAUSEA", "stage": 4}, {"efo_term": "MULTIPLE MYELOMA", "stage": 3}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 3}, {"efo_term": "VOMITING", "stage": 3}, {"efo_term": "GERM CELL TUMOR", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "GASTROPARESIS", "stage": 3}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 2}, {"efo_term": "PRURITUS", "stage": 2}, {"efo_term": "HIV INFECTION", "stage": 1}, {"efo_term": "OPIOID DEPENDENCE", "stage": 1}, {"efo_term": "HEROIN DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "APREPITANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1471", "mechanisms": ["Neurokinin 1 receptor antagonist"], "genes": ["TACR1"], "type": "Small molecule", "diseases": ["MARIJUANA DEPENDENCE", "MULTIPLE MYELOMA", "NON-SMALL CELL LUNG CARCINOMA", "POST OPERATIVE NAUSEA AND VOMITING", "HIV INFECTION", "OPIOID DEPENDENCE", "VOMITING", "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "ACUTE MYELOID LEUKEMIA", "NAUSEA", "GERM CELL TUMOR", "BREAST CARCINOMA", "HEROIN DEPENDENCE", "PRURITUS", "GASTROPARESIS"]}, {"indications": [{"efo_term": "ATOPIC ECZEMA", "stage": 2}, {"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 2}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 1}], "max_phase": 2, "name": "DNK333", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL105060", "mechanisms": ["Neurokinin 1 receptor antagonist"], "genes": ["TACR1"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "ATOPIC ECZEMA", "IRRITABLE BOWEL SYNDROME"]}, {"indications": [{"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "ORVEPITANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105667", "mechanisms": ["Neurokinin 1 receptor antagonist"], "genes": ["TACR1"], "type": "Small molecule", "diseases": ["POST-TRAUMATIC STRESS DISORDER", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 3}], "max_phase": 3, "name": "Ibodutant", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL266125", "mechanisms": ["Neurokinin 2 receptor antagonist"], "genes": ["TACR2"], "type": "Small molecule", "diseases": ["IRRITABLE BOWEL SYNDROME"]}, {"indications": [{"efo_term": "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "stage": 4}], "max_phase": 4, "name": "NETUPITANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL206253", "mechanisms": ["Neurokinin 1 receptor antagonist"], "genes": ["TACR1"], "type": "Small molecule", "diseases": ["CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 1}], "max_phase": 2, "name": "VOFOPITANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL522302", "mechanisms": ["Neurokinin 1 receptor antagonist"], "genes": ["TACR1"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER"]}, {"indications": [{"efo_term": "PRURITUS", "stage": 2}], "max_phase": 2, "name": "SERLOPITANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL447955", "mechanisms": ["Neurokinin 1 receptor antagonist"], "genes": ["TACR1"], "type": "Small molecule", "diseases": ["PRURITUS"]}, {"indications": [{"efo_term": "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "stage": 4}], "max_phase": 4, "name": "FOSAPREPITANT DIMEGLUMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201782", "mechanisms": ["Neurokinin 1 receptor antagonist"], "genes": ["TACR1"], "type": "Small molecule", "diseases": ["CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING"]}, {"indications": [{"efo_term": "NAUSEA", "stage": 4}], "max_phase": 3, "name": "CASOPITANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1672054", "mechanisms": ["Neurokinin 1 receptor antagonist"], "genes": ["TACR1"], "type": "Small molecule", "diseases": ["NAUSEA"]}, {"indications": [{"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}], "max_phase": 2, "name": "TRADIPITANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544984", "mechanisms": ["Neurokinin 1 receptor antagonist"], "genes": ["TACR1"], "type": "Small molecule", "diseases": ["ALCOHOL DEPENDENCE"]}, {"indications": [{"efo_term": "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "stage": 4}], "max_phase": 4, "name": "ROLAPITANT HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707330", "mechanisms": ["Neurokinin 1 receptor antagonist"], "genes": ["TACR1"], "type": "Small molecule", "diseases": ["CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 2}], "max_phase": 2, "name": "TALNETANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL10188", "mechanisms": ["Neurokinin 3 receptor antagonist"], "genes": ["TACR3"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 2}], "max_phase": 2, "name": "AZD2624", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545233", "mechanisms": ["Neurokinin 3 receptor antagonist"], "genes": ["TACR3"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [], "max_phase": 2, "name": "EZLOPITANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL515966", "mechanisms": ["Neurokinin 1 receptor antagonist"], "genes": ["TACR1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "FIGOPITANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104927", "mechanisms": ["Neurokinin 1 receptor antagonist"], "genes": ["TACR1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "VESTIPITANT MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104992", "mechanisms": ["Neurokinin 1 receptor antagonist"], "genes": ["TACR1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "Burapitant", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544947", "mechanisms": ["Neurokinin 1 receptor antagonist"], "genes": ["TACR1"], "type": "Small molecule", "diseases": []}], "heat": 0.06125052180916, "nodes": [{"assoc": 0.0644877255216, "id": "ENSG00000006128", "label": "TAC1"}, {"assoc": 0.068456040684, "id": "ENSG00000075073", "label": "TACR2"}, {"assoc": 0.100226880618, "id": "ENSG00000115353", "label": "TACR1"}, {"assoc": 0.0524899622222, "id": "ENSG00000169836", "label": "TACR3"}, {"assoc": 0.020592, "id": "ENSG00000176358", "label": "TAC4"}], "size": 5}, {"diseases": [], "links": [{"source": "ENSG00000102970", "type": "stimulatory", "target": "ENSG00000179934"}, {"source": "ENSG00000102970", "type": "stimulatory", "target": "ENSG00000183813", "reverse": "rev-directed"}, {"source": "ENSG00000108702", "type": "stimulatory", "target": "ENSG00000179934"}, {"source": "ENSG00000179934", "target": "ENSG00000275385", "reverse": "rev-stimulatory"}], "drugs": [], "heat": 0.12112948656302, "nodes": [{"assoc": 0.107046668497, "id": "ENSG00000102970", "label": "CCL17"}, {"assoc": 0.0503484472789, "id": "ENSG00000108702", "label": "CCL1"}, {"assoc": 0.220947646654, "id": "ENSG00000179934", "label": "CCR8"}, {"assoc": 0.149438293616, "id": "ENSG00000183813", "label": "CCR4"}, {"assoc": 0.0778663767692, "id": "ENSG00000275385", "label": "CCL18"}], "size": 5}, {"diseases": [], "links": [{"source": "ENSG00000106113", "target": "ENSG00000147571", "reverse": "rev-stimulatory"}, {"source": "ENSG00000106113", "target": "ENSG00000163794", "reverse": "rev-stimulatory"}, {"source": "ENSG00000106113", "target": "ENSG00000178473", "reverse": "rev-stimulatory"}, {"source": "ENSG00000163794", "target": "ENSG00000174697"}], "drugs": [], "heat": 0.10518677118, "nodes": [{"assoc": 0.0565641111111, "id": "ENSG00000106113", "label": "CRHR2"}, {"assoc": 0.0828250623459, "id": "ENSG00000147571", "label": "CRH"}, {"assoc": 0.0663605, "id": "ENSG00000163794", "label": "UCN"}, {"assoc": 0.281934182443, "id": "ENSG00000174697", "label": "LEP"}, {"assoc": 0.03825, "id": "ENSG00000178473", "label": "UCN3"}], "size": 5}, {"diseases": ["EPILEPSY", "LIVER DISEASE", "UNIPOLAR DEPRESSION", "PARKINSON'S DISEASE", "CANCER", "INJURY", "INFLUENZA INFECTION", "POSTENCEPHALITIC PARKINSON DISEASE", "INFECTION", "SECONDARY PARKINSON DISEASE", "CEREBRAL ATHEROSCLEROSIS", "GAMBLING BEHAVIOUR", "BIPOLAR DISORDER", "SUICIDAL IDEATION", "COCAINE DEPENDENCE", "NICOTINE DEPENDENCE", "TINNITUS", "PAIN", "NEUROPATHIC PAIN", "OBSESSIVE-COMPULSIVE DISORDER", "SCHIZOPHRENIA", "AUTISM SPECTRUM DISORDER", "DIABETIC RETINOPATHY"], "links": [{"source": "ENSG00000116032", "target": "ENSG00000183454"}, {"source": "ENSG00000176884", "target": "ENSG00000183454"}, {"source": "ENSG00000176884", "target": "ENSG00000198785"}, {"source": "ENSG00000176884", "target": "ENSG00000273079", "reverse": "rev-stimulatory"}], "drugs": [{"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "INFLUENZA INFECTION", "stage": 4}, {"efo_term": "POSTENCEPHALITIC PARKINSON DISEASE", "stage": 4}, {"efo_term": "INFECTION", "stage": 4}, {"efo_term": "SECONDARY PARKINSON DISEASE", "stage": 4}, {"efo_term": "CEREBRAL ATHEROSCLEROSIS", "stage": 4}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "INJURY", "stage": 2}], "max_phase": 4, "name": "AMANTADINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1569", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "CANCER", "INJURY", "INFLUENZA INFECTION", "POSTENCEPHALITIC PARKINSON DISEASE", "INFECTION", "SECONDARY PARKINSON DISEASE", "CEREBRAL ATHEROSCLEROSIS"]}, {"indications": [{"efo_term": "SUICIDAL IDEATION", "stage": 3}, {"efo_term": "INJURY", "stage": 3}, {"efo_term": "BIPOLAR DISORDER", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}], "max_phase": 4, "name": "KETAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1714", "mechanisms": ["Glutamate [NMDA] receptor negative allosteric modulator"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "SUICIDAL IDEATION", "COCAINE DEPENDENCE", "INJURY"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 4, "name": "ESKETAMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL395091", "mechanisms": ["Glutamate [NMDA] receptor negative allosteric modulator"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["LIVER DISEASE", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "CANCER", "stage": 3}, {"efo_term": "GAMBLING BEHAVIOUR", "stage": 2}], "max_phase": 4, "name": "MEMANTINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1699", "mechanisms": ["Glutamate [NMDA] receptor negative allosteric modulator"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["GAMBLING BEHAVIOUR", "CANCER"]}, {"indications": [{"efo_term": "PAIN", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 3, "name": "RALFINAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107771", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["PAIN", "NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "OBSESSIVE-COMPULSIVE DISORDER", "stage": 2}], "max_phase": 3, "name": "RAPASTINEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544917", "mechanisms": ["Glutamate [NMDA] receptor partial agonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Protein", "diseases": ["OBSESSIVE-COMPULSIVE DISORDER", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "NRX-1074", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545230", "mechanisms": ["Glutamate [NMDA] receptor partial agonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "NEUROPATHIC PAIN", "stage": 1}], "max_phase": 2, "name": "AV-101", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545351", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "DIABETIC RETINOPATHY", "stage": 1}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}], "max_phase": 4, "name": "DEXTROMETHORPHAN HYDROBROMIDE MONOHYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256818", "mechanisms": ["Glutamate [NMDA] receptor subunit epsilon 1 antagonist"], "genes": ["GRIN2A"], "type": "Small molecule", "diseases": ["DIABETIC RETINOPATHY", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "FELBAMATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1094", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}], "max_phase": 4, "name": "ORPHENADRINE (CHLORIDE)", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201023", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "NICOTINE DEPENDENCE", "stage": 2}], "max_phase": 2, "name": "GW468816", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1207366", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["NICOTINE DEPENDENCE"]}, {"indications": [{"efo_term": "TINNITUS", "stage": 3}], "max_phase": 3, "name": "NERAMEXANE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2106798", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["TINNITUS"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "LANICEMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107647", "mechanisms": ["Glutamate [NMDA] receptor blocker"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "PAIN", "stage": 1}], "max_phase": 4, "name": "ESKETAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2364609", "mechanisms": ["Glutamate [NMDA] receptor negative allosteric modulator"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 2, "name": "Indantadol", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707400", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 2, "name": "Radiprodil", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL182066", "mechanisms": ["Glutamate NMDA receptor; GRIN1/GRIN2B antagonist"], "genes": ["GRIN1", "GRIN2B"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "CERC-301", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2068839", "mechanisms": ["Glutamate NMDA receptor; GRIN1/GRIN2B antagonist"], "genes": ["GRIN1", "GRIN2B"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "AUTISM SPECTRUM DISORDER", "stage": 2}], "max_phase": 4, "name": "DEXTROMETHORPHAN POLISTIREX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201461", "mechanisms": ["Glutamate [NMDA] receptor subunit epsilon 1 antagonist"], "genes": ["GRIN2A"], "type": "Small molecule", "diseases": ["AUTISM SPECTRUM DISORDER"]}, {"indications": [], "max_phase": 0, "name": "CNS-5161", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL41306", "mechanisms": ["Glutamate [NMDA] receptor blocker"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ORPHENADRINE CITRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200395", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "NEBOGLAMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1255840", "mechanisms": ["Glutamate [NMDA] receptor positive allosteric modulator"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ACAMPROSATE CALCIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2068724", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "DELUCEMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2110814", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "AZD8108", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707355", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "TRAXOPRODIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17350", "mechanisms": ["Glutamate NMDA receptor; GRIN1/GRIN2B antagonist"], "genes": ["GRIN1", "GRIN2B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "EVT-101", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545349", "mechanisms": ["Glutamate NMDA receptor; GRIN1/GRIN2B antagonist"], "genes": ["GRIN1", "GRIN2B"], "type": "Small molecule", "diseases": []}], "heat": 0.80949828334, "nodes": [{"assoc": 0.75, "id": "ENSG00000116032", "label": "GRIN3B"}, {"assoc": 0.75, "id": "ENSG00000176884", "label": "GRIN1"}, {"assoc": 1.0, "id": "ENSG00000183454", "label": "GRIN2A"}, {"assoc": 0.7974914167, "id": "ENSG00000198785", "label": "GRIN3A"}, {"assoc": 0.75, "id": "ENSG00000273079", "label": "GRIN2B"}], "size": 5}, {"diseases": ["HYPERTENSION", "PULMONARY HYPERTENSION", "HEART FAILURE", "TYPE II DIABETES MELLITUS", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "IDIOPATHIC PULMONARY FIBROSIS", "ASTHMA", "MELANOMA", "SYSTEMIC SCLERODERMA", "IDIOPATHIC AND/OR FAMILIAL PULMONARY ARTERIAL HYPERTENSION", "CONGENITAL HEART DISEASE", "ANTERIOR ISCHEMIC OPTIC NEUROPATHY", "VASCULAR DISEASE", "ALTITUDE SICKNESS", "SICKLE CELL ANEMIA", "SUBARACHNOID HEMORRHAGE", "FOCAL SEGMENTAL GLOMERULOSCLEROSIS", "PROSTATE CARCINOMA", "CANCER", "BREAST CARCINOMA", "LIVER DISEASE"], "links": [{"source": "ENSG00000078401", "type": "stimulatory", "target": "ENSG00000136160"}, {"source": "ENSG00000078401", "type": "stimulatory", "target": "ENSG00000151617", "reverse": "rev-directed"}, {"source": "ENSG00000127129", "type": "stimulatory", "target": "ENSG00000151617"}], "drugs": [{"indications": [{"efo_term": "IDIOPATHIC AND/OR FAMILIAL PULMONARY ARTERIAL HYPERTENSION", "stage": 4}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 3}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 3}, {"efo_term": "IDIOPATHIC PULMONARY FIBROSIS", "stage": 3}, {"efo_term": "SYSTEMIC SCLERODERMA", "stage": 3}, {"efo_term": "ANTERIOR ISCHEMIC OPTIC NEUROPATHY", "stage": 3}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}, {"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "MELANOMA", "stage": 2}, {"efo_term": "CONGENITAL HEART DISEASE", "stage": 2}], "max_phase": 4, "name": "BOSENTAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL957", "mechanisms": ["Endothelin receptor, ET-A/ET-B antagonist"], "genes": ["EDNRB", "EDNRA"], "type": "Small molecule", "diseases": ["PULMONARY HYPERTENSION", "TYPE II DIABETES MELLITUS", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "IDIOPATHIC PULMONARY FIBROSIS", "ASTHMA", "MELANOMA", "SYSTEMIC SCLERODERMA", "IDIOPATHIC AND/OR FAMILIAL PULMONARY ARTERIAL HYPERTENSION", "CONGENITAL HEART DISEASE", "ANTERIOR ISCHEMIC OPTIC NEUROPATHY"]}, {"indications": [{"efo_term": "IDIOPATHIC AND/OR FAMILIAL PULMONARY ARTERIAL HYPERTENSION", "stage": 4}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 3}, {"efo_term": "IDIOPATHIC PULMONARY FIBROSIS", "stage": 3}, {"efo_term": "VASCULAR DISEASE", "stage": 3}, {"efo_term": "HYPERTENSION", "stage": 3}, {"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "ALTITUDE SICKNESS", "stage": 1}, {"efo_term": "SICKLE CELL ANEMIA", "stage": 1}], "max_phase": 4, "name": "AMBRISENTAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1111", "mechanisms": ["Endothelin receptor, ET-A/ET-B antagonist"], "genes": ["EDNRB", "EDNRA"], "type": "Small molecule", "diseases": ["PULMONARY HYPERTENSION", "IDIOPATHIC PULMONARY FIBROSIS", "VASCULAR DISEASE", "HYPERTENSION", "ASTHMA", "IDIOPATHIC AND/OR FAMILIAL PULMONARY ARTERIAL HYPERTENSION", "ALTITUDE SICKNESS", "SICKLE CELL ANEMIA"]}, {"indications": [{"efo_term": "IDIOPATHIC AND/OR FAMILIAL PULMONARY ARTERIAL HYPERTENSION", "stage": 4}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 3}, {"efo_term": "SYSTEMIC SCLERODERMA", "stage": 3}, {"efo_term": "IDIOPATHIC PULMONARY FIBROSIS", "stage": 2}], "max_phase": 4, "name": "MACITENTAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103873", "mechanisms": ["Endothelin receptor, ET-A/ET-B antagonist"], "genes": ["EDNRB", "EDNRA"], "type": "Small molecule", "diseases": ["PULMONARY HYPERTENSION", "IDIOPATHIC PULMONARY FIBROSIS", "SYSTEMIC SCLERODERMA", "IDIOPATHIC AND/OR FAMILIAL PULMONARY ARTERIAL HYPERTENSION"]}, {"indications": [{"efo_term": "PROSTATE CARCINOMA", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "CANCER", "stage": 1}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 3, "name": "ZIBOTENTAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1628688", "mechanisms": ["Endothelin receptor ET-A antagonist"], "genes": ["EDNRA"], "type": "Small molecule", "diseases": ["PROSTATE CARCINOMA", "CANCER", "BREAST CARCINOMA", "LIVER DISEASE"]}, {"indications": [{"efo_term": "HEART FAILURE", "stage": 3}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 2}], "max_phase": 3, "name": "TEZOSENTAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL61780", "mechanisms": ["Endothelin receptor ET-B antagonist", "Endothelin receptor ET-A antagonist"], "genes": ["EDNRB", "EDNRA"], "type": "Small molecule", "diseases": ["PULMONARY HYPERTENSION", "HEART FAILURE"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 2}, {"efo_term": "FOCAL SEGMENTAL GLOMERULOSCLEROSIS", "stage": 2}], "max_phase": 2, "name": "SPARSENTAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL539423", "mechanisms": ["Endothelin receptor ET-A antagonist"], "genes": ["EDNRA"], "type": "Small molecule", "diseases": ["HYPERTENSION", "FOCAL SEGMENTAL GLOMERULOSCLEROSIS"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 3}], "max_phase": 3, "name": "DARUSENTAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL23261", "mechanisms": ["Endothelin receptor ET-B antagonist", "Endothelin receptor ET-A antagonist"], "genes": ["EDNRB", "EDNRA"], "type": "Small molecule", "diseases": ["HYPERTENSION"]}, {"indications": [{"efo_term": "SUBARACHNOID HEMORRHAGE", "stage": 3}], "max_phase": 3, "name": "CLAZOSENTAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL109648", "mechanisms": ["Endothelin receptor ET-A antagonist"], "genes": ["EDNRA"], "type": "Small molecule", "diseases": ["SUBARACHNOID HEMORRHAGE"]}, {"indications": [], "max_phase": 2, "name": "ENRASENTAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL431651", "mechanisms": ["Endothelin receptor ET-B antagonist", "Endothelin receptor ET-A antagonist"], "genes": ["EDNRB", "EDNRA"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "ATRASENTAN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2106068", "mechanisms": ["Endothelin receptor ET-A antagonist"], "genes": ["EDNRA"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "NEBENTAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107760", "mechanisms": ["Endothelin receptor ET-A antagonist"], "genes": ["EDNRA"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "AVOSENTAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107803", "mechanisms": ["Endothelin receptor ET-A antagonist"], "genes": ["EDNRA"], "type": "Small molecule", "diseases": []}], "heat": 0.17691880374039998, "nodes": [{"assoc": 0.0844611475626, "id": "ENSG00000078401", "label": "EDN1"}, {"assoc": 0.048556, "id": "ENSG00000127129", "label": "EDN2"}, {"assoc": 0.292152154871, "id": "ENSG00000136160", "label": "EDNRB"}, {"assoc": 0.282505912528, "id": "ENSG00000151617", "label": "EDNRA"}], "size": 4}, {"diseases": ["CELIAC DISEASE", "GASTROPARESIS", "IRRITABLE BOWEL SYNDROME", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "ASTHMA", "NICOTINE DEPENDENCE", "SMOKING CESSATION", "MEMORY IMPAIRMENT", "PARKINSON'S DISEASE", "POST OPERATIVE NAUSEA AND VOMITING", "SARCOIDOSIS", "ALCOHOL DRINKING", "HEART FAILURE", "CERVICAL CARCINOMA", "COGNITIVE IMPAIRMENT", "LUNG CARCINOMA", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "INJURY", "DRUG DEPENDENCE", "ALZHEIMERS DISEASE", "SCHIZOPHRENIA", "NEUROPATHIC PAIN", "UNIPOLAR DEPRESSION", "HYPERTENSION", "OVERACTIVE BLADDER"], "links": [{"source": "ENSG00000080644", "target": "ENSG00000117971"}, {"source": "ENSG00000101204", "target": "ENSG00000160716"}, {"source": "ENSG00000117971", "type": "manual", "target": "ENSG00000169684"}, {"source": "ENSG00000169684", "type": "manual", "target": "ENSG00000160716"}, {"source": "ENSG00000080644", "type": "manual", "target": "ENSG00000117971"}], "drugs": [{"indications": [{"efo_term": "NICOTINE DEPENDENCE", "stage": 4}, {"efo_term": "SMOKING CESSATION", "stage": 3}, {"efo_term": "HEART FAILURE", "stage": 3}, {"efo_term": "CERVICAL CARCINOMA", "stage": 3}, {"efo_term": "LUNG CARCINOMA", "stage": 3}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "POST OPERATIVE NAUSEA AND VOMITING", "stage": 2}, {"efo_term": "ALCOHOL DRINKING", "stage": 2}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}, {"efo_term": "COGNITIVE IMPAIRMENT", "stage": 2}, {"efo_term": "INJURY", "stage": 2}, {"efo_term": "DRUG DEPENDENCE", "stage": 2}, {"efo_term": "MEMORY IMPAIRMENT", "stage": 1}, {"efo_term": "SARCOIDOSIS", "stage": 1}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 1}], "max_phase": 4, "name": "NICOTINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["NICOTINE DEPENDENCE", "SMOKING CESSATION", "MEMORY IMPAIRMENT", "PARKINSON'S DISEASE", "POST OPERATIVE NAUSEA AND VOMITING", "SARCOIDOSIS", "ALCOHOL DRINKING", "HEART FAILURE", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "CERVICAL CARCINOMA", "COGNITIVE IMPAIRMENT", "LUNG CARCINOMA", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "INJURY", "DRUG DEPENDENCE"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}], "max_phase": 2, "name": "ISPRONICLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL188462", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 partial agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE", "SCHIZOPHRENIA", "ATTENTION DEFICIT HYPERACTIVITY DISORDER"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "OVERACTIVE BLADDER", "stage": 2}, {"efo_term": "HYPERTENSION", "stage": 1}], "max_phase": 3, "name": "DEXMECAMYLAMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103881", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 antagonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["HYPERTENSION", "OVERACTIVE BLADDER", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 2}], "max_phase": 2, "name": "POZANICLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL127071", "mechanisms": ["Nicotinic acetylcholine receptor alpha4/beta2/alpha5 partial agonist", "Neuronal acetylcholine receptor; alpha6/beta2 partial agonist"], "genes": ["CHRNA4", "CHRNB2", "CHRNA5"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "NICOTINE DEPENDENCE"]}, {"indications": [{"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 2}, {"efo_term": "GASTROPARESIS", "stage": 1}], "max_phase": 2, "name": "TC-6499", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545353", "mechanisms": ["Neuronal acetylcholine receptor; alpha3/beta4 agonist", "Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA3", "CHRNA4", "CHRNB4", "CHRNB2"], "type": "Small molecule", "diseases": ["GASTROPARESIS", "IRRITABLE BOWEL SYNDROME"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}, {"efo_term": "ASTHMA", "stage": 2}], "max_phase": 2, "name": "ASM-024", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707249", "mechanisms": ["Neuronal acetylcholine receptor; alpha3/beta4 antagonist"], "genes": ["CHRNA3", "CHRNB4"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "ASTHMA"]}, {"indications": [{"efo_term": "NEUROPATHIC PAIN", "stage": 2}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}], "max_phase": 2, "name": "SOFINICLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL238465", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN", "ATTENTION DEFICIT HYPERACTIVITY DISORDER"]}, {"indications": [{"efo_term": "NICOTINE DEPENDENCE", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}], "max_phase": 4, "name": "NICOTINE POLACRILEX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201536", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["NICOTINE DEPENDENCE", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "NICOTINE DEPENDENCE", "stage": 2}, {"efo_term": "SMOKING CESSATION", "stage": 1}], "max_phase": 4, "name": "VARENICLINE TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062259", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["NICOTINE DEPENDENCE", "SMOKING CESSATION"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}], "max_phase": 2, "name": "AZD1446", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2179529", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER"]}, {"indications": [{"efo_term": "CELIAC DISEASE", "stage": 2}], "max_phase": 2, "name": "LARAZOTIDE ACETATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103815", "mechanisms": ["Neuronal acetylcholine receptor; alpha3/beta4 partial agonist"], "genes": ["CHRNA3", "CHRNB4"], "type": "Protein", "diseases": ["CELIAC DISEASE"]}, {"indications": [], "max_phase": 4, "name": "TRIMETHAPHAN CAMSYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1245", "mechanisms": ["Neuronal acetylcholine receptor; alpha3/beta4 antagonist"], "genes": ["CHRNA3", "CHRNB4"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MECAMYLAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237082", "mechanisms": ["Neuronal acetylcholine receptor; alpha3/beta4 negative allosteric modulator"], "genes": ["CHRNA3", "CHRNB4"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PENTOLINIUM TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1318287", "mechanisms": ["Neuronal acetylcholine receptor; alpha3/beta4 antagonist"], "genes": ["CHRNA3", "CHRNB4"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "TEBANICLINE TOSYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL430497", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "ALTINICLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL111659", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "TC-2216", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL504652", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 antagonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "CP-601927", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707250", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 partial agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "ABT-560", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707354", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 modulator"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": []}], "heat": 0.5051968444444, "nodes": [{"assoc": 0.264873111111, "id": "ENSG00000080644", "label": "CHRNA3"}, {"assoc": 1.0, "id": "ENSG00000101204", "label": "CHRNA4"}, {"assoc": 0.261111111111, "id": "ENSG00000117971", "label": "CHRNB4"}, {"assoc": 1.0, "id": "ENSG00000160716", "label": "CHRNB2"}, {"assoc": 0, "id": "ENSG00000169684", "label": "CHRNA5"}], "size": 5}, {"diseases": ["PROSTATE CARCINOMA", "ULCERATIVE COLITIS", "BULLOUS PEMPHIGOID"], "links": [{"source": "ENSG00000108691", "type": "directed", "target": "ENSG00000108700"}, {"source": "ENSG00000108691", "type": "directed", "target": "ENSG00000172156"}, {"source": "ENSG00000108691", "type": "directed", "target": "ENSG00000181374", "reverse": "rev-stimulatory"}], "drugs": [{"indications": [{"efo_term": "ULCERATIVE COLITIS", "stage": 2}, {"efo_term": "BULLOUS PEMPHIGOID", "stage": 2}], "max_phase": 2, "name": "BERTILIMUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109103", "mechanisms": ["Eotaxin inhibitor"], "genes": ["CCL11"], "type": "Antibody", "diseases": ["ULCERATIVE COLITIS", "BULLOUS PEMPHIGOID"]}, {"indications": [{"efo_term": "PROSTATE CARCINOMA", "stage": 2}], "max_phase": 2, "name": "CARLUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1742999", "mechanisms": ["C-C motif chemokine 2 inhibitor"], "genes": ["CCL2"], "type": "Antibody", "diseases": ["PROSTATE CARCINOMA"]}], "heat": 0.188975462558, "nodes": [{"assoc": 0.261646950238, "id": "ENSG00000108691", "label": "CCL2"}, {"assoc": 0.0932723, "id": "ENSG00000108700", "label": "CCL8"}, {"assoc": 0.291907903073, "id": "ENSG00000172156", "label": "CCL11"}, {"assoc": 0.109074696921, "id": "ENSG00000181374", "label": "CCL13"}], "size": 4}, {"diseases": ["DIFFUSE SCLERODERMA", "RHEUMATOID ARTHRITIS", "SYSTEMIC LUPUS ERYTHEMATOSUS", "ANKYLOSING SPONDYLITIS", "CROHN'S DISEASE", "MULTIPLE SCLEROSIS", "VITILIGO", "HYPERTENSION", "PSORIATIC ARTHRITIS", "ULCERATIVE COLITIS", "ACUTE GRAFT VS. HOST DISEASE", "ALOPECIA AREATA", "TYPE I DIABETES MELLITUS", "ASTHMA", "CHRONIC CHILDHOOD ARTHRITIS", "WEGENER'S GRANULOMATOSIS", "ALOPECIA TOTALIS", "ANTI-NEUTROPHIL ANTIBODY ASSOCIATED VASCULITIS", "IMMUNE SYSTEM DISEASE", "PSORIASIS", "SARCOIDOSIS", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "NEPHROTIC SYNDROME", "UVEITIS", "URTICARIA", "PROTEINURIA", "BREAST CARCINOMA", "CANCER", "GASTRIC ADENOCARCINOMA", "NEOPLASM", "MELANOMA", "ESOPHAGEAL CARCINOMA", "NON-SMALL CELL LUNG CARCINOMA", "BREAST NEOPLASM", "BLADDER CARCINOMA", "DIFFUSE LARGE B-CELL LYMPHOMA", "GLIOBLASTOMA MULTIFORME", "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "MULTIPLE MYELOMA", "OVARIAN CARCINOMA", "PANCREATIC DUCTAL ADENOCARCINOMA", "PRIMARY MYELOFIBROSIS", "PROSTATE CARCINOMA", "SQUAMOUS CELL LUNG CARCINOMA", "COLORECTAL CANCER", "PANCREATIC CARCINOMA", "MESOTHELIOMA", "HEPATOCELLULAR CARCINOMA", "COLORECTAL ADENOCARCINOMA", "LYMPHOID NEOPLASM", "MYELODYSPLASTIC SYNDROME", "OVARIAN NEOPLASM", "HEREDITARY BREAST AND OVARIAN CANCER SYNDROME", "MERKEL CELL SKIN CANCER", "NASOPHARYNGEAL NEOPLASM", "HODGKINS LYMPHOMA", "ENDOMETRIAL NEOPLASM", "LYMPHOMA", "NON-HODGKINS LYMPHOMA", "CARCINOMA", "METASTATIC MELANOMA", "CHRONIC MYELOGENOUS LEUKEMIA", "CUTANEOUS MELANOMA", "PROSTATE ADENOCARCINOMA", "SMALL CELL LUNG CARCINOMA", "LUNG CARCINOMA", "RENAL CARCINOMA"], "links": [{"source": "ENSG00000114013", "type": "stimulatory", "target": "ENSG00000163599", "reverse": "rev-directed"}, {"source": "ENSG00000120217", "type": "stimulatory", "target": "ENSG00000121594", "reverse": "rev-stimulatory"}, {"source": "ENSG00000121594", "type": "stimulatory", "target": "ENSG00000163599", "reverse": "rev-directed"}], "drugs": [{"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 4}, {"efo_term": "CHRONIC CHILDHOOD ARTHRITIS", "stage": 4}, {"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "CROHN'S DISEASE", "stage": 3}, {"efo_term": "PSORIATIC ARTHRITIS", "stage": 3}, {"efo_term": "ULCERATIVE COLITIS", "stage": 3}, {"efo_term": "DIFFUSE SCLERODERMA", "stage": 2}, {"efo_term": "SYSTEMIC LUPUS ERYTHEMATOSUS", "stage": 2}, {"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 2}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "HYPERTENSION", "stage": 2}, {"efo_term": "ALOPECIA AREATA", "stage": 2}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 2}, {"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "ALOPECIA TOTALIS", "stage": 2}, {"efo_term": "ANTI-NEUTROPHIL ANTIBODY ASSOCIATED VASCULITIS", "stage": 2}, {"efo_term": "PSORIASIS", "stage": 2}, {"efo_term": "SARCOIDOSIS", "stage": 2}, {"efo_term": "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "NEPHROTIC SYNDROME", "stage": 2}, {"efo_term": "UVEITIS", "stage": 2}, {"efo_term": "VITILIGO", "stage": 1}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 1}, {"efo_term": "WEGENER'S GRANULOMATOSIS", "stage": 1}, {"efo_term": "URTICARIA", "stage": 1}], "max_phase": 4, "name": "ABATACEPT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201823", "mechanisms": ["T-lymphocyte activation antigen CD86 inhibitor", "T-lymphocyte activation antigen CD80 inhibitor"], "genes": ["CD86", "CD80"], "type": "Protein", "diseases": ["DIFFUSE SCLERODERMA", "RHEUMATOID ARTHRITIS", "SYSTEMIC LUPUS ERYTHEMATOSUS", "ANKYLOSING SPONDYLITIS", "CROHN'S DISEASE", "MULTIPLE SCLEROSIS", "VITILIGO", "HYPERTENSION", "PSORIATIC ARTHRITIS", "ULCERATIVE COLITIS", "ACUTE GRAFT VS. HOST DISEASE", "ALOPECIA AREATA", "TYPE I DIABETES MELLITUS", "ASTHMA", "CHRONIC CHILDHOOD ARTHRITIS", "WEGENER'S GRANULOMATOSIS", "ALOPECIA TOTALIS", "ANTI-NEUTROPHIL ANTIBODY ASSOCIATED VASCULITIS", "IMMUNE SYSTEM DISEASE", "PSORIASIS", "SARCOIDOSIS", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "NEPHROTIC SYNDROME", "UVEITIS", "URTICARIA"]}, {"indications": [{"efo_term": "CANCER", "stage": 3}, {"efo_term": "NEOPLASM", "stage": 3}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 3}, {"efo_term": "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "stage": 3}, {"efo_term": "SQUAMOUS CELL LUNG CARCINOMA", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "ESOPHAGEAL CARCINOMA", "stage": 2}, {"efo_term": "BREAST NEOPLASM", "stage": 2}, {"efo_term": "BLADDER CARCINOMA", "stage": 2}, {"efo_term": "GLIOBLASTOMA MULTIFORME", "stage": 2}, {"efo_term": "OVARIAN CARCINOMA", "stage": 2}, {"efo_term": "PANCREATIC DUCTAL ADENOCARCINOMA", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "COLORECTAL CANCER", "stage": 2}, {"efo_term": "PANCREATIC CARCINOMA", "stage": 2}, {"efo_term": "MESOTHELIOMA", "stage": 2}, {"efo_term": "HEPATOCELLULAR CARCINOMA", "stage": 2}, {"efo_term": "GASTRIC ADENOCARCINOMA", "stage": 1}, {"efo_term": "MELANOMA", "stage": 1}, {"efo_term": "DIFFUSE LARGE B-CELL LYMPHOMA", "stage": 1}, {"efo_term": "MULTIPLE MYELOMA", "stage": 1}, {"efo_term": "PRIMARY MYELOFIBROSIS", "stage": 1}], "max_phase": 3, "name": "DURVALUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3301587", "mechanisms": ["Programmed cell death 1 ligand 1 inhibitor"], "genes": ["CD274"], "type": "Antibody", "diseases": ["BREAST CARCINOMA", "CANCER", "GASTRIC ADENOCARCINOMA", "NEOPLASM", "MELANOMA", "ESOPHAGEAL CARCINOMA", "NON-SMALL CELL LUNG CARCINOMA", "BREAST NEOPLASM", "BLADDER CARCINOMA", "DIFFUSE LARGE B-CELL LYMPHOMA", "GLIOBLASTOMA MULTIFORME", "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "MULTIPLE MYELOMA", "OVARIAN CARCINOMA", "PANCREATIC DUCTAL ADENOCARCINOMA", "PRIMARY MYELOFIBROSIS", "PROSTATE CARCINOMA", "SQUAMOUS CELL LUNG CARCINOMA", "COLORECTAL CANCER", "PANCREATIC CARCINOMA", "MESOTHELIOMA", "HEPATOCELLULAR CARCINOMA"]}, {"indications": [{"efo_term": "CANCER", "stage": 4}, {"efo_term": "MELANOMA", "stage": 4}, {"efo_term": "METASTATIC MELANOMA", "stage": 4}, {"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "CUTANEOUS MELANOMA", "stage": 4}, {"efo_term": "PROSTATE CARCINOMA", "stage": 3}, {"efo_term": "PROSTATE ADENOCARCINOMA", "stage": 3}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "LUNG CARCINOMA", "stage": 2}, {"efo_term": "GASTRIC ADENOCARCINOMA", "stage": 2}, {"efo_term": "MERKEL CELL SKIN CANCER", "stage": 2}, {"efo_term": "CARCINOMA", "stage": 1}, {"efo_term": "PANCREATIC CARCINOMA", "stage": 1}, {"efo_term": "CHRONIC MYELOGENOUS LEUKEMIA", "stage": 1}, {"efo_term": "BREAST CARCINOMA", "stage": 1}, {"efo_term": "RENAL CARCINOMA", "stage": 1}, {"efo_term": "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "stage": 1}], "max_phase": 4, "name": "IPILIMUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789844", "mechanisms": ["Cytotoxic T-lymphocyte protein 4 inhibitor"], "genes": ["CTLA4"], "type": "Antibody", "diseases": ["CANCER", "CARCINOMA", "MELANOMA", "PROSTATE CARCINOMA", "METASTATIC MELANOMA", "NON-SMALL CELL LUNG CARCINOMA", "PANCREATIC CARCINOMA", "NEOPLASM", "CHRONIC MYELOGENOUS LEUKEMIA", "CUTANEOUS MELANOMA", "PROSTATE ADENOCARCINOMA", "SMALL CELL LUNG CARCINOMA", "BREAST CARCINOMA", "LUNG CARCINOMA", "GASTRIC ADENOCARCINOMA", "RENAL CARCINOMA", "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "MERKEL CELL SKIN CANCER"]}, {"indications": [{"efo_term": "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "stage": 3}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 3}, {"efo_term": "HEPATOCELLULAR CARCINOMA", "stage": 2}, {"efo_term": "MESOTHELIOMA", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "GLIOBLASTOMA MULTIFORME", "stage": 2}, {"efo_term": "MELANOMA", "stage": 1}, {"efo_term": "METASTATIC MELANOMA", "stage": 1}, {"efo_term": "PANCREATIC CARCINOMA", "stage": 1}, {"efo_term": "NEOPLASM", "stage": 1}, {"efo_term": "GASTRIC ADENOCARCINOMA", "stage": 1}, {"efo_term": "LYMPHOMA", "stage": 1}, {"efo_term": "MYELODYSPLASTIC SYNDROME", "stage": 1}], "max_phase": 3, "name": "TREMELIMUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108658", "mechanisms": ["Cytotoxic T-lymphocyte protein 4 inhibitor"], "genes": ["CTLA4"], "type": "Antibody", "diseases": ["HEPATOCELLULAR CARCINOMA", "MESOTHELIOMA", "BREAST CARCINOMA", "MELANOMA", "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "METASTATIC MELANOMA", "PANCREATIC CARCINOMA", "NEOPLASM", "NON-SMALL CELL LUNG CARCINOMA", "GLIOBLASTOMA MULTIFORME", "GASTRIC ADENOCARCINOMA", "LYMPHOMA", "MYELODYSPLASTIC SYNDROME"]}, {"indications": [{"efo_term": "MERKEL CELL SKIN CANCER", "stage": 4}, {"efo_term": "GASTRIC ADENOCARCINOMA", "stage": 3}, {"efo_term": "CANCER", "stage": 3}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 3}, {"efo_term": "NEOPLASM", "stage": 3}, {"efo_term": "OVARIAN CARCINOMA", "stage": 3}, {"efo_term": "BREAST NEOPLASM", "stage": 3}, {"efo_term": "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "stage": 3}, {"efo_term": "GLIOBLASTOMA MULTIFORME", "stage": 2}, {"efo_term": "NASOPHARYNGEAL NEOPLASM", "stage": 2}, {"efo_term": "ENDOMETRIAL NEOPLASM", "stage": 2}, {"efo_term": "HODGKINS LYMPHOMA", "stage": 1}], "max_phase": 4, "name": "AVELUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3833373", "mechanisms": ["Programmed cell death 1 ligand 1 other"], "genes": ["CD274"], "type": "Antibody", "diseases": ["MERKEL CELL SKIN CANCER", "GASTRIC ADENOCARCINOMA", "GLIOBLASTOMA MULTIFORME", "CANCER", "NON-SMALL CELL LUNG CARCINOMA", "NASOPHARYNGEAL NEOPLASM", "NEOPLASM", "OVARIAN CARCINOMA", "BREAST NEOPLASM", "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "HODGKINS LYMPHOMA", "ENDOMETRIAL NEOPLASM"]}, {"indications": [{"efo_term": "CANCER", "stage": 3}, {"efo_term": "COLORECTAL ADENOCARCINOMA", "stage": 3}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 3}, {"efo_term": "NEOPLASM", "stage": 3}, {"efo_term": "OVARIAN NEOPLASM", "stage": 2}, {"efo_term": "HEREDITARY BREAST AND OVARIAN CANCER SYNDROME", "stage": 2}, {"efo_term": "BLADDER CARCINOMA", "stage": 2}, {"efo_term": "LYMPHOID NEOPLASM", "stage": 1}, {"efo_term": "MYELODYSPLASTIC SYNDROME", "stage": 1}, {"efo_term": "BREAST CARCINOMA", "stage": 1}, {"efo_term": "PROSTATE CARCINOMA", "stage": 1}], "max_phase": 4, "name": "ATEZOLIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707227", "mechanisms": ["Programmed cell death 1 ligand 1 inhibitor"], "genes": ["CD274"], "type": "Antibody", "diseases": ["CANCER", "COLORECTAL ADENOCARCINOMA", "NON-SMALL CELL LUNG CARCINOMA", "LYMPHOID NEOPLASM", "MYELODYSPLASTIC SYNDROME", "BREAST CARCINOMA", "NEOPLASM", "OVARIAN NEOPLASM", "HEREDITARY BREAST AND OVARIAN CANCER SYNDROME", "BLADDER CARCINOMA", "PROSTATE CARCINOMA"]}, {"indications": [{"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "PROTEINURIA", "stage": 2}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 2}], "max_phase": 4, "name": "BELATACEPT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1742990", "mechanisms": ["T-lymphocyte activation antigen CD86 inhibitor", "T-lymphocyte activation antigen CD80 inhibitor"], "genes": ["CD86", "CD80"], "type": "Protein", "diseases": ["IMMUNE SYSTEM DISEASE", "PROTEINURIA", "TYPE I DIABETES MELLITUS"]}, {"indications": [{"efo_term": "LYMPHOMA", "stage": 2}, {"efo_term": "NON-HODGKINS LYMPHOMA", "stage": 1}], "max_phase": 3, "name": "GALIXIMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109191", "mechanisms": ["T-lymphocyte activation antigen CD80 inhibitor"], "genes": ["CD80"], "type": "Antibody", "diseases": ["LYMPHOMA", "NON-HODGKINS LYMPHOMA"]}], "heat": 0.1844713667555, "nodes": [{"assoc": 0.234417293749, "id": "ENSG00000114013", "label": "CD86"}, {"assoc": 0.068594591016, "id": "ENSG00000120217", "label": "CD274"}, {"assoc": 0.234297254189, "id": "ENSG00000121594", "label": "CD80"}, {"assoc": 0.200576328068, "id": "ENSG00000163599", "label": "CTLA4"}], "size": 4}, {"diseases": [], "links": [{"source": "ENSG00000140943", "type": "directed", "target": "ENSG00000176697"}, {"source": "ENSG00000176697", "type": "stimulatory", "target": "ENSG00000185652", "reverse": "rev-stimulatory"}, {"source": "ENSG00000176697", "target": "ENSG00000225950", "reverse": "rev-stimulatory"}], "drugs": [], "heat": 0.13187426698695, "nodes": [{"assoc": 0.153021647477, "id": "ENSG00000140943", "label": "MBTPS1"}, {"assoc": 0.223751005656, "id": "ENSG00000176697", "label": "BDNF"}, {"assoc": 0.0748214703704, "id": "ENSG00000185652", "label": "NTF3"}, {"assoc": 0.0759029444444, "id": "ENSG00000225950", "label": "NTF4"}], "size": 4}, {"diseases": ["ACNE", "PERIODONTITIS", "BLEPHARITIS", "COLORECTAL ADENOCARCINOMA", "DIABETIC RETINOPATHY", "URETHRITIS", "HEMORRHAGE", "NEOPLASM OF MATURE B-CELLS", "ALZHEIMERS DISEASE", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "PAIN", "PLEURAL EFFUSION", "ABDOMINAL AORTIC ANEURYSM", "MARFAN SYNDROME", "PRIMARY SYSTEMIC AMYLOIDOSIS", "DRY EYE SYNDROME", "SEPTICEMIC PLAGUE", "POLYCYSTIC OVARY SYNDROME", "MYOCARDIAL INFARCTION", "PANCREATIC CARCINOMA", "SEIZURES", "DIABETIC FOOT", "AGE-RELATED MACULAR DEGENERATION", "TUBERCULOSIS"], "links": [{"source": "ENSG00000003436", "target": "ENSG00000118113", "reverse": "rev-stimulatory"}, {"source": "ENSG00000003436", "target": "ENSG00000262406", "reverse": "rev-stimulatory"}], "drugs": [{"indications": [{"efo_term": "PERIODONTITIS", "stage": 3}, {"efo_term": "URETHRITIS", "stage": 3}, {"efo_term": "HEMORRHAGE", "stage": 3}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 3}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 3}, {"efo_term": "PLEURAL EFFUSION", "stage": 3}, {"efo_term": "POLYCYSTIC OVARY SYNDROME", "stage": 3}, {"efo_term": "BLEPHARITIS", "stage": 2}, {"efo_term": "COLORECTAL ADENOCARCINOMA", "stage": 2}, {"efo_term": "ACNE", "stage": 2}, {"efo_term": "DIABETIC RETINOPATHY", "stage": 2}, {"efo_term": "NEOPLASM OF MATURE B-CELLS", "stage": 2}, {"efo_term": "PAIN", "stage": 2}, {"efo_term": "ABDOMINAL AORTIC ANEURYSM", "stage": 2}, {"efo_term": "MARFAN SYNDROME", "stage": 2}, {"efo_term": "PRIMARY SYSTEMIC AMYLOIDOSIS", "stage": 2}, {"efo_term": "DRY EYE SYNDROME", "stage": 2}, {"efo_term": "SEPTICEMIC PLAGUE", "stage": 2}, {"efo_term": "MYOCARDIAL INFARCTION", "stage": 2}, {"efo_term": "PANCREATIC CARCINOMA", "stage": 2}, {"efo_term": "SEIZURES", "stage": 2}, {"efo_term": "DIABETIC FOOT", "stage": 2}, {"efo_term": "AGE-RELATED MACULAR DEGENERATION", "stage": 2}, {"efo_term": "TUBERCULOSIS", "stage": 2}], "max_phase": 4, "name": "DOXYCYCLINE HYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200699", "mechanisms": ["Matrix metalloproteinase 8 inhibitor"], "genes": ["MMP8"], "type": "Small molecule", "diseases": ["BLEPHARITIS", "COLORECTAL ADENOCARCINOMA", "PERIODONTITIS", "ACNE", "DIABETIC RETINOPATHY", "URETHRITIS", "HEMORRHAGE", "NEOPLASM OF MATURE B-CELLS", "ALZHEIMERS DISEASE", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "PAIN", "PLEURAL EFFUSION", "ABDOMINAL AORTIC ANEURYSM", "MARFAN SYNDROME", "PRIMARY SYSTEMIC AMYLOIDOSIS", "DRY EYE SYNDROME", "SEPTICEMIC PLAGUE", "POLYCYSTIC OVARY SYNDROME", "MYOCARDIAL INFARCTION", "PANCREATIC CARCINOMA", "SEIZURES", "DIABETIC FOOT", "AGE-RELATED MACULAR DEGENERATION", "TUBERCULOSIS"]}, {"indications": [{"efo_term": "ACNE", "stage": 4}, {"efo_term": "PERIODONTITIS", "stage": 3}], "max_phase": 4, "name": "DOXYCYCLINE HYCLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200567", "mechanisms": ["Matrix metalloproteinase 8 inhibitor"], "genes": ["MMP8"], "type": "Small molecule", "diseases": ["ACNE", "PERIODONTITIS"]}, {"indications": [], "max_phase": 4, "name": "DOXYCYCLINE CALCIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2364574", "mechanisms": ["Matrix metalloproteinase 8 inhibitor"], "genes": ["MMP8"], "type": "Small molecule", "diseases": []}], "heat": 0.1315793582889, "nodes": [{"assoc": 0.184201734492, "id": "ENSG00000003436", "label": "TFPI"}, {"assoc": 0.117586348377, "id": "ENSG00000118113", "label": "MMP8"}, {"assoc": 0.0929499919977, "id": "ENSG00000262406", "label": "MMP12"}], "size": 3}, {"diseases": [], "links": [{"source": "ENSG00000006210", "type": "stimulatory", "target": "ENSG00000168329"}, {"source": "ENSG00000006606", "type": "stimulatory", "target": "ENSG00000168329"}], "drugs": [], "heat": 0.1373065523206, "nodes": [{"assoc": 0.222878117611, "id": "ENSG00000006210", "label": "CX3CL1"}, {"assoc": 0.115603981554, "id": "ENSG00000006606", "label": "CCL26"}, {"assoc": 0.0734375577968, "id": "ENSG00000168329", "label": "CX3CR1"}], "size": 3}, {"diseases": ["HIV INFECTION", "RHEUMATOID ARTHRITIS", "CUTANEOUS T-CELL LYMPHOMA", "LYMPHOMA"], "links": [{"source": "ENSG00000010610", "target": "ENSG00000179344", "reverse": "rev-stimulatory"}, {"source": "ENSG00000010610", "target": "ENSG00000237541", "reverse": "rev-stimulatory"}, {"source": "ENSG00000179344", "target": "ENSG00000237541"}], "drugs": [{"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}, {"efo_term": "CUTANEOUS T-CELL LYMPHOMA", "stage": 2}, {"efo_term": "LYMPHOMA", "stage": 2}], "max_phase": 3, "name": "ZANOLIMUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108063", "mechanisms": ["T-cell surface antigen CD4 other"], "genes": ["CD4"], "type": "Antibody", "diseases": ["RHEUMATOID ARTHRITIS", "CUTANEOUS T-CELL LYMPHOMA", "LYMPHOMA"]}, {"indications": [{"efo_term": "HIV INFECTION", "stage": 3}], "max_phase": 3, "name": "IBALIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743029", "mechanisms": ["T-cell surface antigen CD4 inhibitor"], "genes": ["CD4"], "type": "Antibody", "diseases": ["HIV INFECTION"]}, {"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}], "max_phase": 2, "name": "TREGALIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743083", "mechanisms": ["T-cell surface antigen CD4 agonist"], "genes": ["CD4"], "type": "Antibody", "diseases": ["RHEUMATOID ARTHRITIS"]}, {"indications": [], "max_phase": 2, "name": "CLENOLIXIMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108187", "mechanisms": ["T-cell surface antigen CD4 inhibitor"], "genes": ["CD4"], "type": "Antibody", "diseases": []}, {"indications": [], "max_phase": 1, "name": "CEDELIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108266", "mechanisms": ["T-cell surface antigen CD4 inhibitor"], "genes": ["CD4"], "type": "Antibody", "diseases": []}, {"indications": [], "max_phase": 2, "name": "PRILIXIMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108475", "mechanisms": ["T-cell surface antigen CD4 negative modulator"], "genes": ["CD4"], "type": "Antibody", "diseases": []}, {"indications": [], "max_phase": 2, "name": "KELIXIMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108489", "mechanisms": ["T-cell surface antigen CD4 negative modulator"], "genes": ["CD4"], "type": "Antibody", "diseases": []}, {"indications": [], "max_phase": 2, "name": "TRX-1", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109474", "mechanisms": ["T-cell surface antigen CD4 inhibitor"], "genes": ["CD4"], "type": "Antibody", "diseases": []}], "heat": 0.3881779561363334, "nodes": [{"assoc": 0.29525180813, "id": "ENSG00000010610", "label": "CD4"}, {"assoc": 0.489089060379, "id": "ENSG00000179344", "label": "HLA-DQB1"}, {"assoc": 0.3801929999, "id": "ENSG00000237541", "label": "HLA-DQA2"}], "size": 3}, {"diseases": ["INSOMNIA", "PAIN", "PRURITUS", "SCOLIOSIS", "SICKLE CELL ANEMIA", "TINNITUS", "EPILEPSY", "PROSTATE CARCINOMA", "ALCOHOL DEPENDENCE", "CARPAL TUNNEL SYNDROME", "NEUROPATHIC PAIN", "PREMATURE BIRTH", "FIBROMYALGIA", "LUMBAR DISC DEGENERATION", "NEOPLASM", "PARTIAL EPILEPSY", "CIRRHOSIS OF LIVER", "NICOTINE DEPENDENCE", "SPONTANEOUS ABORTION", "DRUG DEPENDENCE", "OPIOID DEPENDENCE", "VOMITING", "PSYCHOSIS", "DIABETIC NEUROPATHY", "NEUROPATHY", "RESTLESS LEGS SYNDROME", "SEIZURES", "ABNORMALITY OF REFRACTION", "GENERALIZED TONIC-CLONIC SEIZURES", "IRRITABLE BOWEL SYNDROME", "CHRONIC PANCREATITIS", "BONE FRACTURE", "DRY EYE SYNDROME", "SQUAMOUS CELL CARCINOMA", "COUGH", "GENICULATE HERPES ZOSTER", "OVERACTIVE BLADDER", "PREGNANCY", "MARIJUANA DEPENDENCE", "REFLEX SYMPATHETIC DYSTROPHY", "MIGRAINE DISORDER", "ANXIETY", "RENAL INSUFFICIENCY"], "links": [{"source": "ENSG00000096093", "type": "stimulatory", "target": "ENSG00000142185"}, {"source": "ENSG00000096093", "target": "ENSG00000198216"}], "drugs": [{"indications": [{"efo_term": "FIBROMYALGIA", "stage": 4}, {"efo_term": "SEIZURES", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "NEUROPATHIC PAIN", "stage": 4}, {"efo_term": "NEUROPATHY", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "RESTLESS LEGS SYNDROME", "stage": 3}, {"efo_term": "GENERALIZED TONIC-CLONIC SEIZURES", "stage": 3}, {"efo_term": "LUMBAR DISC DEGENERATION", "stage": 3}, {"efo_term": "BONE FRACTURE", "stage": 3}, {"efo_term": "CIRRHOSIS OF LIVER", "stage": 3}, {"efo_term": "GENICULATE HERPES ZOSTER", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 2}, {"efo_term": "CHRONIC PANCREATITIS", "stage": 2}, {"efo_term": "DRY EYE SYNDROME", "stage": 2}, {"efo_term": "OVERACTIVE BLADDER", "stage": 2}, {"efo_term": "REFLEX SYMPATHETIC DYSTROPHY", "stage": 2}, {"efo_term": "ABNORMALITY OF REFRACTION", "stage": 1}, {"efo_term": "SQUAMOUS CELL CARCINOMA", "stage": 1}, {"efo_term": "COUGH", "stage": 1}, {"efo_term": "PREGNANCY", "stage": 1}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 0}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 0}], "max_phase": 4, "name": "PREGABALIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1059", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNA1E"], "type": "Small molecule", "diseases": ["FIBROMYALGIA", "NEUROPATHY", "PAIN", "PARTIAL EPILEPSY", "RESTLESS LEGS SYNDROME", "SEIZURES", "ABNORMALITY OF REFRACTION", "ALCOHOL DEPENDENCE", "EPILEPSY", "GENERALIZED TONIC-CLONIC SEIZURES", "IRRITABLE BOWEL SYNDROME", "NEUROPATHIC PAIN", "LUMBAR DISC DEGENERATION", "CHRONIC PANCREATITIS", "NICOTINE DEPENDENCE", "BONE FRACTURE", "DRY EYE SYNDROME", "SQUAMOUS CELL CARCINOMA", "CIRRHOSIS OF LIVER", "COUGH", "GENICULATE HERPES ZOSTER", "DIABETIC NEUROPATHY", "OVERACTIVE BLADDER", "PREGNANCY", "MARIJUANA DEPENDENCE", "REFLEX SYMPATHETIC DYSTROPHY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "INSOMNIA", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "SCOLIOSIS", "stage": 3}, {"efo_term": "CARPAL TUNNEL SYNDROME", "stage": 3}, {"efo_term": "FIBROMYALGIA", "stage": 3}, {"efo_term": "LUMBAR DISC DEGENERATION", "stage": 3}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "CIRRHOSIS OF LIVER", "stage": 3}, {"efo_term": "VOMITING", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}, {"efo_term": "SICKLE CELL ANEMIA", "stage": 2}, {"efo_term": "TINNITUS", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 2}, {"efo_term": "SPONTANEOUS ABORTION", "stage": 2}, {"efo_term": "OPIOID DEPENDENCE", "stage": 2}, {"efo_term": "PRURITUS", "stage": 1}, {"efo_term": "NEUROPATHIC PAIN", "stage": 1}, {"efo_term": "PREMATURE BIRTH", "stage": 1}, {"efo_term": "DRUG DEPENDENCE", "stage": 1}, {"efo_term": "PSYCHOSIS", "stage": 1}], "max_phase": 4, "name": "GABAPENTIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL940", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNA1E"], "type": "Small molecule", "diseases": ["INSOMNIA", "PAIN", "PRURITUS", "SCOLIOSIS", "SICKLE CELL ANEMIA", "TINNITUS", "EPILEPSY", "PROSTATE CARCINOMA", "ALCOHOL DEPENDENCE", "CARPAL TUNNEL SYNDROME", "NEUROPATHIC PAIN", "PREMATURE BIRTH", "FIBROMYALGIA", "LUMBAR DISC DEGENERATION", "NEOPLASM", "PARTIAL EPILEPSY", "CIRRHOSIS OF LIVER", "NICOTINE DEPENDENCE", "SPONTANEOUS ABORTION", "DRUG DEPENDENCE", "OPIOID DEPENDENCE", "VOMITING", "PSYCHOSIS", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "RESTLESS LEGS SYNDROME", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "MIGRAINE DISORDER", "stage": 2}], "max_phase": 4, "name": "GABAPENTIN ENACARBIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1628502", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNA1E"], "type": "Small molecule", "diseases": ["RESTLESS LEGS SYNDROME", "EPILEPSY", "ALCOHOL DEPENDENCE", "MIGRAINE DISORDER"]}, {"indications": [{"efo_term": "ANXIETY", "stage": 3}, {"efo_term": "RENAL INSUFFICIENCY", "stage": 1}], "max_phase": 3, "name": "IMAGABALIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103836", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNA1E"], "type": "Small molecule", "diseases": ["ANXIETY", "RENAL INSUFFICIENCY"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 2}], "max_phase": 2, "name": "ATAGABALIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL593430", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNA1E"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [], "max_phase": 4, "name": "BEPRIDIL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200382", "mechanisms": ["Voltage-gated calcium channel blocker"], "genes": ["CACNA1E"], "type": "Small molecule", "diseases": []}], "heat": 0.47820151116666665, "nodes": [{"assoc": 0.3352285335, "id": "ENSG00000096093", "label": "EFHC1"}, {"assoc": 0.099376, "id": "ENSG00000142185", "label": "TRPM2"}, {"assoc": 1.0, "id": "ENSG00000198216", "label": "CACNA1E"}], "size": 3}, {"diseases": ["RHEUMATOID ARTHRITIS", "CROHN'S DISEASE", "IMMUNE SYSTEM DISEASE", "MULTIPLE MYELOMA", "MYELODYSPLASTIC SYNDROME", "TYPE I DIABETES MELLITUS", "GIANT LYMPH NODE HYPERPLASIA", "PROSTATE CARCINOMA", "RENAL CARCINOMA", "RENAL CELL CARCINOMA", "SCHIZOPHRENIA", "UNIPOLAR DEPRESSION", "ASTHMA", "PSORIATIC ARTHRITIS", "ACUTE GRAFT VS. HOST DISEASE", "SYSTEMIC LUPUS ERYTHEMATOSUS", "CHRONIC CHILDHOOD ARTHRITIS", "SYSTEMIC SCLERODERMA", "SJOGREN SYNDROME", "MYOCARDIAL INFARCTION", "ANKYLOSING SPONDYLITIS", "FIBROUS DYSPLASIA OF BONE", "PRIMARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS", "CHRONIC KIDNEY DISEASE", "HIV INFECTION", "PULMONARY HYPERTENSION", "ACUTE MYELOID LEUKEMIA", "AMYOTROPHIC LATERAL SCLEROSIS", "DIABETIC RETINOPATHY", "UVEITIS", "GRAVES OPHTHALMOPATHY", "NEUROMYELITIS OPTICA"], "links": [{"source": "ENSG00000099985", "type": "stimulatory", "target": "ENSG00000136244"}, {"source": "ENSG00000136244", "type": "stimulatory", "target": "ENSG00000160712", "reverse": "rev-directed"}], "drugs": [{"indications": [{"efo_term": "CHRONIC CHILDHOOD ARTHRITIS", "stage": 4}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 4}, {"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "SYSTEMIC SCLERODERMA", "stage": 3}, {"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 3}, {"efo_term": "GRAVES OPHTHALMOPATHY", "stage": 3}, {"efo_term": "SJOGREN SYNDROME", "stage": 2}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 2}, {"efo_term": "MYOCARDIAL INFARCTION", "stage": 2}, {"efo_term": "FIBROUS DYSPLASIA OF BONE", "stage": 2}, {"efo_term": "PRIMARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS", "stage": 2}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 2}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 2}, {"efo_term": "AMYOTROPHIC LATERAL SCLEROSIS", "stage": 2}, {"efo_term": "DIABETIC RETINOPATHY", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "UVEITIS", "stage": 2}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 2}, {"efo_term": "SCHIZOPHRENIA", "stage": 1}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 1}, {"efo_term": "HIV INFECTION", "stage": 1}], "max_phase": 4, "name": "TOCILIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237022", "mechanisms": ["Interleukin-6 receptor alpha subunit inhibitor"], "genes": ["IL6R"], "type": "Antibody", "diseases": ["CHRONIC CHILDHOOD ARTHRITIS", "RHEUMATOID ARTHRITIS", "SCHIZOPHRENIA", "SYSTEMIC SCLERODERMA", "SJOGREN SYNDROME", "ACUTE GRAFT VS. HOST DISEASE", "MYOCARDIAL INFARCTION", "ANKYLOSING SPONDYLITIS", "FIBROUS DYSPLASIA OF BONE", "PRIMARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS", "CHRONIC KIDNEY DISEASE", "HIV INFECTION", "IMMUNE SYSTEM DISEASE", "PULMONARY HYPERTENSION", "ACUTE MYELOID LEUKEMIA", "AMYOTROPHIC LATERAL SCLEROSIS", "DIABETIC RETINOPATHY", "UNIPOLAR DEPRESSION", "UVEITIS", "TYPE I DIABETES MELLITUS", "GRAVES OPHTHALMOPATHY"]}, {"indications": [{"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "GIANT LYMPH NODE HYPERPLASIA", "stage": 4}, {"efo_term": "MULTIPLE MYELOMA", "stage": 2}, {"efo_term": "MYELODYSPLASTIC SYNDROME", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "RENAL CARCINOMA", "stage": 2}, {"efo_term": "RENAL CELL CARCINOMA", "stage": 2}, {"efo_term": "SCHIZOPHRENIA", "stage": 1}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 0}], "max_phase": 4, "name": "SILTUXIMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743070", "mechanisms": ["Interleukin-6 inhibitor"], "genes": ["IL6"], "type": "Antibody", "diseases": ["IMMUNE SYSTEM DISEASE", "MULTIPLE MYELOMA", "MYELODYSPLASTIC SYNDROME", "TYPE I DIABETES MELLITUS", "GIANT LYMPH NODE HYPERPLASIA", "PROSTATE CARCINOMA", "RENAL CARCINOMA", "RENAL CELL CARCINOMA", "SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}, {"efo_term": "CROHN'S DISEASE", "stage": 2}, {"efo_term": "PSORIATIC ARTHRITIS", "stage": 2}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 1}], "max_phase": 2, "name": "CLAZAKIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108589", "mechanisms": ["Interleukin-6 inhibitor"], "genes": ["IL6"], "type": "Antibody", "diseases": ["RHEUMATOID ARTHRITIS", "CROHN'S DISEASE", "PSORIATIC ARTHRITIS", "ACUTE GRAFT VS. HOST DISEASE"]}, {"indications": [{"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 3}, {"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 2}, {"efo_term": "CHRONIC CHILDHOOD ARTHRITIS", "stage": 2}], "max_phase": 3, "name": "SARILUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108730", "mechanisms": ["Interleukin-6 receptor alpha subunit antagonist"], "genes": ["IL6R"], "type": "Antibody", "diseases": ["RHEUMATOID ARTHRITIS", "ANKYLOSING SPONDYLITIS", "IMMUNE SYSTEM DISEASE", "CHRONIC CHILDHOOD ARTHRITIS"]}, {"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "ASTHMA", "stage": 2}], "max_phase": 3, "name": "SIRUKUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743071", "mechanisms": ["Interleukin-6 inhibitor"], "genes": ["IL6"], "type": "Antibody", "diseases": ["RHEUMATOID ARTHRITIS", "UNIPOLAR DEPRESSION", "ASTHMA"]}, {"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 3}, {"efo_term": "CROHN'S DISEASE", "stage": 2}], "max_phase": 3, "name": "OLOKIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743050", "mechanisms": ["Interleukin-6 inhibitor"], "genes": ["IL6"], "type": "Antibody", "diseases": ["RHEUMATOID ARTHRITIS", "CROHN'S DISEASE"]}, {"indications": [{"efo_term": "SYSTEMIC LUPUS ERYTHEMATOSUS", "stage": 2}, {"efo_term": "CROHN'S DISEASE", "stage": 2}], "max_phase": 2, "name": "PF-04236921", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109613", "mechanisms": ["Interleukin-6 inhibitor"], "genes": ["IL6"], "type": "Antibody", "diseases": ["SYSTEMIC LUPUS ERYTHEMATOSUS", "CROHN'S DISEASE"]}, {"indications": [{"efo_term": "NEUROMYELITIS OPTICA", "stage": 3}], "max_phase": 0, "name": "SA237", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3833307", "mechanisms": ["IL6Ralpha/GP130 antagonist"], "genes": ["IL6R"], "type": "Antibody", "diseases": ["NEUROMYELITIS OPTICA"]}, {"indications": [], "max_phase": 2, "name": "ELSILIMOMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108591", "mechanisms": ["Interleukin-6 inhibitor"], "genes": ["IL6"], "type": "Antibody", "diseases": []}], "heat": 0.2790666811325, "nodes": [{"assoc": 0.0755440196995, "id": "ENSG00000099985", "label": "OSM"}, {"assoc": 0.332821146599, "id": "ENSG00000136244", "label": "IL6"}, {"assoc": 0.428834877099, "id": "ENSG00000160712", "label": "IL6R"}], "size": 3}, {"diseases": ["ANTI-NEUTROPHIL ANTIBODY ASSOCIATED VASCULITIS", "ATYPICAL HEMOLYTIC-UREMIC SYNDROME", "PAROXYSMAL NOCTURNAL HEMOGLOBINURIA", "MYASTHENIA GRAVIS", "AGE-RELATED MACULAR DEGENERATION", "CHRONIC KIDNEY DISEASE", "ACUTE GRAFT VS. HOST DISEASE", "IMMUNE SYSTEM DISEASE", "NEUROMYELITIS OPTICA", "DIABETES MELLITUS", "THROMBOCYTOPENIA", "MYOCARDIAL INFARCTION", "IGA GLOMERULONEPHRITIS", "VASCULITIS"], "links": [{"source": "ENSG00000106804", "type": "stimulatory", "target": "ENSG00000134830"}, {"source": "ENSG00000106804", "type": "stimulatory", "target": "ENSG00000197405"}, {"source": "ENSG00000134830", "target": "ENSG00000197405"}], "drugs": [{"indications": [{"efo_term": "ATYPICAL HEMOLYTIC-UREMIC SYNDROME", "stage": 4}, {"efo_term": "PAROXYSMAL NOCTURNAL HEMOGLOBINURIA", "stage": 4}, {"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "MYASTHENIA GRAVIS", "stage": 3}, {"efo_term": "NEUROMYELITIS OPTICA", "stage": 3}, {"efo_term": "ANTI-NEUTROPHIL ANTIBODY ASSOCIATED VASCULITIS", "stage": 2}, {"efo_term": "AGE-RELATED MACULAR DEGENERATION", "stage": 2}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 2}, {"efo_term": "DIABETES MELLITUS", "stage": 2}, {"efo_term": "THROMBOCYTOPENIA", "stage": 2}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 1}], "max_phase": 4, "name": "ECULIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201828", "mechanisms": ["Complement C5 inhibitor"], "genes": ["C5"], "type": "Antibody", "diseases": ["ANTI-NEUTROPHIL ANTIBODY ASSOCIATED VASCULITIS", "ATYPICAL HEMOLYTIC-UREMIC SYNDROME", "PAROXYSMAL NOCTURNAL HEMOGLOBINURIA", "MYASTHENIA GRAVIS", "AGE-RELATED MACULAR DEGENERATION", "CHRONIC KIDNEY DISEASE", "ACUTE GRAFT VS. HOST DISEASE", "IMMUNE SYSTEM DISEASE", "NEUROMYELITIS OPTICA", "DIABETES MELLITUS", "THROMBOCYTOPENIA"]}, {"indications": [{"efo_term": "ATYPICAL HEMOLYTIC-UREMIC SYNDROME", "stage": 2}, {"efo_term": "IGA GLOMERULONEPHRITIS", "stage": 2}, {"efo_term": "VASCULITIS", "stage": 2}], "max_phase": 2, "name": "CCX168", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545099", "mechanisms": ["C5a anaphylatoxin chemotactic receptor antagonist"], "genes": ["C5AR1"], "type": "Small molecule", "diseases": ["ATYPICAL HEMOLYTIC-UREMIC SYNDROME", "IGA GLOMERULONEPHRITIS", "VASCULITIS"]}, {"indications": [{"efo_term": "MYOCARDIAL INFARCTION", "stage": 3}], "max_phase": 3, "name": "PEXELIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107979", "mechanisms": ["Complement C5 inhibitor"], "genes": ["C5"], "type": "Antibody", "diseases": ["MYOCARDIAL INFARCTION"]}], "heat": 0.14025981186263334, "nodes": [{"assoc": 0.2, "id": "ENSG00000106804", "label": "C5"}, {"assoc": 0.0559087638889, "id": "ENSG00000134830", "label": "C5AR2"}, {"assoc": 0.164870671699, "id": "ENSG00000197405", "label": "C5AR1"}], "size": 3}, {"diseases": ["PSORIASIS", "RHEUMATOID ARTHRITIS", "ANKYLOSING SPONDYLITIS", "PSORIATIC ARTHRITIS", "IMMUNE SYSTEM DISEASE", "TYPE I DIABETES MELLITUS", "MULTIPLE SCLEROSIS", "ASTHMA", "BEHCET'S SYNDROME", "ALOPECIA AREATA", "CROHN'S DISEASE", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "PYODERMA", "ATOPIC ECZEMA", "UVEITIS", "DRY EYE SYNDROME"], "links": [{"source": "ENSG00000112115", "type": "stimulatory", "target": "ENSG00000177663", "reverse": "rev-inhibitory"}, {"source": "ENSG00000163702", "target": "ENSG00000177663"}], "drugs": [{"indications": [{"efo_term": "PSORIASIS", "stage": 4}, {"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 3}, {"efo_term": "PSORIATIC ARTHRITIS", "stage": 3}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 3}, {"efo_term": "BEHCET'S SYNDROME", "stage": 3}, {"efo_term": "UVEITIS", "stage": 3}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 2}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "ALOPECIA AREATA", "stage": 2}, {"efo_term": "CROHN'S DISEASE", "stage": 2}, {"efo_term": "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "ATOPIC ECZEMA", "stage": 2}, {"efo_term": "DRY EYE SYNDROME", "stage": 2}, {"efo_term": "PYODERMA", "stage": 1}], "max_phase": 4, "name": "SECUKINUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743068", "mechanisms": ["Interleukin 17A inhibitor"], "genes": ["IL17A"], "type": "Antibody", "diseases": ["ANKYLOSING SPONDYLITIS", "PSORIASIS", "TYPE I DIABETES MELLITUS", "MULTIPLE SCLEROSIS", "PSORIATIC ARTHRITIS", "ASTHMA", "RHEUMATOID ARTHRITIS", "IMMUNE SYSTEM DISEASE", "BEHCET'S SYNDROME", "ALOPECIA AREATA", "CROHN'S DISEASE", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "PYODERMA", "ATOPIC ECZEMA", "UVEITIS", "DRY EYE SYNDROME"]}, {"indications": [{"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "PSORIASIS", "stage": 4}, {"efo_term": "PSORIATIC ARTHRITIS", "stage": 3}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}, {"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 2}, {"efo_term": "CROHN'S DISEASE", "stage": 2}, {"efo_term": "ASTHMA", "stage": 2}], "max_phase": 4, "name": "BRODALUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1742996", "mechanisms": ["Interleukin-17 receptor A antagonist"], "genes": ["IL17RA"], "type": "Antibody", "diseases": ["IMMUNE SYSTEM DISEASE", "PSORIASIS", "RHEUMATOID ARTHRITIS", "PSORIATIC ARTHRITIS", "ANKYLOSING SPONDYLITIS", "CROHN'S DISEASE", "ASTHMA"]}, {"indications": [{"efo_term": "PSORIASIS", "stage": 4}, {"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 3}, {"efo_term": "PSORIATIC ARTHRITIS", "stage": 3}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}], "max_phase": 4, "name": "IXEKIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743034", "mechanisms": ["Interleukin 17A inhibitor"], "genes": ["IL17A"], "type": "Antibody", "diseases": ["PSORIASIS", "RHEUMATOID ARTHRITIS", "ANKYLOSING SPONDYLITIS", "PSORIATIC ARTHRITIS", "IMMUNE SYSTEM DISEASE"]}], "heat": 0.237889673786, "nodes": [{"assoc": 0.354821903875, "id": "ENSG00000112115", "label": "IL17A"}, {"assoc": 0.068636, "id": "ENSG00000163702", "label": "IL17RC"}, {"assoc": 0.290211117483, "id": "ENSG00000177663", "label": "IL17RA"}], "size": 3}, {"diseases": [], "links": [{"source": "ENSG00000113249", "target": "ENSG00000145850", "reverse": "rev-stimulatory"}, {"source": "ENSG00000113249", "target": "ENSG00000196189"}], "drugs": [], "heat": 0.0743369754312, "nodes": [{"assoc": 0.114902062348, "id": "ENSG00000113249", "label": "HAVCR1"}, {"assoc": 0.0799928639456, "id": "ENSG00000145850", "label": "TIMD4"}, {"assoc": 0.028116, "id": "ENSG00000196189", "label": "SEMA4A"}], "size": 3}, {"diseases": ["CLEAR CELL RENAL CARCINOMA", "GLIOSARCOMA", "ABNORMALITY OF BLOOD AND BLOOD-FORMING TISSUES", "CHRONIC LYMPHOCYTIC LEUKEMIA", "LEUKEMIA", "MULTIPLE MYELOMA", "NON-HODGKINS LYMPHOMA", "NON-SMALL CELL LUNG CARCINOMA", "PANCREATIC CARCINOMA", "SQUAMOUS CELL LUNG CARCINOMA", "BREAST CARCINOMA", "CHRONIC MYELOGENOUS LEUKEMIA", "PROSTATE CARCINOMA", "ACUTE LYMPHOBLASTIC LEUKEMIA", "GLIOBLASTOMA MULTIFORME", "LUNG CARCINOMA", "METASTATIC MELANOMA", "SYSTEMIC SCLERODERMA", "ACUTE MYELOID LEUKEMIA", "CANCER", "MALIGNANT PLEURAL MESOTHELIOMA", "NEOPLASM", "DIFFUSE LARGE B-CELL LYMPHOMA", "MELANOMA", "MESOTHELIOMA", "POLYCYTHEMIA VERA", "BREAST NEOPLASM", "HEPATOCELLULAR CARCINOMA", "LYMPHOMA", "SMALL CELL LUNG CARCINOMA", "PROSTATE ADENOCARCINOMA", "CHOLANGIOCARCINOMA", "CHRONIC KIDNEY DISEASE", "GASTROINTESTINAL STROMAL TUMOR", "PLEXIFORM NEUROFIBROMA", "PULMONARY HYPERTENSION", "OVARIAN CARCINOMA", "SARCOMA", "MALIGNANT PERIPHERAL NERVE SHEATH TUMOR", "ASTHMA", "CENTRAL NERVOUS SYSTEM CANCER", "NEUROFIBROMATOSIS TYPE 1", "CARCINOMA", "GASTRIC CARCINOMA", "CHONDROSARCOMA", "TYPE I DIABETES MELLITUS", "MALE BREAST CARCINOMA", "HYPEREOSINOPHILIC SYNDROME", "MERKEL CELL SKIN CANCER", "THYROID CARCINOMA", "RENAL CARCINOMA", "RENAL CELL CARCINOMA", "SQUAMOUS CELL CARCINOMA", "AGE-RELATED MACULAR DEGENERATION", "BLADDER CARCINOMA", "VON HIPPEL-LINDAU DISEASE", "KIDNEY NEOPLASM", "KAPOSI'S SARCOMA", "ESOPHAGEAL CARCINOMA", "PANCREATIC NEUROENDOCRINE TUMOR", "PAPILLARY RENAL CELL CARCINOMA", "RECTUM CANCER", "ADRENOCORTICAL CARCINOMA", "ADENOID CYSTIC CARCINOMA", "SALIVARY GLAND NEOPLASM", "LIVER DISEASE", "SKIN ULCER", "DIABETIC FOOT", "CUTANEOUS MELANOMA", "MULTIPLE SCLEROSIS", "RHEUMATOID ARTHRITIS", "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "ALZHEIMERS DISEASE", "PSORIASIS", "COLORECTAL ADENOCARCINOMA", "BILE DUCT CARCINOMA", "OVARIAN NEOPLASM", "COLORECTAL CANCER", "NASOPHARYNGEAL NEOPLASM"], "links": [{"source": "ENSG00000113721", "type": "stimulatory", "target": "ENSG00000134853", "reverse": "rev-stimulatory"}, {"source": "ENSG00000134853", "type": "directed", "target": "ENSG00000151422"}], "drugs": [{"indications": [{"efo_term": "ACUTE LYMPHOBLASTIC LEUKEMIA", "stage": 4}, {"efo_term": "CANCER", "stage": 4}, {"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "LEUKEMIA", "stage": 3}, {"efo_term": "CHRONIC MYELOGENOUS LEUKEMIA", "stage": 3}, {"efo_term": "ABNORMALITY OF BLOOD AND BLOOD-FORMING TISSUES", "stage": 2}, {"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 2}, {"efo_term": "MULTIPLE MYELOMA", "stage": 2}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "PANCREATIC CARCINOMA", "stage": 2}, {"efo_term": "SQUAMOUS CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "LUNG CARCINOMA", "stage": 2}, {"efo_term": "METASTATIC MELANOMA", "stage": 2}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 2}, {"efo_term": "MALIGNANT PLEURAL MESOTHELIOMA", "stage": 2}, {"efo_term": "DIFFUSE LARGE B-CELL LYMPHOMA", "stage": 2}, {"efo_term": "MELANOMA", "stage": 2}, {"efo_term": "MESOTHELIOMA", "stage": 2}, {"efo_term": "POLYCYTHEMIA VERA", "stage": 2}, {"efo_term": "BREAST NEOPLASM", "stage": 2}, {"efo_term": "HEPATOCELLULAR CARCINOMA", "stage": 2}, {"efo_term": "LYMPHOMA", "stage": 2}, {"efo_term": "SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "PROSTATE ADENOCARCINOMA", "stage": 2}, {"efo_term": "CHOLANGIOCARCINOMA", "stage": 2}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 2}, {"efo_term": "GLIOSARCOMA", "stage": 2}, {"efo_term": "NON-HODGKINS LYMPHOMA", "stage": 1}, {"efo_term": "GLIOBLASTOMA MULTIFORME", "stage": 1}, {"efo_term": "SYSTEMIC SCLERODERMA", "stage": 1}], "max_phase": 4, "name": "DASATINIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421", "mechanisms": ["Platelet-derived growth factor receptor beta inhibitor"], "genes": ["PDGFRB"], "type": "Small molecule", "diseases": ["ABNORMALITY OF BLOOD AND BLOOD-FORMING TISSUES", "CHRONIC LYMPHOCYTIC LEUKEMIA", "LEUKEMIA", "MULTIPLE MYELOMA", "NON-HODGKINS LYMPHOMA", "NON-SMALL CELL LUNG CARCINOMA", "PANCREATIC CARCINOMA", "SQUAMOUS CELL LUNG CARCINOMA", "BREAST CARCINOMA", "CHRONIC MYELOGENOUS LEUKEMIA", "PROSTATE CARCINOMA", "ACUTE LYMPHOBLASTIC LEUKEMIA", "GLIOBLASTOMA MULTIFORME", "LUNG CARCINOMA", "METASTATIC MELANOMA", "SYSTEMIC SCLERODERMA", "ACUTE MYELOID LEUKEMIA", "CANCER", "MALIGNANT PLEURAL MESOTHELIOMA", "NEOPLASM", "DIFFUSE LARGE B-CELL LYMPHOMA", "MELANOMA", "MESOTHELIOMA", "POLYCYTHEMIA VERA", "BREAST NEOPLASM", "HEPATOCELLULAR CARCINOMA", "LYMPHOMA", "SMALL CELL LUNG CARCINOMA", "PROSTATE ADENOCARCINOMA", "CHOLANGIOCARCINOMA", "CHRONIC KIDNEY DISEASE", "GLIOSARCOMA"]}, {"indications": [{"efo_term": "GASTROINTESTINAL STROMAL TUMOR", "stage": 4}, {"efo_term": "CHRONIC MYELOGENOUS LEUKEMIA", "stage": 3}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 3}, {"efo_term": "SARCOMA", "stage": 3}, {"efo_term": "PLEXIFORM NEUROFIBROMA", "stage": 2}, {"efo_term": "POLYCYTHEMIA VERA", "stage": 2}, {"efo_term": "ACUTE LYMPHOBLASTIC LEUKEMIA", "stage": 2}, {"efo_term": "LEUKEMIA", "stage": 2}, {"efo_term": "OVARIAN CARCINOMA", "stage": 2}, {"efo_term": "SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "SYSTEMIC SCLERODERMA", "stage": 2}, {"efo_term": "MELANOMA", "stage": 2}, {"efo_term": "MALIGNANT PERIPHERAL NERVE SHEATH TUMOR", "stage": 2}, {"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "NEUROFIBROMATOSIS TYPE 1", "stage": 2}, {"efo_term": "CARCINOMA", "stage": 2}, {"efo_term": "GASTRIC CARCINOMA", "stage": 2}, {"efo_term": "CHONDROSARCOMA", "stage": 2}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 2}, {"efo_term": "MALE BREAST CARCINOMA", "stage": 2}, {"efo_term": "HYPEREOSINOPHILIC SYNDROME", "stage": 2}, {"efo_term": "MERKEL CELL SKIN CANCER", "stage": 2}, {"efo_term": "CENTRAL NERVOUS SYSTEM CANCER", "stage": 1}, {"efo_term": "CANCER", "stage": 1}, {"efo_term": "NEOPLASM", "stage": 1}], "max_phase": 4, "name": "IMATINIB MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1642", "mechanisms": ["Platelet-derived growth factor receptor beta inhibitor"], "genes": ["PDGFRB"], "type": "Small molecule", "diseases": ["CHRONIC MYELOGENOUS LEUKEMIA", "GASTROINTESTINAL STROMAL TUMOR", "PLEXIFORM NEUROFIBROMA", "POLYCYTHEMIA VERA", "PULMONARY HYPERTENSION", "ACUTE LYMPHOBLASTIC LEUKEMIA", "LEUKEMIA", "OVARIAN CARCINOMA", "SARCOMA", "SMALL CELL LUNG CARCINOMA", "SYSTEMIC SCLERODERMA", "MELANOMA", "MALIGNANT PERIPHERAL NERVE SHEATH TUMOR", "ASTHMA", "CENTRAL NERVOUS SYSTEM CANCER", "NEUROFIBROMATOSIS TYPE 1", "CARCINOMA", "GASTRIC CARCINOMA", "CHONDROSARCOMA", "TYPE I DIABETES MELLITUS", "CANCER", "MALE BREAST CARCINOMA", "NEOPLASM", "HYPEREOSINOPHILIC SYNDROME", "MERKEL CELL SKIN CANCER"]}, {"indications": [{"efo_term": "RENAL CELL CARCINOMA", "stage": 3}, {"efo_term": "CLEAR CELL RENAL CARCINOMA", "stage": 3}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "VON HIPPEL-LINDAU DISEASE", "stage": 2}, {"efo_term": "BLADDER CARCINOMA", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "MULTIPLE MYELOMA", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "ADRENOCORTICAL CARCINOMA", "stage": 2}, {"efo_term": "ADENOID CYSTIC CARCINOMA", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 2}, {"efo_term": "MALIGNANT PLEURAL MESOTHELIOMA", "stage": 2}, {"efo_term": "HEPATOCELLULAR CARCINOMA", "stage": 2}, {"efo_term": "GASTRIC CARCINOMA", "stage": 2}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "GASTROINTESTINAL STROMAL TUMOR", "stage": 2}, {"efo_term": "SALIVARY GLAND NEOPLASM", "stage": 2}, {"efo_term": "THYROID CARCINOMA", "stage": 2}, {"efo_term": "GLIOSARCOMA", "stage": 2}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 1}, {"efo_term": "MELANOMA", "stage": 1}, {"efo_term": "GLIOBLASTOMA MULTIFORME", "stage": 1}], "max_phase": 3, "name": "DOVITINIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL522892", "mechanisms": ["Platelet-derived growth factor receptor inhibitor"], "genes": ["PDGFRB", "PDGFRA"], "type": "Small molecule", "diseases": ["ACUTE MYELOID LEUKEMIA", "CANCER", "VON HIPPEL-LINDAU DISEASE", "BLADDER CARCINOMA", "BREAST CARCINOMA", "MELANOMA", "MULTIPLE MYELOMA", "PROSTATE CARCINOMA", "ADRENOCORTICAL CARCINOMA", "ADENOID CYSTIC CARCINOMA", "NEOPLASM", "RENAL CELL CARCINOMA", "MALIGNANT PLEURAL MESOTHELIOMA", "HEPATOCELLULAR CARCINOMA", "GASTRIC CARCINOMA", "CLEAR CELL RENAL CARCINOMA", "NON-SMALL CELL LUNG CARCINOMA", "GASTROINTESTINAL STROMAL TUMOR", "SALIVARY GLAND NEOPLASM", "GLIOBLASTOMA MULTIFORME", "THYROID CARCINOMA", "GLIOSARCOMA"]}, {"indications": [{"efo_term": "GASTROINTESTINAL STROMAL TUMOR", "stage": 4}, {"efo_term": "RENAL CARCINOMA", "stage": 4}, {"efo_term": "RENAL CELL CARCINOMA", "stage": 4}, {"efo_term": "CLEAR CELL RENAL CARCINOMA", "stage": 4}, {"efo_term": "PANCREATIC NEUROENDOCRINE TUMOR", "stage": 4}, {"efo_term": "PAPILLARY RENAL CELL CARCINOMA", "stage": 4}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 3}, {"efo_term": "HEPATOCELLULAR CARCINOMA", "stage": 3}, {"efo_term": "KIDNEY NEOPLASM", "stage": 3}, {"efo_term": "BREAST NEOPLASM", "stage": 3}, {"efo_term": "BLADDER CARCINOMA", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "KAPOSI'S SARCOMA", "stage": 2}, {"efo_term": "MESOTHELIOMA", "stage": 2}, {"efo_term": "LYMPHOMA", "stage": 2}, {"efo_term": "ESOPHAGEAL CARCINOMA", "stage": 2}, {"efo_term": "MULTIPLE MYELOMA", "stage": 2}, {"efo_term": "DIFFUSE LARGE B-CELL LYMPHOMA", "stage": 2}, {"efo_term": "VON HIPPEL-LINDAU DISEASE", "stage": 1}], "max_phase": 4, "name": "SUNITINIB MALATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1567", "mechanisms": ["Platelet-derived growth factor receptor inhibitor"], "genes": ["PDGFRB", "PDGFRA"], "type": "Small molecule", "diseases": ["BLADDER CARCINOMA", "BREAST CARCINOMA", "GASTROINTESTINAL STROMAL TUMOR", "NON-SMALL CELL LUNG CARCINOMA", "PROSTATE CARCINOMA", "RENAL CARCINOMA", "RENAL CELL CARCINOMA", "HEPATOCELLULAR CARCINOMA", "CLEAR CELL RENAL CARCINOMA", "VON HIPPEL-LINDAU DISEASE", "KIDNEY NEOPLASM", "CANCER", "BREAST NEOPLASM", "KAPOSI'S SARCOMA", "MESOTHELIOMA", "LYMPHOMA", "ESOPHAGEAL CARCINOMA", "MULTIPLE MYELOMA", "DIFFUSE LARGE B-CELL LYMPHOMA", "PANCREATIC NEUROENDOCRINE TUMOR", "PAPILLARY RENAL CELL CARCINOMA"]}, {"indications": [{"efo_term": "CANCER", "stage": 4}, {"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "COLORECTAL ADENOCARCINOMA", "stage": 3}, {"efo_term": "HEPATOCELLULAR CARCINOMA", "stage": 3}, {"efo_term": "COLORECTAL CANCER", "stage": 3}, {"efo_term": "ADENOID CYSTIC CARCINOMA", "stage": 2}, {"efo_term": "BILE DUCT CARCINOMA", "stage": 2}, {"efo_term": "GASTROINTESTINAL STROMAL TUMOR", "stage": 2}, {"efo_term": "PANCREATIC CARCINOMA", "stage": 2}, {"efo_term": "SARCOMA", "stage": 2}, {"efo_term": "CHOLANGIOCARCINOMA", "stage": 2}, {"efo_term": "CARCINOMA", "stage": 2}, {"efo_term": "OVARIAN NEOPLASM", "stage": 2}, {"efo_term": "MELANOMA", "stage": 2}, {"efo_term": "THYROID CARCINOMA", "stage": 2}, {"efo_term": "OVARIAN CARCINOMA", "stage": 2}, {"efo_term": "RECTUM CANCER", "stage": 2}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "GLIOBLASTOMA MULTIFORME", "stage": 2}], "max_phase": 4, "name": "REGORAFENIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1946170", "mechanisms": ["Platelet-derived growth factor receptor inhibitor"], "genes": ["PDGFRB", "PDGFRA"], "type": "Small molecule", "diseases": ["COLORECTAL ADENOCARCINOMA", "ADENOID CYSTIC CARCINOMA", "BILE DUCT CARCINOMA", "CANCER", "GASTROINTESTINAL STROMAL TUMOR", "PANCREATIC CARCINOMA", "SARCOMA", "HEPATOCELLULAR CARCINOMA", "CHOLANGIOCARCINOMA", "NEOPLASM", "CARCINOMA", "OVARIAN NEOPLASM", "MELANOMA", "THYROID CARCINOMA", "OVARIAN CARCINOMA", "RECTUM CANCER", "COLORECTAL CANCER", "NON-SMALL CELL LUNG CARCINOMA", "GLIOBLASTOMA MULTIFORME"]}, {"indications": [{"efo_term": "HEPATOCELLULAR CARCINOMA", "stage": 3}, {"efo_term": "RENAL CARCINOMA", "stage": 3}, {"efo_term": "CLEAR CELL RENAL CARCINOMA", "stage": 3}, {"efo_term": "GASTROINTESTINAL STROMAL TUMOR", "stage": 2}, {"efo_term": "SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "THYROID CARCINOMA", "stage": 2}, {"efo_term": "PANCREATIC CARCINOMA", "stage": 2}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "MULTIPLE MYELOMA", "stage": 2}, {"efo_term": "MELANOMA", "stage": 2}, {"efo_term": "MESOTHELIOMA", "stage": 2}, {"efo_term": "PROSTATE ADENOCARCINOMA", "stage": 2}, {"efo_term": "MALE BREAST CARCINOMA", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 1}], "max_phase": 4, "name": "SORAFENIB TOSYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200485", "mechanisms": ["Platelet-derived growth factor receptor beta inhibitor"], "genes": ["PDGFRB"], "type": "Small molecule", "diseases": ["GASTROINTESTINAL STROMAL TUMOR", "HEPATOCELLULAR CARCINOMA", "NEOPLASM", "SMALL CELL LUNG CARCINOMA", "THYROID CARCINOMA", "PANCREATIC CARCINOMA", "RENAL CARCINOMA", "NON-SMALL CELL LUNG CARCINOMA", "MULTIPLE MYELOMA", "MELANOMA", "CLEAR CELL RENAL CARCINOMA", "MESOTHELIOMA", "PROSTATE ADENOCARCINOMA", "MALE BREAST CARCINOMA"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "ASTHMA", "stage": 3}, {"efo_term": "GASTROINTESTINAL STROMAL TUMOR", "stage": 3}, {"efo_term": "MULTIPLE MYELOMA", "stage": 3}, {"efo_term": "METASTATIC MELANOMA", "stage": 3}, {"efo_term": "PANCREATIC CARCINOMA", "stage": 3}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}, {"efo_term": "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "PSORIASIS", "stage": 2}, {"efo_term": "OVARIAN CARCINOMA", "stage": 2}], "max_phase": 3, "name": "MASITINIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1908391", "mechanisms": ["Platelet-derived growth factor receptor inhibitor"], "genes": ["PDGFRB", "PDGFRA"], "type": "Small molecule", "diseases": ["NEOPLASM", "MULTIPLE SCLEROSIS", "RHEUMATOID ARTHRITIS", "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "ALZHEIMERS DISEASE", "ASTHMA", "GASTROINTESTINAL STROMAL TUMOR", "MULTIPLE MYELOMA", "METASTATIC MELANOMA", "PSORIASIS", "PANCREATIC CARCINOMA", "OVARIAN CARCINOMA"]}, {"indications": [{"efo_term": "SARCOMA", "stage": 4}, {"efo_term": "CLEAR CELL RENAL CARCINOMA", "stage": 4}, {"efo_term": "RENAL CELL CARCINOMA", "stage": 4}, {"efo_term": "LUNG CARCINOMA", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "CUTANEOUS MELANOMA", "stage": 2}, {"efo_term": "MALE BREAST CARCINOMA", "stage": 2}, {"efo_term": "MESOTHELIOMA", "stage": 2}, {"efo_term": "GLIOSARCOMA", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 1}], "max_phase": 4, "name": "PAZOPANIB HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201733", "mechanisms": ["Platelet-derived growth factor receptor inhibitor"], "genes": ["PDGFRB", "PDGFRA"], "type": "Small molecule", "diseases": ["SARCOMA", "LUNG CARCINOMA", "PROSTATE CARCINOMA", "CUTANEOUS MELANOMA", "MALE BREAST CARCINOMA", "MESOTHELIOMA", "CLEAR CELL RENAL CARCINOMA", "RENAL CELL CARCINOMA", "NEOPLASM", "GLIOSARCOMA"]}, {"indications": [{"efo_term": "RENAL CELL CARCINOMA", "stage": 2}, {"efo_term": "THYROID CARCINOMA", "stage": 2}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 2}, {"efo_term": "SQUAMOUS CELL CARCINOMA", "stage": 2}, {"efo_term": "SARCOMA", "stage": 2}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "GASTRIC CARCINOMA", "stage": 2}, {"efo_term": "HEPATOCELLULAR CARCINOMA", "stage": 2}], "max_phase": 2, "name": "Anlotinib", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545021", "mechanisms": ["Platelet-derived growth factor receptor beta inhibitor"], "genes": ["PDGFRB"], "type": "Small molecule", "diseases": ["RENAL CELL CARCINOMA", "THYROID CARCINOMA", "CANCER", "NEOPLASM", "SQUAMOUS CELL CARCINOMA", "SARCOMA", "NON-SMALL CELL LUNG CARCINOMA", "GASTRIC CARCINOMA", "HEPATOCELLULAR CARCINOMA"]}, {"indications": [{"efo_term": "SARCOMA", "stage": 2}, {"efo_term": "DIFFUSE LARGE B-CELL LYMPHOMA", "stage": 2}, {"efo_term": "MULTIPLE MYELOMA", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 2}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "MESOTHELIOMA", "stage": 2}, {"efo_term": "MELANOMA", "stage": 1}, {"efo_term": "AGE-RELATED MACULAR DEGENERATION", "stage": 1}], "max_phase": 3, "name": "VATALANIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL101253", "mechanisms": ["Platelet-derived growth factor receptor inhibitor"], "genes": ["PDGFRB", "PDGFRA"], "type": "Small molecule", "diseases": ["SARCOMA", "DIFFUSE LARGE B-CELL LYMPHOMA", "MELANOMA", "MULTIPLE MYELOMA", "PROSTATE CARCINOMA", "NEOPLASM", "AGE-RELATED MACULAR DEGENERATION", "NON-SMALL CELL LUNG CARCINOMA", "MESOTHELIOMA"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "CANCER", "stage": 4}, {"efo_term": "OVARIAN CARCINOMA", "stage": 3}, {"efo_term": "GLIOBLASTOMA MULTIFORME", "stage": 3}, {"efo_term": "RENAL CELL CARCINOMA", "stage": 2}, {"efo_term": "LUNG CARCINOMA", "stage": 1}, {"efo_term": "RECTUM CANCER", "stage": 1}], "max_phase": 3, "name": "CEDIRANIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL491473", "mechanisms": ["Platelet-derived growth factor receptor inhibitor"], "genes": ["PDGFRB", "PDGFRA"], "type": "Small molecule", "diseases": ["NEOPLASM", "LUNG CARCINOMA", "OVARIAN CARCINOMA", "CANCER", "RENAL CELL CARCINOMA", "GLIOBLASTOMA MULTIFORME", "RECTUM CANCER"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 2}, {"efo_term": "LEUKEMIA", "stage": 2}, {"efo_term": "LIVER DISEASE", "stage": 1}, {"efo_term": "RECTUM CANCER", "stage": 1}], "max_phase": 3, "name": "MIDOSTAURIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533", "mechanisms": ["Platelet-derived growth factor receptor inhibitor"], "genes": ["PDGFRB", "PDGFRA"], "type": "Small molecule", "diseases": ["ACUTE MYELOID LEUKEMIA", "LEUKEMIA", "LIVER DISEASE", "NEOPLASM", "RECTUM CANCER"]}, {"indications": [{"efo_term": "GASTROINTESTINAL STROMAL TUMOR", "stage": 2}, {"efo_term": "NASOPHARYNGEAL NEOPLASM", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 2}, {"efo_term": "RENAL CELL CARCINOMA", "stage": 2}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}], "max_phase": 3, "name": "Famitinib", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545026", "mechanisms": ["Platelet-derived growth factor receptor inhibitor"], "genes": ["PDGFRB", "PDGFRA"], "type": "Small molecule", "diseases": ["GASTROINTESTINAL STROMAL TUMOR", "NASOPHARYNGEAL NEOPLASM", "NEOPLASM", "RENAL CELL CARCINOMA", "NON-SMALL CELL LUNG CARCINOMA"]}, {"indications": [{"efo_term": "SARCOMA", "stage": 4}, {"efo_term": "GASTROINTESTINAL STROMAL TUMOR", "stage": 2}, {"efo_term": "CENTRAL NERVOUS SYSTEM CANCER", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 1}, {"efo_term": "CANCER", "stage": 1}], "max_phase": 4, "name": "OLARATUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743049", "mechanisms": ["Platelet-derived growth factor receptor alpha antagonist"], "genes": ["PDGFRA"], "type": "Antibody", "diseases": ["SARCOMA", "NEOPLASM", "GASTROINTESTINAL STROMAL TUMOR", "CANCER", "CENTRAL NERVOUS SYSTEM CANCER"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "HEPATOCELLULAR CARCINOMA", "stage": 1}], "max_phase": 2, "name": "FORETINIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1230609", "mechanisms": ["Platelet-derived growth factor receptor inhibitor"], "genes": ["PDGFRB", "PDGFRA"], "type": "Small molecule", "diseases": ["NEOPLASM", "BREAST CARCINOMA", "HEPATOCELLULAR CARCINOMA", "CANCER"]}, {"indications": [{"efo_term": "RENAL CELL CARCINOMA", "stage": 2}, {"efo_term": "HEPATOCELLULAR CARCINOMA", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 1}], "max_phase": 3, "name": "LINIFANIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL223360", "mechanisms": ["Platelet-derived growth factor receptor inhibitor"], "genes": ["PDGFRB", "PDGFRA"], "type": "Small molecule", "diseases": ["RENAL CELL CARCINOMA", "NEOPLASM", "HEPATOCELLULAR CARCINOMA"]}, {"indications": [{"efo_term": "CLEAR CELL RENAL CARCINOMA", "stage": 2}, {"efo_term": "GLIOSARCOMA", "stage": 1}], "max_phase": 2, "name": "TANDUTINIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL124660", "mechanisms": ["Platelet-derived growth factor receptor beta inhibitor"], "genes": ["PDGFRB"], "type": "Small molecule", "diseases": ["CLEAR CELL RENAL CARCINOMA", "GLIOSARCOMA"]}, {"indications": [{"efo_term": "CANCER", "stage": 1}, {"efo_term": "AGE-RELATED MACULAR DEGENERATION", "stage": 1}], "max_phase": 1, "name": "CM-082", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545427", "mechanisms": ["Platelet-derived growth factor receptor beta inhibitor"], "genes": ["PDGFRB"], "type": "Small molecule", "diseases": ["CANCER", "AGE-RELATED MACULAR DEGENERATION"]}, {"indications": [{"efo_term": "HEPATOCELLULAR CARCINOMA", "stage": 3}, {"efo_term": "NEOPLASM", "stage": 1}], "max_phase": 3, "name": "ORANTINIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL274654", "mechanisms": ["Platelet-derived growth factor receptor inhibitor"], "genes": ["PDGFRB", "PDGFRA"], "type": "Small molecule", "diseases": ["NEOPLASM", "HEPATOCELLULAR CARCINOMA"]}, {"indications": [{"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 3}, {"efo_term": "NEOPLASM", "stage": 1}], "max_phase": 3, "name": "QUIZARTINIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL576982", "mechanisms": ["Platelet-derived growth factor receptor inhibitor"], "genes": ["PDGFRB", "PDGFRA"], "type": "Small molecule", "diseases": ["ACUTE MYELOID LEUKEMIA", "NEOPLASM"]}, {"indications": [{"efo_term": "SKIN ULCER", "stage": 4}, {"efo_term": "DIABETIC FOOT", "stage": 1}], "max_phase": 4, "name": "BECAPLERMIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201556", "mechanisms": ["Platelet-derived growth factor receptor agonist"], "genes": ["PDGFRB", "PDGFRA"], "type": "Protein", "diseases": ["SKIN ULCER", "DIABETIC FOOT"]}, {"indications": [{"efo_term": "BREAST NEOPLASM", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 1}], "max_phase": 2, "name": "SU-014813", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1721885", "mechanisms": ["Platelet-derived growth factor receptor inhibitor"], "genes": ["PDGFRB", "PDGFRA"], "type": "Small molecule", "diseases": ["BREAST NEOPLASM", "NEOPLASM"]}, {"indications": [{"efo_term": "CANCER", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 2}], "max_phase": 2, "name": "ILORASERTIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1980297", "mechanisms": ["Platelet-derived growth factor receptor inhibitor"], "genes": ["PDGFRB", "PDGFRA"], "type": "Small molecule", "diseases": ["CANCER", "NEOPLASM"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 1}], "max_phase": 1, "name": "RG-1530", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1980391", "mechanisms": ["Platelet-derived growth factor receptor beta inhibitor"], "genes": ["PDGFRB"], "type": "Small molecule", "diseases": ["NEOPLASM"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 1}], "max_phase": 2, "name": "JI-101", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545155", "mechanisms": ["Platelet-derived growth factor receptor beta inhibitor"], "genes": ["PDGFRB"], "type": "Small molecule", "diseases": ["NEOPLASM"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 1}], "max_phase": 1, "name": "TAK-593", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2180604", "mechanisms": ["Platelet-derived growth factor receptor inhibitor"], "genes": ["PDGFRB", "PDGFRA"], "type": "Small molecule", "diseases": ["NEOPLASM"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 1}], "max_phase": 2, "name": "X-82", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545401", "mechanisms": ["Platelet-derived growth factor receptor inhibitor"], "genes": ["PDGFRB", "PDGFRA"], "type": "Small molecule", "diseases": ["NEOPLASM"]}, {"indications": [{"efo_term": "GASTROINTESTINAL STROMAL TUMOR", "stage": 2}], "max_phase": 2, "name": "XL-820", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545402", "mechanisms": ["Platelet-derived growth factor receptor inhibitor"], "genes": ["PDGFRB", "PDGFRA"], "type": "Small molecule", "diseases": ["GASTROINTESTINAL STROMAL TUMOR"]}, {"indications": [{"efo_term": "SMALL CELL LUNG CARCINOMA", "stage": 2}], "max_phase": 2, "name": "AMUVATINIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103851", "mechanisms": ["Platelet-derived growth factor receptor alpha  inhibitor"], "genes": ["PDGFRA"], "type": "Small molecule", "diseases": ["SMALL CELL LUNG CARCINOMA"]}, {"indications": [], "max_phase": 2, "name": "TG100-801", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL403989", "mechanisms": ["Platelet-derived growth factor receptor beta inhibitor"], "genes": ["PDGFRB"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "TELATINIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2079588", "mechanisms": ["Platelet-derived growth factor receptor beta inhibitor"], "genes": ["PDGFRB"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "CDP-860", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109544", "mechanisms": ["Platelet-derived growth factor receptor beta inhibitor"], "genes": ["PDGFRB"], "type": "Antibody", "diseases": []}, {"indications": [], "max_phase": 1, "name": "Puquitinib", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545088", "mechanisms": ["Platelet-derived growth factor receptor beta inhibitor"], "genes": ["PDGFRB"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "PD-0166285", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545196", "mechanisms": ["Platelet-derived growth factor receptor beta inhibitor"], "genes": ["PDGFRB"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "CEP-2563", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545332", "mechanisms": ["Platelet-derived growth factor receptor beta inhibitor"], "genes": ["PDGFRB"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "ENMD-981693", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL52885", "mechanisms": ["Platelet-derived growth factor receptor inhibitor"], "genes": ["PDGFRB", "PDGFRA"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "MOTESANIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL572881", "mechanisms": ["Platelet-derived growth factor receptor inhibitor"], "genes": ["PDGFRB", "PDGFRA"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "CRENOLANIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105728", "mechanisms": ["Platelet-derived growth factor receptor inhibitor"], "genes": ["PDGFRB", "PDGFRA"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "NINTEDANIB ESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3039504", "mechanisms": ["Platelet-derived growth factor receptor inhibitor"], "genes": ["PDGFRB", "PDGFRA"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "SU-14813", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545160", "mechanisms": ["Platelet-derived growth factor receptor inhibitor"], "genes": ["PDGFRB", "PDGFRA"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "XL-999", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545285", "mechanisms": ["Platelet-derived growth factor receptor inhibitor"], "genes": ["PDGFRB", "PDGFRA"], "type": "Small molecule", "diseases": []}], "heat": 0.6317001231480001, "nodes": [{"assoc": 0.784297659722, "id": "ENSG00000113721", "label": "PDGFRB"}, {"assoc": 0.766151625, "id": "ENSG00000134853", "label": "PDGFRA"}, {"assoc": 0.344651084722, "id": "ENSG00000151422", "label": "FER"}], "size": 3}, {"diseases": [], "links": [{"source": "ENSG00000115604", "target": "ENSG00000150782", "reverse": "rev-stimulatory"}, {"source": "ENSG00000137496", "type": "inhibitory", "target": "ENSG00000150782", "reverse": "rev-directed"}], "drugs": [], "heat": 0.3004986094503333, "nodes": [{"assoc": 0.633115187815, "id": "ENSG00000115604", "label": "IL18R1"}, {"assoc": 0.0687545, "id": "ENSG00000137496", "label": "IL18BP"}, {"assoc": 0.199626140536, "id": "ENSG00000150782", "label": "IL18"}], "size": 3}, {"diseases": ["ACTINIC KERATOSIS", "BASAL CELL CARCINOMA", "CENTRAL NERVOUS SYSTEM CANCER", "MELANOMA", "VIRAL DISEASE", "VULVAR INTRAEPITHELIAL NEOPLASIA", "BREAST CARCINOMA", "OSTEOSARCOMA", "PROSTATE CARCINOMA", "GLIOBLASTOMA MULTIFORME", "CERVICAL CARCINOMA", "INFLUENZA INFECTION", "INTERSTITIAL LUNG DISEASE"], "links": [{"source": "ENSG00000129988", "target": "ENSG00000170458", "reverse": "rev-directed"}, {"source": "ENSG00000170458", "type": "directed", "target": "ENSG00000196664"}], "drugs": [{"indications": [{"efo_term": "ACTINIC KERATOSIS", "stage": 4}, {"efo_term": "VIRAL DISEASE", "stage": 4}, {"efo_term": "BASAL CELL CARCINOMA", "stage": 3}, {"efo_term": "VULVAR INTRAEPITHELIAL NEOPLASIA", "stage": 3}, {"efo_term": "INFLUENZA INFECTION", "stage": 3}, {"efo_term": "MELANOMA", "stage": 2}, {"efo_term": "CERVICAL CARCINOMA", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 1}, {"efo_term": "OSTEOSARCOMA", "stage": 1}, {"efo_term": "PROSTATE CARCINOMA", "stage": 1}, {"efo_term": "GLIOBLASTOMA MULTIFORME", "stage": 1}, {"efo_term": "CENTRAL NERVOUS SYSTEM CANCER", "stage": 0}], "max_phase": 4, "name": "IMIQUIMOD", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1282", "mechanisms": ["Toll-like receptor 7 agonist"], "genes": ["TLR7"], "type": "Small molecule", "diseases": ["ACTINIC KERATOSIS", "BASAL CELL CARCINOMA", "CENTRAL NERVOUS SYSTEM CANCER", "MELANOMA", "VIRAL DISEASE", "VULVAR INTRAEPITHELIAL NEOPLASIA", "BREAST CARCINOMA", "OSTEOSARCOMA", "PROSTATE CARCINOMA", "GLIOBLASTOMA MULTIFORME", "CERVICAL CARCINOMA", "INFLUENZA INFECTION"]}, {"indications": [{"efo_term": "INTERSTITIAL LUNG DISEASE", "stage": 2}], "max_phase": 4, "name": "HYDROXYCHLOROQUINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1690", "mechanisms": ["Toll-like receptor 7 antagonist"], "genes": ["TLR7"], "type": "Small molecule", "diseases": ["INTERSTITIAL LUNG DISEASE"]}, {"indications": [], "max_phase": 2, "name": "IC14", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109330", "mechanisms": ["Monocyte differentiation antigen CD14 inhibitor"], "genes": ["CD14"], "type": "Antibody", "diseases": []}], "heat": 0.185042236527, "nodes": [{"assoc": 0.147900263889, "id": "ENSG00000129988", "label": "LBP"}, {"assoc": 0.278094521668, "id": "ENSG00000170458", "label": "CD14"}, {"assoc": 0.129131924024, "id": "ENSG00000196664", "label": "TLR7"}], "size": 3}, {"diseases": ["ALLERGY", "ASTHMA", "URTICARIA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "EOSINOPHILIC ESOPHAGITIS", "IMMUNE SYSTEM DISEASE", "OBSTRUCTIVE LUNG DISEASE", "COLORECTAL ADENOCARCINOMA", "SINUSITIS", "ATOPIC ECZEMA", "INFLUENZA INFECTION", "UNIPOLAR DEPRESSION", "BULLOUS PEMPHIGOID", "ALLERGIC RHINITIS"], "links": [{"source": "ENSG00000149534", "type": "directed", "target": "ENSG00000179639", "reverse": "rev-directed"}, {"source": "ENSG00000179639", "type": "directed", "target": "ENSG00000211891"}], "drugs": [{"indications": [{"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "URTICARIA", "stage": 4}, {"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "INFLUENZA INFECTION", "stage": 3}, {"efo_term": "ALLERGY", "stage": 2}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}, {"efo_term": "EOSINOPHILIC ESOPHAGITIS", "stage": 2}, {"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 2}, {"efo_term": "SINUSITIS", "stage": 2}, {"efo_term": "ATOPIC ECZEMA", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "BULLOUS PEMPHIGOID", "stage": 2}, {"efo_term": "COLORECTAL ADENOCARCINOMA", "stage": 1}], "max_phase": 4, "name": "OMALIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201589", "mechanisms": ["Ig epsilon chain C region inhibitor"], "genes": ["IGHE"], "type": "Antibody", "diseases": ["ALLERGY", "ASTHMA", "URTICARIA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "EOSINOPHILIC ESOPHAGITIS", "IMMUNE SYSTEM DISEASE", "OBSTRUCTIVE LUNG DISEASE", "COLORECTAL ADENOCARCINOMA", "SINUSITIS", "ATOPIC ECZEMA", "INFLUENZA INFECTION", "UNIPOLAR DEPRESSION", "BULLOUS PEMPHIGOID"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "URTICARIA", "stage": 2}, {"efo_term": "ATOPIC ECZEMA", "stage": 2}, {"efo_term": "BULLOUS PEMPHIGOID", "stage": 2}, {"efo_term": "ALLERGY", "stage": 1}], "max_phase": 2, "name": "Ligelizumab", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109457", "mechanisms": ["Ig epsilon chain C region inhibitor"], "genes": ["IGHE"], "type": "Antibody", "diseases": ["ASTHMA", "ALLERGY", "URTICARIA", "ATOPIC ECZEMA", "BULLOUS PEMPHIGOID"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "URTICARIA", "stage": 2}, {"efo_term": "ALLERGIC RHINITIS", "stage": 1}], "max_phase": 2, "name": "QUILIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109456", "mechanisms": ["Ig epsilon chain C region inhibitor"], "genes": ["IGHE"], "type": "Antibody", "diseases": ["ASTHMA", "URTICARIA", "ALLERGIC RHINITIS"]}, {"indications": [], "max_phase": 2, "name": "TALIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107888", "mechanisms": ["Ig epsilon chain C region inhibitor"], "genes": ["IGHE"], "type": "Antibody", "diseases": []}, {"indications": [], "max_phase": 2, "name": "AL-901", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109455", "mechanisms": ["Ig epsilon chain C region inhibitor"], "genes": ["IGHE"], "type": "Antibody", "diseases": []}], "heat": 0.3996940549847667, "nodes": [{"assoc": 0.132261519047, "id": "ENSG00000149534", "label": "MS4A2"}, {"assoc": 0.0668206459073, "id": "ENSG00000179639", "label": "FCER1A"}, {"assoc": 1.0, "id": "ENSG00000211891", "label": "IGHE"}], "size": 3}, {"diseases": ["RHEUMATOID ARTHRITIS", "SJOGREN SYNDROME"], "links": [{"source": "ENSG00000157873", "target": "ENSG00000226979", "reverse": "rev-stimulatory"}, {"source": "ENSG00000226979", "target": "ENSG00000227507"}], "drugs": [{"indications": [{"efo_term": "SJOGREN SYNDROME", "stage": 2}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}], "max_phase": 2, "name": "BAMINERCEPT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1742988", "mechanisms": ["Heterotrimeric lymphotoxin LTa1b2 inhibitor"], "genes": ["LTA", "LTB"], "type": "Protein", "diseases": ["SJOGREN SYNDROME", "RHEUMATOID ARTHRITIS"]}, {"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 1}], "max_phase": 2, "name": "PATECLIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743056", "mechanisms": ["TNF-beta inhibitor"], "genes": ["LTA"], "type": "Antibody", "diseases": ["RHEUMATOID ARTHRITIS"]}], "heat": 0.1272451935057, "nodes": [{"assoc": 0.204235555556, "id": "ENSG00000157873", "label": "TNFRSF14"}, {"assoc": 0.118005512494, "id": "ENSG00000226979", "label": "LTA"}, {"assoc": 0.0594945124671, "id": "ENSG00000227507", "label": "LTB"}], "size": 3}, {"diseases": ["TYPE I DIABETES MELLITUS", "CHRONIC PANCREATITIS", "BREAST CARCINOMA", "BULLOUS PEMPHIGOID", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "ASTHMA", "PSORIASIS", "ULCERATIVE COLITIS", "RESPIRATORY SYNCYTIAL VIRUS INFECTION", "VIRAL DISEASE"], "links": [{"source": "ENSG00000163464", "target": "ENSG00000163734", "reverse": "rev-stimulatory"}, {"source": "ENSG00000163464", "type": "directed", "target": "ENSG00000180871"}, {"source": "ENSG00000163734", "type": "stimulatory", "target": "ENSG00000180871"}], "drugs": [{"indications": [{"efo_term": "TYPE I DIABETES MELLITUS", "stage": 3}, {"efo_term": "CHRONIC PANCREATITIS", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 2}], "max_phase": 3, "name": "REPARIXIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL191413", "mechanisms": ["Interleukin-8 receptor A modulator", "Interleukin-8 receptor B modulator"], "genes": ["CXCR1", "CXCR2"], "type": "Small molecule", "diseases": ["TYPE I DIABETES MELLITUS", "CHRONIC PANCREATITIS", "BREAST CARCINOMA"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}, {"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "PSORIASIS", "stage": 2}], "max_phase": 2, "name": "NAVARIXIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL216981", "mechanisms": ["Interleukin-8 receptor B antagonist"], "genes": ["CXCR2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "ASTHMA", "PSORIASIS"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}, {"efo_term": "VIRAL DISEASE", "stage": 2}, {"efo_term": "RESPIRATORY SYNCYTIAL VIRUS INFECTION", "stage": 1}], "max_phase": 2, "name": "DANIRIXIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3039531", "mechanisms": ["Interleukin-8 receptor B antagonist"], "genes": ["CXCR2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "RESPIRATORY SYNCYTIAL VIRUS INFECTION", "VIRAL DISEASE"]}, {"indications": [{"efo_term": "TYPE I DIABETES MELLITUS", "stage": 2}, {"efo_term": "BULLOUS PEMPHIGOID", "stage": 2}], "max_phase": 2, "name": "Ladarixin", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL189475", "mechanisms": ["Interleukin-8 receptor A modulator", "Interleukin-8 receptor B modulator"], "genes": ["CXCR1", "CXCR2"], "type": "Small molecule", "diseases": ["TYPE I DIABETES MELLITUS", "BULLOUS PEMPHIGOID"]}, {"indications": [{"efo_term": "ULCERATIVE COLITIS", "stage": 2}], "max_phase": 2, "name": "ELUBRIXIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2178579", "mechanisms": ["Interleukin-8 receptor B antagonist"], "genes": ["CXCR2"], "type": "Small molecule", "diseases": ["ULCERATIVE COLITIS"]}, {"indications": [], "max_phase": 2, "name": "NAVARIXIN HYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103864", "mechanisms": ["Interleukin-8 receptor A antagonist", "Interleukin-8 receptor B antagonist"], "genes": ["CXCR1", "CXCR2"], "type": "Small molecule", "diseases": []}], "heat": 0.2127058494306667, "nodes": [{"assoc": 0.285402604351, "id": "ENSG00000163464", "label": "CXCR1"}, {"assoc": 0.057362, "id": "ENSG00000163734", "label": "CXCL3"}, {"assoc": 0.295352943941, "id": "ENSG00000180871", "label": "CXCR2"}], "size": 3}, {"diseases": ["CONSTIPATION", "LIVER DISEASE", "DIGESTIVE SYSTEM DISEASE", "POST OPERATIVE NAUSEA AND VOMITING", "ALZHEIMERS DISEASE", "GASTROPARESIS", "GASTROESOPHAGEAL REFLUX DISEASE", "GLAUCOMA", "OPEN-ANGLE GLAUCOMA", "CARDIOVASCULAR DISEASE", "HEMANGIOMA", "OCULAR HYPERTENSION", "SKIN ULCER", "UNIPOLAR DEPRESSION", "ASTHMA", "SMOKING CESSATION", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "CONGESTIVE HEART FAILURE", "GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY", "CONGENITAL MYASTHENIC SYNDROME", "IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION", "MEMORY IMPAIRMENT", "IDIOPATHIC PULMONARY FIBROSIS", "OBSTRUCTIVE LUNG DISEASE", "FAMILIAL DYSAUTONOMIA", "RESPIRATORY FAILURE", "INFLAMMATION", "TYPE II DIABETES MELLITUS", "HYPERTENSION", "CUTANEOUS MELANOMA", "OBESITY", "EMPHYSEMA", "CHRONIC BRONCHITIS", "DRUG DEPENDENCE", "ANTERIOR ISCHEMIC OPTIC NEUROPATHY", "ACUTE RESPIRATORY DISTRESS SYNDROME", "OVARIAN CYST", "DIABETIC FOOT", "HEART FAILURE", "PULMONARY HYPERTENSION", "CANCER", "EPILEPSY", "ATRIAL FIBRILLATION", "POST-TRAUMATIC STRESS DISORDER", "BREAST CARCINOMA", "COCAINE DEPENDENCE", "NICOTINE DEPENDENCE", "PROSTATE CARCINOMA", "NASAL OBSTRUCTION", "SUDDEN CARDIAC ARREST", "BRONCHIOLITIS", "HEMORRHAGE", "SEASONAL ALLERGIC RHINITIS", "ALLERGIC RHINITIS", "URTICARIA", "ANGIOEDEMA", "SINUSITIS", "PREECLAMPSIA", "RENAL INSUFFICIENCY", "HYPOTENSION", "ORTHOSTATIC HYPOTENSION", "FIBROMYALGIA", "CHRONIC KIDNEY DISEASE", "PARKINSON'S DISEASE", "MULTIPLE SYSTEM ATROPHY", "PAIN", "OVERACTIVE BLADDER", "NEUROGENIC BLADDER", "LEFT VENTRICULAR HYPERTROPHY", "CHRONIC INTERSTITIAL CYSTITIS"], "links": [{"source": "ENSG00000164270", "target": "ENSG00000169252"}, {"source": "ENSG00000169252", "target": "ENSG00000188778"}], "drugs": [{"indications": [{"efo_term": "HEART FAILURE", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "CONGESTIVE HEART FAILURE", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 3}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 2}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "EPILEPSY", "stage": 2}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}], "max_phase": 4, "name": "CARVEDILOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL723", "mechanisms": ["Adrenergic receptor beta antagonist"], "genes": ["ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["HEART FAILURE", "HYPERTENSION", "PULMONARY HYPERTENSION", "CANCER", "EPILEPSY", "ATRIAL FIBRILLATION", "CONGESTIVE HEART FAILURE", "POST-TRAUMATIC STRESS DISORDER", "BREAST CARCINOMA", "CARDIOVASCULAR DISEASE", "COCAINE DEPENDENCE", "NICOTINE DEPENDENCE", "PROSTATE CARCINOMA"]}, {"indications": [{"efo_term": "NASAL OBSTRUCTION", "stage": 4}, {"efo_term": "GLAUCOMA", "stage": 4}, {"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "HEMORRHAGE", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "URTICARIA", "stage": 4}, {"efo_term": "SUDDEN CARDIAC ARREST", "stage": 4}, {"efo_term": "ANGIOEDEMA", "stage": 4}, {"efo_term": "SINUSITIS", "stage": 4}, {"efo_term": "ASTHMA", "stage": 3}, {"efo_term": "SUDDEN CARDIAC ARREST", "stage": 3}, {"efo_term": "BRONCHIOLITIS", "stage": 3}], "max_phase": 4, "name": "EPINEPHRINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL679", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["ASTHMA", "NASAL OBSTRUCTION", "SUDDEN CARDIAC ARREST", "BRONCHIOLITIS", "GLAUCOMA", "OBSTRUCTIVE LUNG DISEASE", "HEMORRHAGE", "CARDIOVASCULAR DISEASE", "SEASONAL ALLERGIC RHINITIS", "ALLERGIC RHINITIS", "URTICARIA", "ANGIOEDEMA", "SINUSITIS"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CONGESTIVE HEART FAILURE", "stage": 3}, {"efo_term": "FAMILIAL DYSAUTONOMIA", "stage": 3}, {"efo_term": "IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION", "stage": 2}, {"efo_term": "MEMORY IMPAIRMENT", "stage": 2}, {"efo_term": "RESPIRATORY FAILURE", "stage": 2}, {"efo_term": "GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY", "stage": 1}, {"efo_term": "CONGENITAL MYASTHENIC SYNDROME", "stage": 1}, {"efo_term": "IDIOPATHIC PULMONARY FIBROSIS", "stage": 1}, {"efo_term": "INFLAMMATION", "stage": 1}], "max_phase": 4, "name": "ALBUTEROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL714", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "CONGESTIVE HEART FAILURE", "GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY", "CONGENITAL MYASTHENIC SYNDROME", "IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION", "MEMORY IMPAIRMENT", "IDIOPATHIC PULMONARY FIBROSIS", "OBSTRUCTIVE LUNG DISEASE", "FAMILIAL DYSAUTONOMIA", "RESPIRATORY FAILURE", "INFLAMMATION"]}, {"indications": [{"efo_term": "ORTHOSTATIC HYPOTENSION", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "HYPOTENSION", "stage": 2}, {"efo_term": "FIBROMYALGIA", "stage": 2}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "MULTIPLE SYSTEM ATROPHY", "stage": 2}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 1}], "max_phase": 4, "name": "DROXIDOPA", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103827", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["HYPOTENSION", "ORTHOSTATIC HYPOTENSION", "FIBROMYALGIA", "CARDIOVASCULAR DISEASE", "CHRONIC KIDNEY DISEASE", "PARKINSON'S DISEASE", "MULTIPLE SYSTEM ATROPHY"]}, {"indications": [{"efo_term": "OVERACTIVE BLADDER", "stage": 4}, {"efo_term": "CHRONIC INTERSTITIAL CYSTITIS", "stage": 3}, {"efo_term": "HEART FAILURE", "stage": 2}, {"efo_term": "PAIN", "stage": 2}, {"efo_term": "NEUROGENIC BLADDER", "stage": 2}, {"efo_term": "LEFT VENTRICULAR HYPERTROPHY", "stage": 2}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 4, "name": "MIRABEGRON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2095212", "mechanisms": ["Beta-3 adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": ["HEART FAILURE", "PAIN", "LIVER DISEASE", "OVERACTIVE BLADDER", "NEUROGENIC BLADDER", "LEFT VENTRICULAR HYPERTROPHY", "CHRONIC INTERSTITIAL CYSTITIS"]}, {"indications": [{"efo_term": "GLAUCOMA", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "OCULAR HYPERTENSION", "stage": 4}, {"efo_term": "OPEN-ANGLE GLAUCOMA", "stage": 2}, {"efo_term": "HEMANGIOMA", "stage": 2}, {"efo_term": "SKIN ULCER", "stage": 2}], "max_phase": 4, "name": "TIMOLOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL499", "mechanisms": ["Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["GLAUCOMA", "OPEN-ANGLE GLAUCOMA", "CARDIOVASCULAR DISEASE", "HEMANGIOMA", "OCULAR HYPERTENSION", "SKIN ULCER"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}, {"efo_term": "CHRONIC BRONCHITIS", "stage": 4}, {"efo_term": "OBESITY", "stage": 2}], "max_phase": 4, "name": "SALMETEROL XINAFOATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1082607", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "OBESITY", "EMPHYSEMA", "CHRONIC BRONCHITIS"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "ACUTE RESPIRATORY DISTRESS SYNDROME", "stage": 2}], "max_phase": 4, "name": "ALBUTEROL SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201026", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "ACUTE RESPIRATORY DISTRESS SYNDROME"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "HEMANGIOMA", "stage": 3}, {"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "SMOKING CESSATION", "stage": 2}], "max_phase": 4, "name": "NADOLOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL649", "mechanisms": ["Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CARDIOVASCULAR DISEASE", "SMOKING CESSATION", "HEMANGIOMA"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}, {"efo_term": "CHRONIC BRONCHITIS", "stage": 4}], "max_phase": 4, "name": "VILANTEROL TRIFENATATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1084172", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "EMPHYSEMA", "CHRONIC BRONCHITIS"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}, {"efo_term": "CHRONIC BRONCHITIS", "stage": 4}, {"efo_term": "ASTHMA", "stage": 2}], "max_phase": 4, "name": "INDACATEROL MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789842", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "ASTHMA", "EMPHYSEMA", "CHRONIC BRONCHITIS"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "CUTANEOUS MELANOMA", "stage": 2}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 1}], "max_phase": 4, "name": "PROPRANOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1671", "mechanisms": ["Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["TYPE II DIABETES MELLITUS", "HYPERTENSION", "CUTANEOUS MELANOMA"]}, {"indications": [{"efo_term": "GLAUCOMA", "stage": 3}, {"efo_term": "HEMANGIOMA", "stage": 3}, {"efo_term": "ANTERIOR ISCHEMIC OPTIC NEUROPATHY", "stage": 1}], "max_phase": 4, "name": "TIMOLOL MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200870", "mechanisms": ["Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["GLAUCOMA", "HEMANGIOMA", "ANTERIOR ISCHEMIC OPTIC NEUROPATHY"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "BREAST CARCINOMA", "stage": 2}], "max_phase": 4, "name": "CARVEDILOL PHOSPHATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201167", "mechanisms": ["Adrenergic receptor beta antagonist"], "genes": ["ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["HYPERTENSION", "BREAST CARCINOMA"]}, {"indications": [{"efo_term": "CONSTIPATION", "stage": 3}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 4, "name": "PRUCALOPRIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL117287", "mechanisms": ["Serotonin 4 (5-HT4) receptor agonist"], "genes": ["HTR4"], "type": "Small molecule", "diseases": ["CONSTIPATION", "LIVER DISEASE"]}, {"indications": [{"efo_term": "GASTROPARESIS", "stage": 2}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 1}], "max_phase": 2, "name": "VELUSETRAG", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2087337", "mechanisms": ["Serotonin 4 (5-HT4) receptor agonist"], "genes": ["HTR4"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE", "GASTROPARESIS"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 4, "name": "PINDOLOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL500", "mechanisms": ["Beta-2 adrenergic receptor partial agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["CARDIOVASCULAR DISEASE", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 3}], "max_phase": 4, "name": "TERBUTALINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1160544", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "DRUG DEPENDENCE", "stage": 2}], "max_phase": 4, "name": "METAPROTERENOL SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200812", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "DRUG DEPENDENCE"]}, {"indications": [{"efo_term": "OVARIAN CYST", "stage": 1}, {"efo_term": "DIABETIC FOOT", "stage": 1}], "max_phase": 4, "name": "ESMOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201115", "mechanisms": ["Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["OVARIAN CYST", "DIABETIC FOOT"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}], "max_phase": 4, "name": "ARFORMOTEROL TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1951071", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "EMPHYSEMA"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}], "max_phase": 4, "name": "OLODATEROL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105743", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "EMPHYSEMA"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 1}], "max_phase": 2, "name": "BEDORADRINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2218893", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "ASTHMA"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}], "max_phase": 4, "name": "FORMOTEROL FUMARATE DIHYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2303638", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}], "max_phase": 2, "name": "ABEDITEROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3039530", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}], "max_phase": 2, "name": "AZD3199", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545103", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "DIGESTIVE SYSTEM DISEASE", "stage": 4}], "max_phase": 4, "name": "CISAPRIDE MONOHYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200788", "mechanisms": ["Serotonin 4 (5-HT4) receptor agonist"], "genes": ["HTR4"], "type": "Small molecule", "diseases": ["DIGESTIVE SYSTEM DISEASE"]}, {"indications": [{"efo_term": "POST OPERATIVE NAUSEA AND VOMITING", "stage": 4}], "max_phase": 4, "name": "METOCLOPRAMIDE HYDROCHLORIDE HYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200940", "mechanisms": ["Serotonin 4 (5-HT4) receptor agonist"], "genes": ["HTR4"], "type": "Small molecule", "diseases": ["POST OPERATIVE NAUSEA AND VOMITING"]}, {"indications": [{"efo_term": "CONSTIPATION", "stage": 2}], "max_phase": 2, "name": "NARONAPRIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103858", "mechanisms": ["Serotonin 4 (5-HT4) receptor agonist"], "genes": ["HTR4"], "type": "Small molecule", "diseases": ["CONSTIPATION"]}, {"indications": [{"efo_term": "GASTROESOPHAGEAL REFLUX DISEASE", "stage": 2}], "max_phase": 2, "name": "Revexepride", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545035", "mechanisms": ["Serotonin 4 (5-HT4) receptor agonist"], "genes": ["HTR4"], "type": "Small molecule", "diseases": ["GASTROESOPHAGEAL REFLUX DISEASE"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}], "max_phase": 2, "name": "CARMOTEROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1094785", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}], "max_phase": 4, "name": "PIRBUTEROL ACETATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200444", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}], "max_phase": 4, "name": "NEBIVOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201731", "mechanisms": ["Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["HYPERTENSION"]}, {"indications": [{"efo_term": "OBESITY", "stage": 2}], "max_phase": 2, "name": "LY377604", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2012520", "mechanisms": ["Beta-2 adrenergic receptor antagonist", "Beta-3 adrenergic receptor agonist"], "genes": ["ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["OBESITY"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 3}], "max_phase": 4, "name": "LEVALBUTEROL TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062258", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}], "max_phase": 2, "name": "BATEFENTEROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3039518", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}], "max_phase": 4, "name": "ISOPROTERENOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1711", "mechanisms": ["Adrenergic receptor beta agonist"], "genes": ["ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["ASTHMA"]}, {"indications": [{"efo_term": "OPEN-ANGLE GLAUCOMA", "stage": 4}], "max_phase": 4, "name": "CARTEOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201002", "mechanisms": ["Adrenergic receptor beta antagonist"], "genes": ["ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["OPEN-ANGLE GLAUCOMA"]}, {"indications": [{"efo_term": "PREECLAMPSIA", "stage": 2}], "max_phase": 4, "name": "LABETALOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200323", "mechanisms": ["Adrenergic receptor antagonist"], "genes": ["ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["PREECLAMPSIA"]}, {"indications": [{"efo_term": "RENAL INSUFFICIENCY", "stage": 0}], "max_phase": 4, "name": "NORADRENALINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1356607", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["RENAL INSUFFICIENCY"]}, {"indications": [{"efo_term": "NEUROGENIC BLADDER", "stage": 1}], "max_phase": 3, "name": "RITOBEGRON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107773", "mechanisms": ["Beta-3 adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": ["NEUROGENIC BLADDER"]}, {"indications": [{"efo_term": "OVERACTIVE BLADDER", "stage": 2}], "max_phase": 2, "name": "VIBEGRON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107826", "mechanisms": ["Beta-3 adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": ["OVERACTIVE BLADDER"]}, {"indications": [], "max_phase": 4, "name": "TEGASEROD MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1516474", "mechanisms": ["Serotonin 4 (5-HT4) receptor partial agonist"], "genes": ["HTR4"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "Capeserod", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2027925", "mechanisms": ["Serotonin 4 (5-HT4) receptor partial agonist"], "genes": ["HTR4"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "SOTALOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1700", "mechanisms": ["Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PENBUTOLOL SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200363", "mechanisms": ["Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BITOLTEROL MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200405", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DOBUTAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200418", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "OXPRENOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200745", "mechanisms": ["Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROTOKYLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200893", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ISOETHARINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200920", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METIPRANOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200947", "mechanisms": ["Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LEVALBUTEROL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201061", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROPAFENONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201063", "mechanisms": ["Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ISOETHARINE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201153", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "RITODRINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201160", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LEVOBUNOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201177", "mechanisms": ["Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "MILVETEROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1940832", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "GSK159802", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545087", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "LAS190792", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545272", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ISOPROTERENOL SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200447", "mechanisms": ["Adrenergic receptor beta agonist"], "genes": ["ADRB2", "ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HYDROXYAMPHETAMINE HYDROBROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200705", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB2", "ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIPIVEFRIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200833", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB2", "ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MEPHENTERMINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200996", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB2", "ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "EPINEPHRINE BITARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256958", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB2", "ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "RAFABEGRON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL279260", "mechanisms": ["Beta-3 adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "SOLABEGRON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL208427", "mechanisms": ["Beta-3 adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "AMIBEGRON HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL545437", "mechanisms": ["Beta-3 adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": []}], "heat": 0.6877835000000001, "nodes": [{"assoc": 0.0633505, "id": "ENSG00000164270", "label": "HTR4"}, {"assoc": 1.0, "id": "ENSG00000169252", "label": "ADRB2"}, {"assoc": 1.0, "id": "ENSG00000188778", "label": "ADRB3"}], "size": 3}, {"diseases": [], "links": [{"source": "ENSG00000167711", "target": "ENSG00000197766"}, {"source": "ENSG00000167711", "target": "ENSG00000240247"}], "drugs": [], "heat": 0.14240062280003332, "nodes": [{"assoc": 0.168323419501, "id": "ENSG00000167711", "label": "SERPINF2"}, {"assoc": 0.162637263889, "id": "ENSG00000197766", "label": "CFD"}, {"assoc": 0.0962411850101, "id": "ENSG00000240247", "label": "DEFA1B"}], "size": 3}], "auto_delta": "0.00387173"}